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ABSTRACT 
A large number of micro-organisms were cultured from marine substrates collected 
from multiple sites along the coast of the South Island of New Zealand. Depending on 
growth rate and colony morphology the micro-organisms were classified as terrestrial, 
facultative marine or obligate marine. Micro-organisms were selected for large scale 
culture and extraction based on either apparent unusual morphology or observed 
cytotoxicity in small scale extracts. 
Two very pale yellow compounds were isolated from cytotoxic extracts prepared from 
culture broths of a Fusarium sp. The first compound (A) was identified as a novel 
trichothecene called 4-deacetoxy-8-isobutyrylneosolaniol. The second compound (B) 
was identified as the 4-hydroxy derivative of A, previously only known through semi-
synthetic preparation. 
The known compound cepha1ochromin (C) was purified from the culture broths of two 
unidentified Cephalosporium-like Hyphomycetes. The identity with cephalochromin 
was confirmed by comparison of published NMR and circular dichroism spectroscopy. 
An intense yellow compound was isolated from an extract prepared from culture broths 
of an Alternaria sp. This compound was identified by NMR spectroscopy as a novel 
altersolanol called altersolano1 J (D). 
The known compound I-hydroxyaclacinomycin T (E) was isolated from the culture 
broths of a Streptomyces sp. A further five related compounds (F - J) were also isolated 
the culture broths. Compounds F and G, were shown by NMR spectroscopy to be 
stereo isomers of pyrromycin called 9-epi-pyrromycin and (7R*9R*10R*)-pyrromycin 
respectively. The low isolated mass of compound H prevented a complete 
identification but was tentatively assigned by NMR spectroscopy as an N-demethyl 
derivative of pyrromycin. Compounds 1 and J were both shown by NMR spectroscopy 
to be novel pyrromycin derivatives called 1-hydroxyauramycin T and 1-
hydroxysulfurmycin T respectively. 
The known compounds actinomycin V (K), actinomycin Xo (L) and actinomycin D (M) 
were purified from extracts of the culture broths of three Streptomyces sp. 
ii 
The identities of all these compounds were established by ID and 2D NMR 
spectroscopy and comparison to previously reported data. 
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Chapter 1 ~ futroduction 
CHAPTER ONE 
JNTRODUCT10N 
1.1 Natural products 
Until the late 19th Centmy the major source of drugs was from terrestrial plants. After 
the discovery of penicillin (1) in the early 1900's however, interest was directed towards 
bioactive secondary metabolites from terrestrial micro-organisms. Extensive studies 
were carried out and these yielded a dazzling array of bioactive metabolites. Since the 
early 1940's over 5,000 antibiotic agents have been identified, primarily from 
actinomycetes. Antibiotic production by fungi is second only to the actinomycetes with 
approximately 1,600 compounds characterisedPl Of the top ten commercially used 
antibiotics or antibiotic classes isolated from fungi, the penicillins such as penicillin G 
(1), the cephalosporins such as cephalosporin C (2), griseofulvin (3) and fusidic acid (4) 
have been the most important. 
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1.2 A brief history of bioactive compounds 
Fewer than 10% of the total terrestrial organisms have been examined for biologically 
active compounds. [2] Fungi comprise a large number of those terrestrial organisms that 
have been examinedY] Including undescribed species the number of fungi are 
estimated to be in excess of 1.5 millionp] but only a fraction of these, approximately 5 
%/1] have been described, let alone examined in the full range of possible assays for 
biological activity. 
Most bioactive compounds produced in nature are typically secondary metabolites 
which are not essential for the growth of an organism, but have been shown to confer 
selective advantages to the organism, such as antifeeding. [4,5] Perhaps the most famous 
class of these secondary metabolites would be the penicillins which inhibited the 
growth of other micro-organisms, but had no effect on the fungus producing it. 
Other well known fungal compounds used in medicine are cyclosporin A and the 
cholesterol biosynthesis inhibitors, the statins. Cyclosporin A (5) was initially 
discovered as an antifungal agent from Tolypocladium inflatum. [6] Further work 
however, found it to possess excellent immunosuppressant activityY] The cholesterol-
lowering agent mevastatin (6) was originally isolated from Penicillium citrinum in 
1976JS] The statins are perhaps one of the most important classes of compounds to 
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enter the pharmaceutical market within the last 20 years with over US$ 7.52 billion 
dollars per year generated from sales in 1997. Indeed one of this group, simvastatin 
was the second highest selling drug world-wide that year. [9] 
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Even some fungal metabolites that have been known for a long time are finding new 
uses in medicine today. Mycophenolic acid (7), a highly toxic metabolite from various 
species of Penicillium, originally discovered in 1896 with the structure reported in 
1952YO] was recently found to have immunosuppressant activityJll] The mycophenolic 
acid (7) pro drug , Mofetil (8), is broken down in the body to release mycophenolic acid, 
which subsequently inhibits proliferation of cells involved in the immune response. [7] 
This compound has also recently been isolated from several species of fungi in the 
Marine Chemistry Group at the University of Canterbury. 
OH 
o 
Of all the compounds with biological activity isolated to date, terrestrial organisms have 
been the most common source. Unfortunately, the yield of potentially useful new 
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compounds from terrestrial organisms has been in decline for some time, due mostly to 
the rediscovery of known compounds. However, the need for new bioactive compounds 
is not declining, but rather is still increasing. This is not only because new diseases are 
still being discovered, but also because existing disease-causing agents can easily 
mutate into strains resistant to the array of pharmaceuticals in use today. 
Within the last 30 years the focus has turned towards the marine environment. This is 
because it covers over 70 % of the Earth's surface and is over 95 % of the earth's 
biosphere[12] with diverse habitats ranging from hot tropical environments to cold polar 
ones. Some of these habitats, such as tropical coral reefs, display extreme biodiversity 
(high abundance of different anima.1 and plant species). 
Nearly all forms of marine life have been examined with sponges topping the list of 
those investigated. Compounds isolated from the marine environment are extremely 
diverse in their chemistry, with a higher percentage of halogenated compounds being 
found, [13] such as agelongine (9) from the marine sponge Agelas longissimaY4] due in 
part to the higher natural abundance of halogens in seawater. 
Br ~O~NUCOO-
Hoi 9 #' 
Most of these natural products have been implicated either in chemical defence or 
competition. 
1.3 Biodiversity in the marine environment 
The number of marine animal and micro-organism species is estimated to be in excess 
of 2 million and constitutes a greater diversity at higher taxonomic levels than seen in 
terrestrial ecosystemsY2] Since the early .1970' s a vast succession of novel metabolites 
has been isolated from marine animals, yet less than 0.5 % have actually been screened 
for antineoplastic activity and even fewer have been examined for activity against 
infectious diseases.[I2] 
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Table 1.1 shows some novel metabolites reported from the marine environment between 
1970 and 2000. As can be seen, there are a larger number of sponge metabolites being 
found, however this is most likely because the Porifera has been one of the more 
intensely investigated phyla. 
Newly Reported Metabolites from Marine Organisms 
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Table 1.1: Newly reported metabolites from various marine phyla. 
Adapted from Urban et al. i15 ] 
Table 1.2 shows the number of compounds isolated from marine phyla over the last 30 
years. From 1970 to 1991 the number of natural products being isolated from marine 
organisms steadily increased from just 17 in 1970 to over 600 in 1991. Since 1991 an 
average of over 650 new metabolites have been discovered each year. 
III 
Novel Marine Compounds Discovered per Year 
From 1970 to 2000 
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Table 1.2: The number of novel compounds from marine phyla reported each year. 
Adapted from Blunt et a1Y6] 
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1.3.1 Natural products from the marine environment 
Compounds isolated from marine animals have displayed a wide range of biological 
activities, such as antimicrobial and anticancer activity. By 2001 over 12,000 marine 
natural products had been isolated from a wide variety of organisms, several of these 
exhibiting potent biological activity. [16J 
The production of bioactive secondary metabolites from marine macroorganisms is well 
documented with new compounds constantly being discovered. [17, 18] Table 1.3 shows 
some novel compounds isolated from marine macro organisms. 
Source Organism Metabolites Identij"l£d Activity 
Ecteinascidia turbinata Ecteinascidin 743 (10)[19] Cytotoxic 
Conus magus O)-conotoxin MVIIA (11)[20] Analgesic 
- ......... __ .. 
Lobatamide A (12)[21] 
Lobatamide B (13) 
Aplidium lobatum Lobatamide C (14) 
Cytotoxic 
(Australian tunicate) Lobatamide D (15) 
Lobatamide E (16) 
Lobatamide F (17) 
Elisabethin A (18)[22) 
Pseudopterogorgia elisabethae Elisabethin B (19) Antitumour 
(West-Indian sea whip) Elisabethin C (20) Anti tuberculosis 
Elisabanolide (21) Anti tuberculosis 
Sigmosceptrelfa sp 
Sigmosceptrin A (22)[23] 
Sigmosceptrin B (23) Not tested 
(Marine sponge) 
Sigmosceptrin C (24) 
Cytoseira tamariscifolia 
Methoxybifurcarenone (25)[24) Antimicrobial 
(Brown alga) 
Table 1.3: Some bioactive metabolites isolated from marine macro organisms 
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The letters in structure n refer to the single letter abbreviations commonly used to 
illustrate the 20 amino acids most frequently found in nature. [25J 
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Although all these compounds show potent biological activity of some kind, to date 
only ecteinascidin 743 and ID-conotoxin MVIIA have progressed to clinical trials, with 
ecteinascidin 743 expected to enter phase III trials in 2002.[26] 
Ziconotide (11) (ID-conotoxin MVIIA), a peptide toxin isolated from various species of 
cone snail, is very good at alleviating intractable pain and, unlike regular painkillers 
such as morphine, is not addictive, and is expected to be approved for use as a 
painkiller in early 2002. [27] 
Even though marine organisms are known to produce some of the most toxic 
compounds so far discovered, [28] the supply of the metabolite of interest from these 
organisms is often limited. This led to the hypothesis that some of the biologically 
active components of marine organisms could actually have been derived from 
symbiotic micro-organisms. As a result of this, attention has been directed towards both 
free living and symbiotic marine micro-organisms, both of which have previously 
shown good potential as a source of novel metabolites. 
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1.4 Marine micro-organisms - An overview 
It has been estimated that over 99 % of symbiotic manne micro-organisms are 
unculturab1e' with current techniques. [29] Techniques developed to help find the 
'uncu1turab1e' micro-organisms include 16s rRNA work on microbial po1yketide 
synthases.[30] One major problem associated with isolating microbial symbionts from 
their hosts, is that there may be metabolite flow between the host and symbiont, and 
disrupting this flow may cause the production of unusual secondary metabolites to cease 
unless nutritive media similar to those found in the host organism's cells is used. 
One of the first reported cases of production of a natural product by a symbiont was of 
tetrodotoxin (26). This compound, originally isolated from many different organisms, 
was later found to be produced by a marine bacterium. The paralytic shellfish toxin, 
saxitoxin (27), was found to be produced by dinoflagellates from the genus Gonyaulax, 
and okadaic acid (28) originally isolated from the sponge Halichondria okadai, has 
since been found in the dinoflagellate Prorocentrum limaY 1] 
OH 
o 
28 
Similarities between compounds isolated from terrestrial micro-organisms and some 
sponge metabolites have also been observed. The sponge Discodermia dissoluta 
produces discodermide (29), of which the photo degradation product (30) is very similar 
in structure to alteramide (31), produced by a marine Alteromonas bacterium, and 
ikarngamycin (32), a metabolite from a species of terrestrial StreptomyceteY1J 
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1.5 Marine fungi - A brief history 
Early investigations into the marine environment found only a few species of marine 
fungi. Up until the late 18th Century numerous authors had noted the presence of 
threads or filaments present in marine invertebrates, but none of these structures were 
considered to be fungal hyphae. [32] This was because seawater was generally 
considered to be a fungistatic medium. In fact, investigations of fresh seawater found 
an unknown mycostatic agent present which prevented terrestrial spores from 
germinating, but not marine spores, and was destroyed during heat sterilisation. [33] 
Since the early investigations into the marine environment many marine fungi have 
been isolated, such as the ascomycete Sphaeria posidoniae (Halotthia posidoniae)Y4] 
Up until the mid 1940's only a few marine fungi had been discovered every decade, 
such as those found by Fischer and Sp arrow Y 5, 36] In 1944, a paper on marine fungi by 
Linder and Barghoom[37] stimulated a great deal of interest in marine fungi resulting in 
increased numbers of marine fungi being isolated. However, even when fungi were 
isolated from the marine environment it was observed that most were common species 
of terrestrial fungi, most being various species of Penicillium and Aspergillus.[38] Later 
H 
OH 
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reports show that marine fungi are generally distributed across all major mycological 
genera. [39] This leads to the question "what is a marine fungus?" 
1.5.1 What is a marine fungus? 
Many different theories have been put forward to explain or classify exactly what is a 
marine fungus. The definition of marine fungi has been examined from many different 
perspectives, such as physiological and ecological. Answers to this question range from 
the suggestion that fungi could not occur in seawater due to a lack of dissolved 
oxygen, [40] to those that said a true marine fungus grows and sporulates exclusively in 
the marine environment. [41] 
Initial attempts to define marine fungi introduced the term 'thalassiomycetes', meaning 
'fungi of the sea'J42j Thalassiomycetes were defined as fungi of any class isolated from 
the marine environment, however this did not take into account those fungi that could 
have been washed into the ocean, via rivers, rainfall or land run-off and simply be 
existing as hardy, resistant spores until conditions become favourable for growth again. 
Nor does it account for those fungi originally from a terrestrial environment that have 
managed to adapt, if only slightly, to the high saline marine environment, and as a result 
the term thalassiomycete has fallen into disfavour. 
In 1960 Ritchie[43] proposed that "".a fungus is considered marine ifit is obtained from 
marine or brackish water and it can grow on media containing 35 %0 (parts per 
thousand) of such salts as occur in ocean water." In 1961 this definition was expanded 
to include those fungi that had been exposed either continually or intermittently to 
seawater, but were still able to sporulate after exposure.[32] The effect of salinity on 
fungal growth has been considered by many groups, [44] and it was later found that most 
terrestrial fungi are much less tolerant of variations in salinity than their marine 
counterpartsJ45] Wood[46] suggested that a requirement for ions present only in seawater 
may also help to establish if the fungus in question is marine or terrestriaL 
Jones argued that repeated isolation of any given fungal species from the marine 
environment was a good indicator that the fungus was of marine origin. [47] Pugh further 
suggested that the pattern of physiological behaviour of the fungus in varying 
concentrations of sea water, such as growth and morphological changes, could also be 
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used for classification)48] It was found that marine fungi developed better in seawater 
media than on media prepared with distilled water[49] and Ravishankar et at showed that 
enzyme activity in the marine fungus Cirrenalia pygmea increased with salinities close 
to that found in natural seawater. [50] Some marine fungi have also been shown to 
produce a nitrate reductase, a capability not detected in terrestrial fungi. [51] 
Further suggestions proposed include that resistance to lysis by marine microflora, [52] or 
characteristically high moisture requirementsp3] might both be an indicator of obligate 
marine fungi. 
Kohlmeyer and Kohlmeyer[54] considered fungi to be marine if they grew and sporulated 
in a marine environment, then further divided the marine fungi into two distinct groups, 
obligate and facultative. Obligate marine fungi were those only found in the marine 
environment and facultative marine fungi were those found in both terrestrial and 
marine habitats, but they maintained that a fungus was only marine if the development 
and reproduction took place in seawater. 
By 1979 this definition· was modified slightly[55] to take into account Kirk' S[56] 
postulation that restricting the definition of a marine fungus to those that only grow and 
sporulate in the marine environment would exclude those facultative species that might 
grow well, but not sporulate in the marine environment. It read as follows, "Obligate 
marine fungi are those that grow or sporulate exclusively in a marine or estuarine 
habitat, whereas the facultative marine fungi originate from freshwater or terrestrial 
environments and are able to grow in saltwater". 
At present there are 444 species of marine fungi known, with numerous more species 
awaiting description. [57] Early estimates put the total number of marine fungi at 6,000 
species or more,[55] however the latest estimates have been downscaled to 1,500 
speciesp6] To date, most of the obligate marine fungi isolated belong to the more 
evolved groups such as Ascomycotina, whereas filamentous fungi with flagellated 
spores, ideal for preventing sedimentation in the water column, represent less than 15% 
of the total strains currently isolated. However, this could be the result of selective 
searching, specifically looking for the more evolved fungi, such as those that produce 
macroscopic structures, or by using selective isolation techniques. 
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1.5.2 Morphology of marine fungi 
Many fungi exhibit a distinct morphology having specifically adapted to their 
environment. Fungi found in the marine environment are typically microscopic, 
existing as single cells or short hyphal filaments. The fruiting bodies of these fungi are 
of necessity very small, with the largest of these no more than 4 mm in diameter. 
Marine fungi do not develop larger fruiting bodies, unlike terrestrial fungi, as they are 
exposed to constant movement and abrasion by water and suspended particles, like 
sand. Those fungi that do sporulate in the marine habitat typically only do so III 
sheltered areas such as cracks in wood, or rocks, or other sheltered areasp5] 
1.5.3 Natural products from marine fungi 
Most research on marine micro-organisms has targeted marine bacteriaps, 59] however 
recent studies have begun to examine fungi isolated from the marine environment. [60-63] 
These studies indicate that marine fungi are an excellent source of bioactive secondary 
metabolites. 
Marine fungi represent a large amount of biomass in the marine environment. They 
typically live on high energy substrates, and contribute significantly to biological 
turnover. Because marine fungi are in a highly competitive environment and have no 
physical means of defence, it was theorised that they might produce a plethora of new 
and potentially useful compoundsJ64] 
The number of metabolites isolated from marine fungi to date is small in comparison to 
those from other marine organismsY6] Compounds isolated from marine fungi are 
predominantly antimicrobial or cytotoxic, which is not surprising considering most 
isolation work done on marine fungi is through bioassay guided fractionation. The first 
compound isolated from a marine fungus was cephalosporin C (2),[65] and this is the 
only compound at this stage that has been used as a pharmaceutical. It was not until 
about 40 years later that the first novel compound, leptosphaerin (33), was isolated from 
a marine fungus.[66] 
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Terrestrial bacteria and fungi are the prime sources of bioactive compounds used in 
medicine today. Similar roles were expected from their marine counterparts, which has 
since been proved many times. 
A strain of Aspergillus jumigatus, cultured from the intestinal tract of the saltwater fish 
Pseudolabrus japonicus produced two compounds, fumiquinazolines A (34) and B (35), 
with moderate cytotoxic activity against the P388 murine leukaemia cellline.[3l] 
HN5Y?8P' 
N ~ 
o 
H 0 
HNXr?8P'1 
N ~ 
o 
H 0 
34 35 
An extremely diverse range of compounds have been isolated from fungi cultured from 
the marine envirorunent. Table 1.4 shows some compounds recently isolated from 
marine fungi. 
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Source Organism Metabolites Isolated Activity 
Halymecin A (36)[67] 
Fusarium sp Halymecin B (37) Antimicroalgal 
Halymecin C (38) 
ACl'emonium sp 
Halymecin D (39)[67] 
Antimicroalgal 
Halymecin E (40) 
Aspergillus insulicola Insulicolide A (41)[68] Antitumour 
},1icmascus longirostris Cathestatin C (42)[69] Cysteine Protease Inhibitor 
Kallichroma tethys Isoculmorin (43i7O] Antitumour 
Penicillium sp NIl550lA (44i71 ] Antimicrobial 
Scytalidium sp 
Exumolide A (45)[72] 
Antimicroalgal 
Exumolide B (46) 
Aspergillus niger Asperazine (47i73 ] Cytotoxic 
_ ....... 
Ascosalipyrrolidinone A (48)[74] 
Ascochyta salicorniae Antimicrobial 
Ascosalipyrrolidinone B (49) 
Gymnastatin A (50)175] 
Gymnasella dankaliensis Gymnastatin B(51) Cytotoxic 
Gymnastatin C(52) 
Phomopsis sp 
Phomopsidin (53)176] Microtubule Assembly 
MK8383 (54) Inhibitor 
Iso-cladospolide B (55)177] 
Unidentified fungus 
Seco-patulolide C (56) 
Pandangolidc 1 (57) Not Tested 
Pandangolide 2 (58) 
Neomangicol A (59)[78] Cytotoxic 
Fusarium sp Neomangicol B (60) Antibacterial 
Neomangicol C (61) Cytotoxic 
Fusarium sp Sansalvamide (62)[79J Cytotoxic 
Trichoderma Epoxysorbicillinol (63)[80] Cytotoxic longibrachiatum 
Aspergillus sp 
Aspergillamide A (64)[81J 
Cytotoxic 
Aspergillamide B (65) 
Emericella unguis Guisinol (66)[82] Antibacterial 
Table 1.4: Metabolites recently isolated from marine fungi 
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Similarities can be seen between some of these marine metabolites and other 
metabolites from various terrestrial micro-organisms, such as pandangolide 1 (57), 
isolated from a species of marine fungus, and the known terrestrial metabolite 
cladospolide B (67),[77] 
Terrestrial fungi have been shown to produce a wide variety of interesting compounds 
with an extremely diverse range of bioactivities, Many of these compounds are either in 
use as pharmaceuticals, have been in use in the past, or were 'lead' compounds for those 
that are, 
Both novel marine compounds and compounds previously isolated from terrestrial fungi 
have been found in marine fungi, [83] suggesting some similarities between their 
respective biochemical pathways, Marine fungi are believed to have evolved from 
terrestrial fungi, [43,51] however they have evolved in a much more stressful environment 
which may have led to significant variations in the biochemical pathways, enabling 
unusual modifications to terrestrial fungal metabolites, 
In addition to filamentous fungi a large number of yeasts are found in the marine 
environment. Even though the number of yeasts isolated is much higher than 
filamentous fungi the number of novel biologically active compounds isolated from 
these yeasts is extremely low, 
Chapter 1 - Introduction 19 
1.6 Aims of this research 
Terrestrial organisms have long been a rich source ofbioactive metabolites. Organisms 
from the marine environment have also yielded a number of bioactive metabolites. 
Even though a large number of bioactive metabolites have been isolated from marine 
organisms, when compared with those from terrestrial organisms, only a few are close 
to clinical use. Indeed one of these, Ziconotide (11) is expected to be approved for use 
in 2002.[27] Most of the marine organisms investigated for biological activity are macro-
organisms, such as sponges. Until recently little attention had been paid to compounds 
produced by marine fungi which therefore make the marine fungi an excellent target for 
chemical investigation. 
One of the primary aims of this study was to isolate a number of fungi from marine 
substrates collected from various sites around the South Island of New Zealand. This 
involved the isolation, culture and tentative identification of isolates. 
Fungi and actinomycetes for chemical characterization would be selected initially on 
morphology and cultural characteristics, and later on those cultures whose extracts 
showed cytotoxicity in the rnicroassay (Section 2.3). Once purified the structural 
elucidation of any components would be undertaken using a variety of spectroscopic 
techniques such as NMR spectroscopy and mass spectrometry. 
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CHAPTER Two 
]SOLA TION, 5CKEENING AND 
DEKEFLICATION 
2.1 Introduction 
There are two main methods for isolating fungi and actinomycetes from the marine 
environment. The first is through direct examination of marine material for microbial 
structures and the second is by indirect examination, incubating material in the 
laboratory. The former method is preferable as it indicates that the micro-organism is 
active in the marine environment and can therefore be considered marine. The indirect 
method was used since few microbial structures were observed on any of the marine 
substrates that were collected at any ofthe sites investigated. 
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Microbial cultures were initially selected for chemical examination based on apparent 
uncommon morphology, but as the number of cultures being isolated increased the 
feasibility of this method decreased significantly. As a result a small scale culturing 
system was developed to enable rapid identification of those micro-organisms 
possessing some cytotoxicity in their extracts (Section 2.3). 
A database containing details on the various microbial isolates, including pictures of the 
individual micro-organisms was also created (Section 2.3.2). 
2.2 Origin of macro-algal and driftwood substrates 
All micro-organisms investigated in this study were isolated from macro-algae or 
driftwood. Macro-algal samples were collected from the intertidal zone of several sites 
on the east coast of the South Island of New Zealand between Kaikoura and Dunedin 
(Kaikoura, Lyttelton, Taylors Mistake, Moeraki and Macrocarpa Point). Driftwood and 
the remaining macro-algal samples were collected from a number of locations between 
Hokitika and Haast on the Westcoast of the South Island of New Zealand, (Hokitika 
River mouth, Tauronga Bay, Fox River, Punakaiki, Grey River, Cook Beach, Okarito, 
Ship Creek, Jackson Bay, Waiho River mouth, Okuru Beach, Whakapohai River, Bruce 
Bay, Hunts Beach, GiJ1espies Beach and Haast Spit). 
All macro-algal samples were stored in seawater at 4°C and plated out within four days 
of collection. Driftwood samples were stored in sterile plastic bags and examined 
within seven days of collection. 
2.2.1 Taxonomy of macro-algae 
Voucher samples of the macro-algae were created to aid in identification. Voucher 
specimens of the filamentous or thin macro-algae were made by pressing in a plant 
press as described in Seaweeds of New Zealand.[84] 
Thick or woody macro-algae were initially washed with distilled water to remove 
excess salt and then dried with blotting paper. Once dry the macro-algae were freeze 
dried then placed in a sealed container with desiccant. After the voucher specimens 
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were created the macro-algae were identified using Seaweeds of New Zealand as a 
guide. [84] Any macro-algae for which the identity was ambiguous or unknown were 
identified by Dr Murray Parsons at Landcare Research, Lincoln, New Zealand. 
2.2.2 Classification of micro-organisms 
Isolated micro-organisms were classified as terrestrial, facultative marine or obligate 
marine based on an arbitrary system dependent on their growth on two media. The first 
medium was prepared with seawater and the second prepared with distilled water. A 
precise designation of obligate marine fungi is difficult to give, but for the purpose of 
this research those that grew exclusively on seawater media were considered obligate. 
Those growing preferentially in seawater media, but also in distilled water media were 
considered facultative and those growing preferentially on distilled water media were 
considered terrestrial. 
Approximately 1400 microbial strains were isolated which included 167 obligate 
marine, 591 facultative marine and 241 terrestrial micro-organisms, most of which were 
filamentous fungi. A further 401 isolates with no obvious preference for seawater or 
freshwater media were also isolated. Of the total microbial strains isolated about 50 % 
showed morphologies similar to each other which indicated repeat isolations of the 
same micro-organisms. 
2.2.3 Database 
Each micro-organism was given a unique identification number. This number consisted 
of a three letter acronym derived from the name of the collection site (e.g. Fox - Fox 
River), a number for the substrate (1-50) followed by a number for the collection from 
that site (1-3) and finally a number for the microbial culture isolated from the particular 
substrate. An extensive interactive database was constructed using Microsoft® Access 
and lists details about the micro-organisms isolated in the first round of collections. 
Together with details about growth rate and fungal type the database also contains 
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photographs showing the crude colony characteristics of each fungal isolate. This 
database is searchable and able to be easily updated (see include compact disc). 
2.3 Microassay screening 
Since the number of micro-organisms isolated was extremely high a rapid, miniaturised 
method for assessment of biological activity was developed. To this end micro-
organisms were cultured in 1 mL of appropriate broth in 24-well micro titre plates. 
Incubation time was arbitrarily determined based on the growth rate of the microbes on 
solid agar plates as shown in Table 2.1. 
Growth rate on agar Incubation time 
4 em I week 14 days 
3 em I week 17 days 
2 em I week 21 days 
1 em I week 24 days 
0.5 em I week 30 days 
< 0.5 em I week 40 days 
Table 2.1: Micro-organism growth rate vs. microassay incubation time. 
After the appropriate incubation period had elapsed the cultures were homogenized with 
an Ultra-Turrax® (Janke & Kunkle) in situ and extracted overnight with an equal 
volume of EtOAc. The resulting EtOAc extract was then assayed for cytotoxicity with 
a single point assay against the P388 murine leukemia cancer cel11ine. Table 2.2 shows 
microbial extracts displaying significant cytotoxicity in this assay. 
This method may not detect all potentially cytotoxic micro-organisms, but did provide 
valuable insights as to which micro-organisms should be further investigated. 
2.3. 1 Results 
Of the approximately 800 isolates examined in the microassay almost ten percent (75 
isolates) showed significant cytotoxicity against the P388 cell line (> 90 % cell 
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inhibition compared to the cell control). A further twenty percent showed mild 
cytotoxicity with> 50 % cell inhibition. 
Microbial Cell inhibition Microbial Cell inhibition I Microbial Cell inhibition 
isolate (% of control) isolate (% of control) isolate (% of control) 
Bru 1-1-2 89.3 Fox 18-2-19 95.8 I Kai 25-2-1 88.9 
Bm 11-1-2 95.2 Fox 22-2-3 100 Kai 32-2-1 95.9 
Coo 1-1-3 94.4 Fox 23-2-4 88.1 Kai 33-2-1 95.6 
Coo 6-1-1 95.1 Fox 23-2-6 100 Kai 38-2-5 100 
Fox 2-2-8 100 Fox 27-2-16 94.7 Kai 41-2-1 94.5 
Fox 4-2-10 100 Fox 29-2-1 95.2 Kai 41-2-3 100 
Fox 4-2-13 94.5 Fox 29-2-5 94.8 Kai 51-2-1 100 
Fox 4-2-14 88.1 Fox 29-2-7 100 Kai 51-2-2 100 
Fox 4-2-15 94.8 Fox 34-3-34 100 Kai 58-2-1 100 
Fox 4-2-21 96.8 Fox 35-2-5 91.6 Kai 58-2-2 97.2 
Fox 4-2-23 95.5 Fox 37-2-2 100 Kai 65-2-1 100 
Fox 4-2-37 94.3 Fox 38-2-13 95.9 Kai 65-2-3 100 
Fox 4-2-37 97.2 Fox 38-2-16 97.2 Kai 65-2-5 98.3 
Fox 4-2-6 92.4 Fox 39-2-2 96.9 Moe 2-2-1 93.4 
Fox 6-2-21 95.3 Hok 9-1-2 92.2 Mpt 8-2-4 91.2 
Fox 8-2-18 100 Kai 18-1-2c 95.2 Mpt 16-2-2 97.5 
Fox 9-2-14 97.2 Kai 1-2-3 95.8 Mpt 71-2-12 94.6 
Fox 13-2-10 97.7 Kai 2-2-3 100 Mpt 73-2-5 95.9 
Fox 13-2-6 95.8 Kai 4-2-1 95.8 Mpt 80-2-1 98.3 
Fox 15-2-11 97.5 Kai 5-2-2 89.6 Tay 1-3-2 97.5 
Fox 15-2-11 94.8 Kai 5-2-3 97.0 Tay 1-3-3 98.9 
Fox 15-2-2 94.8 Kai 6-2-2 96.4 Tay 8-3-3 99.1 
Fox 16-2-10 96.4 Kai 6-2-4 100 Tay 9-3-2 98.0 
Fox 16-2-11 100 Kai 11-2-1 92.9 Tay 18-3-2 98.2 
Fox 17-2-4 100 Kai 18-2-1 99.7 Wai 7-1-1 96.4 
Table 2.2: % Cell inhibition for microbial isolates showing cytotoxicity in the microassay. 
Key for Table 2.2. 
Abbreviation Location Abbreviation Location 
Bru Bruce Bay Mpt Macrocarpa Point 
Coo Cook Beach Moe Moeraki 
Fox Fox River Tay Taylors Mistake 
Hok Hokitika River Wai Waiha River 
Kai Kaikaura 
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2.4 Dereplication 
Even though manne derived fungi have not been examined as extensively for 
biologically active compounds as terrestrial fungi there was a strong likelihood that at 
least some of the metabolites produced by the micro-organisms isolated in this study 
would already be known. To limit the amount of time spent isolating metabolites that 
were already known, all bioactive small scale extracts were subjected to a dereplication 
step prior to culturing on a larger scale. 
The dereplication procedure involved partially purifying a small scale crude extract 
(typically < 50 mg) with solid phase extraction enabling the polarity, charge and 
approximate size of the bioactive component(s) to be determined. 
A MeOH solution (50mg/mL) was prepared and an aliquot (200 ilL) loaded onto a C18 
cartridge followed by 200 ~L H20. Three fractions were collected using a stepped 
gradient system of 1:1 MeOHlH20, MeOH and 1:1 MeOHlDCM. A second aliquot 
(200 ilL) was loaded onto a CBA cartridge. Three fractions were also collected from 
this cartridge using a gradient system of 3:2 MeOH/O.05M CH3CONH2, 3:2 MeOHl2% 
NH3 and 4:1 MeOHlO.05% TFA. A third aliquot (200 ilL) was loaded onto LH20 (1.5 
g) and eluted with MeOH. Depending on the sample under examination four to six 
fractions were collected (3.3 mL, 1 mL, 4 mL and 4 mL). 
Active fractions from the solid phase extractions were then examined further by reverse 
phase C 18 analytical HPLC. The eluant from the HPLC was collected in 96 well 
microtitre plates and the region of cytotoxicity determined by P388 assay (Section 
8.1.6). The region of cytotoxicity can be directly related back to the analytical HPLC 
trace thereby highlighting the bioactive peak and enabling the UV chromophore to be 
determined. Potential molecular ions for the cytotoxic compounds can also be obtained 
by examining wells in the 'master' micro titre plate which corresponded to the region of 
cytotoxicity with ESI-MS. This procedure generally provides enough information to 
search available databases. If either a large number of matches or no matches were 
found the microbial isolate was cultured on a much larger scale and the cytotoxic 
compound determined. Whereas if only one or two matches were found no further 
work was performed, unless other discrepancies were noted. 
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To this end a number of small scale extracts were not investigated further due to the 
presence of various known compounds, such as mycophenolic acid (7), penicillic acid 
(68) and patulin (69) to name but a few. 
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A good example of the dereplication procedure can be seen with cephalochromin (1J9) 
in Chapter 4. The initial chemical screen and subsequent HPLC microtitre plates 
(Figure 4.3) clearly showed which peak in the HPLC trace was responsible for the 
observed cytotoxicity. This peak also displayed a very distinctive UV chromophore 
(Figure 4.4). A mass of 519 Da (MH) was obtained from the mass spectrum of 
compounds in the bioactive wells and a search in the Berdy Natural Products Database 
(BNPD) on the molecular mass and UV chromophore found two compounds with 
identical masses and UV chromophores which were atropisomers of each other. 
2.5 Discussion 
The large number of micro-organisms isolated from marine substrates in this study 
suggests that the marine environment is a prolific source of micro-organisms. The 
number of microbes isolated however, does not distinguish between those actively 
growing in the marine environment or those that were present as resistant spores waiting 
for conditions to become conducive for germination. The simple classification system 
used (Section 2.2.2) to distinguish obligate marine micro-organisms from the rest 
provided an indication of those micro-organisms which were possibly active in the 
marine environment. However, without further studies into their growth requirements 
these micro-organisms might still have arisen from resistant spores. 
Approximately ten percent of the organisms screened in the microassay displayed 
significant cytotoxicity with a further twenty percent showing slight cytotoxicity. Time 
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constraints prevented an in depth investigation of most of the microbial isolates 
possessing cytotoxicity in the microassay. Furthennore, the microbial extracts produced 
for the micro assay were tested for cytotoxicity only and it could be that the non-
cytotoxic extracts possessed other forms of biological activity such as antimicrobial or 
antiviral activities. The mass of extract produced in the microassay however, was so 
low that the other biological activities were unable to be determined. 
As can be seen in the following chapters the marine derived micro-organisms are 
capable of yielding both novel and known compounds. Thus marine derived micro-
organisms could be capable of producing a plethora of potentially useful bioactive 
compounds. 
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CHAPTER THREE 
OKA2-1-1 ,.., FU5AKIUMSF 
3.1 Introduction 
Broth extracts from Oka 2-1-1, a Fusarium sp isolated from driftwood collected from 
Okarito Lagoon, showed significant cytotoxicity towards the P388 cell line (941 
nglmL). This fungal isolate was targeted for further chemical investigation because it 
produced unusual orange nodules when grown on agar plates. Preliminary 
investigations (Section 3.2.1) of the crude extract showed that the antitumour activity 
was centred on a series of small peaks in a moderately complex HPLC chromatogram 
(Figure 3.2). Two pale yellow compounds with excellent cytotoxicity against the P388 
cell line (104, 23 nglmL and 109, 99 nglmL) were isolated and purified from culture 
extracts. The chromatography of these compounds is discussed in Section 3.3 and the 
structural elucidation described in Sections 3.4 and 3.5 of this chapter. 
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3.1.1 Importance of Fusarium toxins 
The genus Fusarium is extremely important as various members of this genus are 
responsible for considerable crop losses worldwide either through infection of host 
plants or, contamination of badly stored grains. Even if fungal contamination is not 
observed, mycotoxins may still be present and can enter the food chain through 
feedstuffs. 
Fusarium mycotoxins have been shown to be the causative agent of many diseases in 
both humans and animals.r85] In the late 1970's horses in the United States suffered 
from a sickness called equine leukoencephalomalacia, thought to be caused by the 
fumonisin toxins from Fusarium moniliforme 1. Sheld.[86] Since the early 19th century 
thousands of people have suffered from the potentially fatal syndrome, alimentary· toxic 
aleukia (AT A), caused by ingestion of trichothecene metabolites from Fusarium 
contaminated grain. [87] 
Most of the major biosynthetic classes from isoprenoids to polyketides and peptide 
derivatives, as well as numerous mixed class compounds have representatives amongst 
the Fusarium mycotoxins. The most toxic Fusarium metabolites include the 
trichothecenes, zearalenone, the fumonisins, the fusarins and the cyclic enniatins. [88] 
3.1.2 Toxins from Fusarium 
3.1.2.1 Polyketides 
A great variety of polyketide derivatives have been isolated from a vast array of 
Fusarium spp, including zearalenone (70), monilifonnin (71), chlamydosporol[89] (72), 
various fumonisins, such as fumonisin Bl (73) and some fusarins (74). 
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Polyketide secondary metabolites in Fusarium are not as common as the trichodienoids, 
but are responsible for a number of toxic effects. 
Zearalenone 
Zearalenone (70) is a member of a small group of compounds known as the undecyl 
resorcylic acid derivatives, which include radicicol (75) from Monosporium 
bonorden[90] and Nectria radicicola, [91] and hypothemycin (76) from Hypomyces 
trichothecoides.[92] The structural similarities seen between radicicol and zearalenone 
are not completely unexpected as many Fusarium spp are anamorphs of Nectria spp. 
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Zearalenone is produced by a number of different Fusarium spp and displays an 
oestrogenic effect on animals.[93] This compound is not generally considered toxic as 
oral doses in excess of 10 g/kg were non-lethal in mice and rats.[94] However, the 
oestrogenic effect of zearalenone in young animals can cause harmful physiological 
changes. [85J The naturally occurring hydroxy derivative of zearalenone, a-zearalenol 
(77) is ten times more active than zearalenone. Since many zearalenone reductases have 
been found in animal tissue a-zearalenol is thought to be the active form of 
zearalenone. [85] 
HO 
Although zearalenone itself is non-lethal it is generally an indicator that other more 
toxic compounds from Fusarium spp are present such as trichothecenes. [93] Along with 
oestrogenic effects, zearalenone has also been shown to be highly phytotoxic at low 
concentrations ranging from 10-5 - 10'6 M.[95] 
Moniliformin 
Moniliformin (71) was originally isolated from Fusarium monilijorme[96] and displayed 
significant biological activity towards animals and plants. [97J Even though the structure 
ofmoniliformin was very simple its biosynthetic origins were not immediately apparent. 
Several different biosynthetic pathways were proposed to explain the production of 
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monilifonnin and Be labeling experiments showed that it was fonned VIa the 
condensation of two acetate units.[98] 
Fumonisins 
The fumonisins were originally discovered from an isolate of Fusarium moniliforme 
implicated in many horse deaths from equine leukoencephalomalacia,l99] a disease 
causing extensive degeneration of brain tissue. [100] Three types of fumonisin have been 
isolated, A, Band C. The A type (78) differs from the B type (79) by acylation of the 
secondary amino group attached at e2, while the e type (80) lacks the e 1 methyl 
group yo 1] The A and B type fumonisins have only been isolated from F. moniliforme 
and F. proliferatum, with the e type fumonisins only isolated fromF. oxysporum.[102] 
o 
78 Rl = CH3 
79 Rl =CH3 
80 R' =H 
; R2= COCH3 
'R2 =H , 
'R2 =H , 
Similar structural features are seen between the fumonisins and sphingosine (81). a 
sphingolipid found in the cell membranes of brain and nerve tissue and implicated in 
cell-cell interactions. This similarity could explain the extensive degeneration of brain 
tissue seen in horses affected by fumonisin toxinsJ103] 
OH 
OH 
81 
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Fusarins 
Five fusarins are currently known (A, C, D,[104] E and F[105]) as well as vanous 
isomersyo2] Of these compounds only fusarin C (74) was shown to possess any 
biological activity and was highly mutagenic in the Ames test against Salmonella.[106] 
The fact that none of the other fusarins show biological activity indicates that the 
epoxide / lactam ring system is essential for this activity as no other fusarins contain this 
lactam system. 
3.1.2.2 Amino acid derivatives 
Enniatins 
The enniatins (82) are cyclic depsipeptides comprised of three a-hydroxy acids and 
three amino acids. The three a-hydroxy acids are always a-hydroxy isovaleric acid and 
the amino acids are either of N-methyl-isoleucine, N-methyl-Ieucine, N-methyl-valine or 
valine. [103] They were initially investigated because of their anti-microbial activity, but 
they have since shown to be slightly phytotoxic[107] and to possess insecticidal 
properties against adult blowflies and mosquito larvae.[108] 
82 
The enniatins have been shown to fuse with cell walls, interfering with the functioning 
ofNa+ pumps resulting in a disruption of the ionic balances within the affected cells and 
causing swelling and subsequent rupture.[J03] The more active enniatins are those 
containing N-methyl groups, as these would greatly increase the lipophilicity of the 
enniatins, enabling better cell wall interactions.[IOO] 
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3.1.2.3 Isoprenoids 
The greatest variety of Fusarium mycotoxins arise from a common precursor, 
trichodiene (83), derived from the common metabolite, farnesol (84). The trichodiene 
precursor can subsequently be modified into one of five structural classes, sambucinic 
acid (85), sambucoin (86), the trichothecenes (87), sambucinol (88) and the 
apotrichothecenes (89). To date all of the known trichodienoids are derived from one of 
these five skeletons.[IOO] 
OH 
83 84 
H 
OH 
85 86 87 
H 
OH 
88 89 
After the initial rearrangement oftrichodiene to one the five structural classes (85-89), a 
great many more rearrangements and oxidations may occur within the molecule which 
can give rise to highly oxygenated compounds such as gramilaurone (90). [109] 
.,IIIOH 90 
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The trichodiene derivatives are not the only sesquiterpenes isolated from Fusarium spp. 
Other sesquiterpenes have also been isolated such as the tricyclic culmorins (91i86] and 
the cyclonerols, such as cyclonerodiol (92). [IOOJ Like trichodiene, the culmorins are also 
derived from famesol. However, the cyclisation pattern is slightly different, whereas 
the cyclonerols are derived from nerolidol (93). 
HO "0 ~H 92 
91 
93 
Trichothecenes 
The trichothecenes are produced by members of a number of fungal genera including 
Acremonium, Myrothecium, Stachybotrys and Trichoderma. However, the largest 
variety of trichothecenes are produced by Fusarium. The trichothecenes have been 
divided into 4 classes, A-D, based on modifications made to the carbon skeleton 
common to all trichothecenes (Figure 3.1). 
'1"'------' 4 
Figure 3.1: Carbon skeleton common to the trichothecenes 
In type A trichothecenes, positions 3, 4, 7, 8 and 15 can be substituted with hydroxyl 
groups which may in tum be esterified. Type B trichothecenes show the same 
substitution as type A but position 8 is always a carbonyl group. Type C contains a 
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second epoxide group between positions 7 and 8, and in type D positions 4 and 15 are 
linked by a series of ester groups. [85] Only type A and B have been isolated from 
Fusarium. Trichothecenes are well known inhibitors of protein synthesis in mammalian 
cellsp IO] have been shown to be immunotoxic[IIIJ and have been responsible for, or 
implicated in many diseases such as alimentary toxic aleukia, tlrrough ingestion of 
contaminated grain. [112] 
Even though a vast array of mycotoxins are produced by various Fusarium spp when 
cultured in the laboratory, there is little evidence to suggest that most of these 
compounds are produced in the environment from which the fungi are originally 
isolated. [93] In the case of the trichothecenes where over 150 different variations are 
knownp02j only five have been regularly isolated directly from the source of the 
contamination.[88,97J These five trichothecenes are T-2 toxin (94), diacetoxyscirpenol 
(95), nivalenol (96), deoxynivalenol (97), and neosolaniol (98)y13] 
97 
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3.1.3 Toxins from marine derived Fusarium spp 
To date no obligate marine Fusarium spp have been described, [57] although a few 
Fusarium spp have been isolated from the marine environment in the past. [32] The fIrst 
novel metabolites reported from a marine derived Fusarium were the neomangicols (59-
61)[78J followed closely by the mangicols (99),[114] sansalvamide (62) [79J and N-
methylsansalvamide (100).[115] 
OH 
OH 99 
\~ 
'-- 0yN+(H 
0""H H\\\~'  
HN 0 # 
\ o~"H H NH ~ ~<.o-0 
100 ~ . 
. Recently, three new macrocyclic trichothecenes (101-103) were isolated from a 
Fusarium spp derived from a marine sponge, Dictyoceratide Sp.[116] This was the fIrst 
report of any trichothecene metabolite from a marine derived fungus. 
o 
101 
HO 
102 103 
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Until the discovery of these three macrocyclic trichothecenes no common Fusarium 
metabolites had been isolated from marine derived fungi, with the exception of 
isoculmorin (43) from the marine fungus Kallichroma tethys. [70J 
43 
3.2 Culturing and extraction of Oka 2-1-1 
3.2.1 Preliminary investigations 
The fungal culture Oka 2-1-1, a Fusarium spp, was isolated from driftwood collected at 
the low tide zone of Okarito Lagoon on the West Coast of the South Island of New 
Zealand in February 1999. This isolate produced some unusual orange nodules which 
slowly turned brown on solid media (Figure 3.2) and as such was examined for 
biological activity. The fungus was cultured in 250 mL PDB broth in the dark at 26°C 
for one month. Extraction of this broth culture with EtOAc and subsequent 
concentration under vacuum yiel ded a light purple solid with significant cytotoxicity 
(941 ng/mL). 
Figure 3.2: Fungal isolate Oka 2-1-1 (Fusarium sp) grown on a PDA plate. 
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3.2.1.1 Chemical screening 
The initial extract of Oka 2-1-1 was examined with a technique known as "chemical 
screening", whereby a MeOIl solution (50 mg/mL) is prepared and aliquots 
chromatographed on C18, LII20 and CBA cartridges (Section 2.4). 
Chromatography on CI8 concentrated the cytotoxicity in the MeOH fraction, with less 
activity seen in the preceding methanol-water fraction and no activity in the DCM 
fraction, indicating that the cytotoxic compounds were of medium polarity. Significant 
cytotoxicity was observed in the first fraction eluted from the CBA cartridge, and from 
the last fraction from the LH20 cartridge. This indicated that the compound(s) 
responsible for bioactivity were uncharged and with a molecular weight less than 500 
Da. 
3.2.1.2 HPLC microtitre plate screening 
To determine the peak responsible for bioactivity an aliquot of the crude extract was 
chromatographed on reverse phase CI8 HPLC, with fractions collected into a 96 well 
microtitre plate. The microtitre plate was then assayed for cytotoxicity against the P388 
cell line. The major region of bioactivity in this extract was centred on 3 small peaks in 
the HPLC chromatogram, eluting at approximately 13.5 minutes (Figure 3.3), with a 
minor region of bioactivity eluting approximately 2 minutes earlier. The weak 
cytotoxicity seen eluting at 11.5 minutes was initially assumed to be a single point 
variation in the biological assay, but subsequent pruification of a large scale extract 
showed that the cytotoxicity was due to the presence of another bioactive compound. 
The UV-visible spectrum of these peaks displayed only end absorbance at 190 nm. 
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Figure 3.3 : Spectrum max plot
' 
HPLC trace (black) and bioactivity data (red) of Ok a 2-1-1 extract 
showing region of biological activity (the blue line represents 50% cell death) 
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The lack of a distinct chromophore for these compounds hindered determination of the 
class of compounds responsible for the biological activity. ESI-MS of the bioactive 
wells from the microtitre plate provided no information regarding possible parent ions 
of the compound as the peaks obs(~rved varied significantly between adjacent wells. A 
search on the UV maximum and the physical properties (approximate size, polarity and 
charge) in available databases found over 100 possible matches. Because it was 
impossible to narrow the search parameters further, this extract was purified to obtain 
the bioactive compounds. During the preliminary investigations (Section 3.2.1) it was 
observed that the biological activity of this extract was concentrated into the second 
fraction from the CIS cartridge whilst most of the mass was retained until the third. It 
was therefore decided to use reverse phase CIS for the initial chromatographic step. 
3.2.2 Large scale culturing and extraction 
Very little mass was left from the small scale extract after chemical screening, therefore 
Oka 2-1-1 was cultured in a further 4 L of half strength PDB under the same conditions 
I A spectrum max plot is a chromatogram with each point plotted at Its maximum absorbance over a 
given wavelength range and combined into a single HPLC trace. The plot indicates what the 
chromatogram would look like when the wavelengths are optimized for each peak. The spectrum max 
plots of the HPLC traces depicted in this work were calculated over the wavelength range 190 - 600 nm. 
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as described in Section 3.2.1. Repeated extraction of this culture with distilled EtOAc, 
followed by solvent removal under vacuum yielded a deep purple oily solid (405.1 mg) 
with an HPLC and bioactive profile almost identical to that of the small scale extract 
(Figure 3.3). 
3.3 Chromatography 
The chromatographic steps for the large scale extract of Oka 2-1-1 are shown in Scheme 
3.1. A more detailed description of the chromatographic steps carried out on this extract 
can be found in the Experimental Section. 
EtOAc extract of 
Oka2-1-1 (RKP 1.3.1) 
Column A C18 (50g) 
MeOH in H20 DCMinMeOH 
10% 20% 40% 
30.5 lOA 7.9 
I 
>12500 
60% 70% 80% 
6.1 6.6 
<97.5 
8.6 
323 
90% 
29.3 
748 
RKP 1.127.5-7 
10% 50% 100% 50% 100% MeOH 
32.7 10.0 218.2 
I 
>12500 
1.8 
1172 
104 2.1 Weight (mg) 
1104 T 
--,-- >12500 ICso (nglmL) 
EtOACinDCM 
Column B DIOL (12g) 
MeOH ill EtOAc 
0% 5% 
RKP 2.209.1-2 
2.7mg 
<97.5 nglmL 
Column C DIaL (lg) 
10% 20% 40% 60% 80% 100% 5% 
314 4939 <97.5 167 6276 7512 Y RKP 2.209.6 I 
RKP 2.209.5 (109) 
~ O.7mg 
10% 100% 
I 
>12500 
100%DCM 100% ElOAc 99.2 ng/mL 
0.9 0.8 0.6 0.3 
Purity checked by RKP 2.227.1 (104) 
1 H NMR spectroscopy 1,4 mg 
and JJPLC 23 ng/mL 
Scheme 3.1: Purification flow chart of an extract prepared from the fungal isolate aka 2-1-1. 
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The large scale culture extract (405.1 mg) was initially fractionated on reverse-phase 
C I8 (column A), using a stepped gradient solvent system for elution. The elution profile 
started at 10% H20 in MeOH and increased to 100 % MeOH then changed to DCM in 
MeOH followed by a final MeOH wash. The three fractions (44.5 mg) that eluted 
between 70 and 90% MeOH/H20 (RKP 1.127.5-7) showed the highest cytotoxicity 
towards the P388 cell line with ICso values ranging from < 97.5 ng/mL through to 748 
ng/mL. Although two late eluting fractions, RKP 1 .127 .11 -12 also displayed 
cytotoxicity (1100 ng/mL), furth er work on these two fractions was not performed 
because very little sample was recovered for each fraction (3.2 mg total). Analytical 
HPLC of these two compounds highlighted multiple impurities and the IH NMR 
spectrum only showed signals indicative of triglycerides. Analysis of fractions RKP 
1.127.5-7 by reverse-phase HPLC (Figure 3.4) showed many impurities and ESI MS 
results from these fractions were unable to be reconciled, as no matching peaks or peak 
patterns (+Na +, +Kl were seen between the three fractions. 
Salven I Change 
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Figure 3.4: HPLC chromatogram of RKP 1.127.5-7 
Based upon analytical HPLC, binassay and I H NMR data, fractions 5, 6 and 7 were 
combined and further purified by normal phase chromatography on DIOL (column B). 
The combined bioactive fractions (RKP 1.127.5-7) were eluted off column B using a 
stepped gradient system starting at 100 % DCM, through EtOAc and then to MeOH, 
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collecting] I fractions in total. Two bands of cytotoxicity eluted off column B, the first 
eluted between 0 and 10 % EtOAc in OCM (RKP 2.209.1-2), and the second eluted 
between 40 and 60 % (RKP 2.209.5-6), with moderate cytotoxicity seen in the side 
fractions (RKP 2.209.3,4 and 7). 
RKP 2.209.1-2 
Analytical HPLC (Figure 3.5) and the IH NMR spectrum (Figure 3.6) of RKP 2.209.1 
confirmed the presence of 104, but highlighted many impurities in the sample. 
However HPLC (Figure 3.5) and the IH NMR spectrum (Figure 3.7) of the second 
fraction (RKP 2.209.2) showed a vcry high degree of purity. 
Solvent Change 
Peak of Interes t \ 
Solvent Front 
\ \ 
,......., 
RKP 2.209.3 
RKP 2.209.2 
RKP 2.209.1 
Figure 3.5: HP C chromatogram of RKP 2.209.1-3 
As the recovered mass of RKP 2.209.2 was relatively low « ] mg), it was combined 
with RKP 2.209.1 and further purified using a small scale (1 g) normal phase OIOL 
column (column C). 
Column C was eluted with two co lumn volumes of 100 % OCM then washed with a 
further two column volumes of] 00% EtOAc, collecting four fractions in total. To save 
both time and sample the presence of 104 in these fractions was determined by 
analytical HPLC rather than biological assay, with relative purity examined by IH NMR 
spectroscopy. HPLC analysis of the four fractions from column C located compound 
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104 in the last two fractions (RKP 2.226.3-4), with the 'H NMR spectrum indicating a 
very high degree of purity for both fractions. These fractions were subsequently 
combined (RKP 2.227.1) and examined by lD and 2D NMR spectroscopy. The 
structural elucidation of 104 is discussed in Section 3.4. 
N 
10 
Figure 3.6: IHNMR spectrum ofRKP 2.209.1 in CDC]3' (* 0= peaks from impurities). 
Chapter 3 ~ Fusarium species 47 
\D 
Figure 3.7: lH NMR spectrum ofRKP 2.209.2 in CDCl3 
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RKP 2.209.5-6 
The two later eluting fractions from DIOL column B (RKP 2.209.5-6) which also 
displayed excellent cytotoxicity were examined by analytical HPLC (Figure 3.8) and I H 
NMR spectroscopy. The analytical HPLC chromatogram and I H NMR spectra of RKP 
2.209.5 and 6 showed that RKP 2. 209.5 was reasonably pure, but not RKP 2.209.6. 
Solvent Front 
\ 
I 
--P 
Peak of Interest 
\ 
RKP 2.209.6 
RKP 2.209.5 
Minules 
Figure 3.8: HPLC chromatogram of RKP 2.209.5-6 
The lH NMR spectrum ofRKP 2.209.5 (Figure 3.9) indicated that it was also a member 
of the trichothecene family. Even though some impurities were still present in RKP 
2.209.5 further I D and 20 NMR experiments were perfonned on the fraction as the 
initial I H NMR spectrum displayed sharp, well defined signals. The structural 
elucidation of 109 is discussed in Section 3.5. 
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Figure 3.9: In NMR spectrum ofRKP 2.209.5 in CDCl). 
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3.4 Structural elucidation of 104 
During the purification of 104 numerous attempts to obtain the molecular mass and 
molecular formula were made. However, all attempts were relatively unsuccessful as 
ESI-MS data varied between injections. After purification of 104 and re-analysis by 
positive and negative ion ESI-MS, the molecular ion peaks were then readily detected. 
Positive ion ESI-MS with formic acid displayed two small signals at 395 (MIr) and 
417 (NINa'). Negative ion ESI-MS showed an intense signal at 393 (MH-) , and a 
weaker signal at 375 (MIr -18), equivalent to the loss of water. The signals observed 
for both positive and negative ion ESI-MS indicated that the molecular mass of 104 was 
394 Da. High resolution ESI-MS on the cesium adduct indicated a molecular formula 
for 104 of CZ1H3007 (seven double bond equivalents). 
The lH NMR spectrum (Figure 3.10) of 104 was relatively simple, with a large number 
of well separated doublets and multip1ets. Three methyl singlets were observed at DR 
0.8, 1.74 and 2.05, with a further two methyl doublets at DR 1.17 and 1.16. All the other 
signals were due to methine groups, with no signals above DR 6.0 being observed. A 
l3C APT spectrum was obtained for this sample and showed 19 signals (Figure 3.11). 
However, the molecular formula indicated that there were actually 21 carbons present in 
the molecule. The APT spectrum showed signals corresponding to a quaternary carbon 
at Dc 136.2 and a tertiary carbon at Dc 124.1 indicating a trisubstituted double bond. It 
also displayed four tertiary and tWo secondary carbon resonances at Dc 79.6, 69.0, 68.5, 
67.7 and Dc 65.4, 64.9 respectively. A further five secondary or quaternary carbon 
peaks were observed at Dc 48.6, 45.5, 42.1, 41.7 and 27.5. The APT spectrum also 
confirmed the presence of the methyl signals observed in the IH NMR spectrum. A 
further two quaternary signals were observed in the CIGAR spectrum at Dc 170.4 and 
176.7, indicative of two carbonyl groups, to bring the total number of observed carbon 
resonances to 21, as required by the molecular formula. 
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From COSY, TOCSY and HSQC experiments (Figures 3.28 - 3.30) six difTerent spin 
systems were deduced. Long range coupling was obseIVed between a methyl signal at 
OH ] .74 and a proton resonance at OH 5.79, which was in tum further coupled to a signal 
at OH 4.43. The chemical shift of the signal at OH 5.79 suggested that it was a vinyl 
proton which was confirmed with a lJCH correlation to a carbon at Oc 124.1 (Figure 
3.12a). The methyl signals at OH 1.17 and OH ].16 were both coupled to a multiplet 
signal at OH 2.45 (Figure 3.12b). The proton resonance at OH 5.28 showed correlations 
to two proton signals at OH 2.34 and OH 1.95. The two protons at OH 2.34 and OH 1.95 
both showed lJcH correlations to the same carbon signal at 8c 27.5 (Figure 3.12c). The 
fourth spin system contained four proton signals at OH 4.47,3.50,2.27 and OH 2.14, with 
the HSQC spectrum indicating that the signals at OH 2.27 and OH 2.14 were on the same 
carbon (Figure 3.12d). The final two spin systems (Figure 3.12e-f) each contained two 
proton signals with the HSQC experiment showing that both systems were CH2 groups. 
r~,79 
120.3 _tl~ 
1.74 H3C~H 4.43 
136,2, 67.7, -, _ , 
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H H 3.95 
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64,9 " 
e 
c 
3,07~ 
H H 2.86 
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48.6 " 
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Figure 3.11a-f: Spin systems ofl04 obtained from COSY, TOCSY and HSQC correlations 
Two further methyl groups at OH 2.05 and OH 0.80 showed lJCH correlations to carbons 
at Oc 21.1 and Oc 12.1 respectively. The chemical shift of the carbons obseIVed in the 
HSQC spectmm allowed for five oxygen atoms to be included in the various fragments. 
These oxygen atoms were attached to the carbons at Oc 67.7, 68.5, 79.6, 69.0 and Oc 
64.9 (Figure 3, L3a-d). 
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Figure 3.13a-d: Oxygenation pattern of fragments a, c, d and e in Figure 3.11 
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Correlations from the 2D CIGAR spectrum (Figure 3.31) enabled a full structural 
assignment. The proton signals in Figure 3.12b all showed correlations to a carbonyl 
group at Dc 176.7 indicating an isobutyryl ester (Figure 3.14a). The proton signal at DH 
5.28 showed correlations to the same carbonyl at Dc 176.7, as well as two vinyl carbons 
at Dc 136.2 and 124.1, a vinyl methyl at Dc 20.3 and quaternary ca.rbon at Dc 41.7 
(Figure 3 . 14b). 
5.79 
20,3 1 ryd 11 4~3 
o HQ3~~~'2' 124.1 67.7 ~ __ ~"'~ 
19.2 : H3C 176.7
11 68.5 41.'Z,.. ___ _ ~' " 34~ '0 H 1\2;.5 \" 
H CH
3 
5.28 H H 
18.5 2.34 1.95 
b 
Figure 3.14a-b: CIGAR correlations for tiR 5.28, 2.45, 1.17 and tiR 1.16 
The vinyl proton at DH 5.79 showed correlations to carbons at Dc 68.5, 67.7, 41.7 and 
20.3 confirming the partial structure seen in Figure 3.l4b and enabling ring closure 
between the carbons at Dc 67.7 and Dc 41.7. 
The proton signals at DH 2.34 and DH 1.95 showed 3JCH correlations to a second;fY 
carbon at Dc 64.9 and a quaternary carbon at Dc 45.5 to further expand the fragment seen 
in Figure 3.13b (Figure 3.15). 
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H 
0 ......... 
Figure 3.15: CIGAR correlations for ~ 2.34 and OH 1.95 
The proton pair at OR 4.25 / 3.95 and the methyl singlet at OR 2.05 all showed 3 JCH 
correlations to a quaternary carbonyloc 170.4 (Figure 3.16). 
H 
Figure 3.16: CIGAR correlations for OH 4.25,3.95 and OH 2.05 
A singlet methyl signal at OR 0.80 showed correlations to carbons at Oc 65.4, 45.5, 42.1 
and Oc 41.7. This placed the methyl signal at OH 0.80 next to the quaternary carbon 
signal at Oc 45.5 (Figure 3.17). 
Chapter 3 - Fusarium species 
H 4.43 
H I 
I 
I 
I 
" H
3
.
50 
I 
227 
Figure 3.17: CIGAR correlations for the methyl signal at OH 0.80. 
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The proton signal at OH 3.50 showed correlations to carbon signals at Oc 67.7, 65.4, 45.5 
and Oc 42.1 to give a five and a six membered ring (Figure 3.18). 
H 
H H 2.27 
2.14 
Figure 3.18: CIGAR correlations observed for the proton signal at OH 3.50. 
The chemical shift of the quaternary carbon at Oc 65.4 indicated the presence of an 
oxygen atom, which left 15 Da (CH2 and H) unaccounted for in the molecular formula. 
No CIGAR correlations were observed either to the carbon at Oc 48.6 or from the 
protons at OH 3.07 and OH 2.86. However, ROESY correlations were seen between the 
protons at OH 3.50 and OH 3.07 and between OH 2.86 and OH 0.80 (Figure 3.19). 
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3.50 
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Figure 3.19: ROESY correlations for 8H 3.50 and 8H 0.80. 
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At this point all the atoms from the molecular formula C21H3007, except for a single 
proton had been assigned. However, only six of the double bond equivalents had been 
accounted for. The final double bond equivalent was postulated to arise from an 
epoxide ring between the carbon at Dc 48.6 and the oxygen attached to the carbon at Dc 
65.4. The final proton was then assigned as part of a hydroxyl group at position 3 
(Figure 3.20). The relative stereochemistry of 104 is discussed in Section 3.4.1. 
Figure 3.20: Numbering system used for trichothecenes 
3.4.1 Relative stereochemistry of 104 
The relative stereochemistry of 104 was determined from a 2D ROESY spectrum 
(Figure 3.32) which also enabled the connectivity of the CH2 group at Dc 48.6 to be 
determined. 
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The majority of previously reported trichothecenes put the proton at bH 5.28 in the ~ 
position. The only observable coupling for the proton at bH J .95 was a 2 JHH of 15 Hz. 
Thus the expected 3JHH coupling to ~ 5.28 must be small indicating a dihedral angle 
close to 90°. This places the proton at bH 1.95 in an equatorial position. ROESY 
correlations were seen from the proton signal at bH 1.95 to the quaternary methyl at bH 
0.8. This methyl group showed a correlation to an epoxide proton at bH 2.87 which tum 
showed a correlation to the proton at bH 2.34. The proton at bH 3.50 showed 
correlations to the second epoxide proton at bH 3.07 and another proton at bH 4.47. The 
proton at OH 2.14 showed ROESY correlations to the proton at OH 4.47 and the methyl at 
bH 0.8 as shown in Figure 3.21. 
~. 1 . 50~ ~,~7 H 
H 
0- OIIH 
~ ) 
H H2.14 
2.27 HJ 
:. 0.80 
H 
H 
0~0 3~5 
-'-:, H 
-;. 
H H 
-;. 
H 
Figure 3.21: Important ROESY correlations and J1-ll-l coup ling constants for 104. 
Further ROFSY correlations were seen from OH 4 .43 to OH 4.25, OH 4.25 to OH 2.27 and 
OH 3.95 to OH 0.80 (Figure 3.22). These correlations provided confirmation of the 
relative stereochemistry of 104. 
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Figure 3.22: Additional ROESY correlations observed in 104. 
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The epoxide ring could be in two different configurations, but the correlation seen 
between DH 2.34 and 2.86 proved that the configuration seen in Figure 3.23b was the 
only possible one. If the configuration proposed in Figure 3.23a was the preferred one 
the correlation between DH 2.34 and DH 2.86 would not have been observed. 
Furthermore the configuration in Figure 3.23a would show additional ROESY 
correlations between the protons at DH 3.07 and DH 4 .47 as welJ as DH 2.86 and DH 2.14. 
4.47 
4.47 
2.14 
Figure 3.23a-b: Possible epoxide ring conflgurations for 104. 
Chapter 3 - Fusarium species 60 
An extensive search of numerous databases found only four trichothecenes with a 
similar oxygenation pattern at C3, C8 and C15, and no oxygenation at C4• Of these, three 
were calonectrin derivatives, such as 8-hydroxycalonectrin (105) and one was 
sporotrichiol (106).£102] Compound 104 also showed structural similarities to various T-
2 derivatives, such as 4-deacetoxy-T-2 Toxin (107) and some neosolaniol 
derivatives,lll7] such as 8-isobutyrylneosolaniol (108). However, no absolute matches 
for this structure were found. Compound 104 was therefore considered novel and as 
such, was called 4-,deacetoxy-8-isobutyrylneosolaniol or, 3-hydroxy-8-isobutyryl-15-
acety 1-12,13 -epoxytrichothec-9-ene. 
o 
/ 
AcO 
104 
H 
-::P' 0 
HO"'" ~"" 
HO/ / 
AcO 
105 106 
107 108 
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3.5 Structural elucidation of 109 
The IH NMR spectrum of 109 showed a high degree of similarity to that of 104, with a 
few notable differences. The proton signals at bH 4.47 and bH 4.43 seen in the IH NMR 
spectrum of 104 were absent while two new signals were observed at bH 4.49 and ~ 
4.24 with the signal atbH 4.24 integrating for two protons. Correlations in the COSY 
and HSQC spectra indicated that the same six fragments observed for 104 were also 
present in 109, with the exception of the fragment in Figure 3.24d. The CH2 resonances 
seen in Figure 3.13d were replaced with a proton resonating at bH 4.47 with a IJCH to a 
carbon at bc 81.7 (Figure 3.24d) indicating that this centre was now oxygenated. 
a b c 
4.24 
~H~ 
3.63 H~ 80~ ~H4.49 
78.?( 6 r·7 
,0 : 0, 
3.03/) 
H H 2.77 
---V 
46.7 " 
.," I ... 
d e f 
Figure 3.24a-f: Fragments of 1 09 deduced from COSY, TOCSY and HSQC correlations. 
Even though the recovered mass of 109 was very small « 1 mg) the CIGAR 
correlations seen from the five methyl groups were sufficient to allow assembly of the 
fragments in Figure 3.24 to give 109, an analogue of 104 oxygenated at position 4. The 
methyl signal at bH 0.80 showed correlations to 4 carbons at bc 81.7, 64.5, 48.7 and 
42.3. The methyl group at bH 1.74 showed correlations to carbons at bc 136.5, 123.5 
and 67.9. Two weak 3JcH correlations were seen from the proton at bH 3.63 to two 
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carbons at Dc 81.7 and 67.2. The protons at 8H 4.01 and 4.34 both showed very weak 
correlations to a carbon at 8c 48.7 l with the proton at 8H 4.34 also showing a correlation 
to a carbon at 8c 67.2. As with compound 104 no correlations were observed either to 
the carbon at 8c 46.7, or from the protons at 8H 3.03 or 8H 2.77. However, NOESY 
correlations enabled these protons to be assigned as part of the epoxide (Figure 3.25). 
2.49 H 
CH3 
1.17 
18.6 
OH 
Figure 3.25; CIGAR correlations observed for 109. 
High resolution ESI MS on the sodium adduct of 109 showed an MNa+ at 433.1849 Da 
corresponding to a molecular formula of C21H300sNa, lending further support for the 
structure in Figure 3.25. The relative stereochemistry seen in 109 is discussed below in 
Section 3.5.1. 
o 
109 
/ 
AcO 
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3.5.1 Relative stereochemistry of 109 
The same relative stereochemistry seen in compound 104 was also observed for 109 
except that an extra stereocentre is present in 109 at C4 . The stereochemistry at this 
centre was unable to be determined via the coupling constant between the protons at 6H 
4.49 and 4.24 as the signal at 6H 4.24 is coincident with another signaJ. NOESY 
correlations were seen from the proton signal at 6H 4.49 to the proton signals at 6H 4. 24 
and 6H 4.34, but the correlation to 6H 4.24 could have been due to the protons attached 
at either C3 or C1 [. However, a correlation from the proton signal at 6H 4.49 to the 
proton signal at 6H 4.34 indicated that the stereochemistry at C4 was opposite to that at 
C3 . A Chem3D (Cambridge software) energy minimisation using MM2 parameters on 
the rigid ring system of compound 109 placed the proton at 6H 4.49 within 2.3 A of both 
protons at 6H 4.24 (Figure 3.26) further supporting the proposed stereochemistry at C3 
and C4 respectively. 
Figure 3.26: Energy minimised Chem3D structure of 109 using MM2 parameters 
All previously reported trichothecenes with similar substitutions at C3 and C4 display 
the same stereochemistry as that shown in Figure 3.26 at these two stereogenic 
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centres. [102] Exhaustive searches on all available databases eventually found a single 
compound[ll8] with proton chemical shifts identical to 109. However, this compound 
was not isolated from a natural source but rather, was the result of semi-synthetic 
modifications to neosolaniol (98). A comparison of the experimental and literature IH 
NMR data for 109 can be found in Table 3.2 
3.6 Discussion 
Purification of an extract from a Fusarium sp yielded two trichothecene derivatives, 
each with significant biological activity against the P388 murine leukaemia cell line. A 
literature search on the first of these, compound 104, found no matches and was 
subsequently identified as a novel trichothecene called 4-deacetoxy-8-
isobutyrylneosolaniol. As previously described in Section 3.5.1 the second compound 
(109) had been reported in 1987,D18] but had not previously been isolated as a natural 
compound. 
Experimental IH and I3C data in CDCh for compounds 104 and 109 are shown in 
Tables 3.1 and 3.2 respectively. The literature IH NMR data for 109 in CDCh are also 
shown in Table 3.2. 
16 
19y1° 8 
17 
IS 0 H 
20 
H 
7a 15a 
H 0\ 21 15]3 
0~22 
H 
OH 
Figure 3.27: Triehotheeene numbering system for Tables 3.1 and 3.2. 
Number 'B, multiplicity, (J_ Hz) COSy TOCSY BSQCI APT CIGAR ROESY 
2 3.50 d (4.5) 4.47 4.47,2.27,2.14 79.6 67.7,65.4,45.5,42.1 4.47,3.07 
3 4.47 dt (5, 12) 3.50,2.14 3.50,2.27,2.14 69.0 - 3.50,2.30,2.13 
4a 2.27 dd (3.5, 14.5) 4.47,2.14 4.47,3.50,2.14 42.1 69.0,45.5 , 41.7 4.47,4.25,2.14 
4~ 2.14 dd (14.5, 3.5) 4.47,2.27 4.47,3.50,2.27 42.1 79.6,69.0, 12.1 4.47,227,0.8 
5 - - - 45.5 - -
6 - - - 41.7 - -
7a 1.95 d (15) 2.34 5.28.2.34 27.5 136.2,68.5,67.7,64.9,41.7 2.34,0.8 
7~ 2.34 dd (5.5, 15) 5.28, 1.95 5.28, 1.95 27.5 67.7,64.9,45.5,41.7 5.28,2.86,1.95 
8 5.28 d (5.5) 2.34 2.34,1.95 68.5 176.7,136.2,124.1 , 67.7 ,41.7,20.3 2.34, 1.95, 1.74 
9 - - - 136.2 - -
10 5.79 d (5.5) 4.43,1.74 4.43 , 1.74 124.1 68.5,67.7,41.7,20.3 4.43,1.74 
11 4.43 d (6) 5.79 5.79,1.74 67.7 138.2,124.1,64.9,27.5 5.79,4.25 
12 
- - - 65.4 - -
13a 3.07 d (4) 2.86 2.86 48.6 - 3.50,2.86 
13~ 2.86 d (4) 3.07 3.07 48.6 - 3.07 , 2.34 , 0.8 
14 0.80 s - - 12.1 65.4,45.5 ,42.1 ,41.7 3.95 ,2.86,2.14, 1.95 
15 a 4.25 d (12.5) 3.95 3.95 64.9 170.4,67.7,45.5,41.7,27.5 4.43 ,3.95,2.27 
15 ~ 3.95 d (12.5) 4.25 4.25 64.9 170.4 , 67.7 , 45.5 ,41.7 4.25,0.8 
16 1.74s 5.79 5.79,4.43 20.3 136.2, 124.1,68.5 5.79,5.28 
17 - - - 176.7 - -
18 2.45 m (6.5) 1.17, 1.16 1.17, 1.16 34.1 176.7,19.2,18.5 1.17,1.16 
19 1.17 d (7) 2.45 2.45 19.2 176.7,34.1 ,18.5 2.45 
20 1.16 d (7) 2.45 2.45 18.5 176.7,34.1 , 19.2 2.45 
21 - - - 170.4 - -
22 2.05 s - - 21.1 170.4 -
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Liter)lture IH, Experimental IH, 
COSY HSQC CIGAR NOESY Number 
multiplicity, (JUIl Hz) multiplicity, (JHH Hz) 
3.61 d (4.9) 2 3.63 d (5) 4.25 78.5 81.7,67.2 4.24,3.03 
4.22 dd (4.9, 3) 3 4.24 d (5.5) 3.36 80.7 - 4.49 
4.45 d (3) 4 4.49 d (2.5) 4.24 81.7 - 4.34,4.24 
1.88 dt (15, 1.5) 7 1.90 d (15.5) 2.40 33.1 - 5.28,2.40,0,80 
2.36 dd (15, 5,5) 7 2.40 dd (14.5, 5.5) 5.28, 1.90 33,1 - 5.28,2.77 , 1.90 
5,26 br d (5) 8 5.28 d (5,5) 2.40 687.9 - 2.40, 1.90, 1.74 
5,74 brd (6) JO 5,77 d (5.5) 4.24, 1.74 123.5 - 4.24, 1.74 
4.22 d (6) 11 4.24 d (5.5) 5.77 67.2 - 5.77,4.34 
2,75 d (4) 13 3.03 d (4) 2.77 46.7 . 3.63,2.77 
3.01 d (4) 13 2,77 d (4) 3.03 46.7 - 3.03 ,2.40 , 0.80 
0,78 s 14 0,80 s - 14.1 81.7,64,5,48.7,42.3 4.01 ,2,77 , 1.90 
3.97 d (12.5) 15 4.34 d (13) 4.01 64.8 48.7 4.49,4,01 
4.32 d (12,5) 15 4.01 d (13.5) 4.34 64,8 81.7,67.2 4.34,0.80 
l.72brs 16 1.74 s 5.77 20,9 136.5 , 123.5 , 67.9 5.77,5.28 
2.46 m (7) 18 2.49m (7) 1.18,1.17 34.2 - 1.18,1.17 
1.15 d (7) 19 1.18 d (7) 2.49 18.7 176.6,34.2,18.6 2.49 
1.16 d (7) 20 1.17 d (7) 2.49 18.7 176.6,34.2,18.7 2.49 
2.03 s 22 2.05 s - 20.1 170.4 
Table 3.2: Literature[1181 and experimental NMR data for 109 in CDCh 
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Figure 3.28: COSY spectrum of 104 in CDC13 
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Figure 3,29: TOCSY spectrum of 104 in CDCl3 
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Figure 3.32: ROESY spectrum of 104 in CDC13 
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CHAPTER FOUR 
WAI7-1-1 & Fox J5-2-5 - UNIDENTIFIED 
CEIHAL0510KIUM-LJKE HYFHOMYCETES 
4.1 Introduction. 
Broth extracts from two apparently identical fungi (Wai 7-1-1 and Fox 35-2-5), cultured 
from driftwood collected near the mouth of the Waiho and Fox Rivers respectively, 
showed moderate cytotoxicity towards the P388 cell line (1498 nglmL). Initial 
investigations (Section 4.2.1) of the crude extracts showed that the cytotoxic activities 
were centred on a single peak of moderately complex HPLC chromatograms (Figure 
4.3). An intense yellow-green bis(naphtho-y-pyrone) with excellent cytotoxicity against 
the P388 cell line (116, 774 nglmL) was isolated and purified from culture extracts. 
The chromatography of this compound is discussed in Section 4.3 and the structural 
elucidation described in Section 4.4 of this chapter. 
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4.1.1 Naphtho .. y-pyrones 
Naphtho-y-pyrones are a large class of polyketide compounds with examples found in 
both marine and terrestrial organisms. Naphtho-y-pyrones from the marine enviromnent 
include 110 and 111, both isolated from different species of c11noidYl9, 120] Naphtho-y-
pyrones from the terrestrial enviromnent include ll2 from the terrestrial plant Cassia 
pudibunda[121] and 113 - ll4 from the fungi Gaunomyces polythrii122, 123] and 
Aspergillus parasiticus. [124] 
~O OH ~O 
0 
HO HO 
110 11] 
~O 
~O OH 0 
0 
~O "111/ 
HO O~ 
/0 112 
113 
OH OH 0 
OH 
HO 
114 
4.1.2 Bis(naphtho-y-pyrones) 
Bis(naphtho-y-pyrones) consist of a naphthopyrone unit like those of llO - ll4linked to 
a second naphtho-y-pyrone unit through C7, C9 or C IO (Figure 4.1). 
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OH OH o 
HO 11 
Figure 4.1: Numbering system for naphthopyrone derivatives 
The bis(naphtho-y-pyrones) include a number of different compounds such as 
chaetochromin D (115),[125] cephalochromin (1l6P26] and fonsecinone C (1l7)yz7] 
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The occurrence of the bis(naphtho-y-pyrones) appears to be limited to filamentous fungi 
such as Aspergillus spp, Verticillium spp, Chaetomium spp, Cephalosporium spp, 
Nectria spp and Acremonium sPpYOZ] The bis(naphtho-y-pyrones) show a wide range of 
biological activities including cytotoxicity[128] and enzyme inhibition.[IZ9] 
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4.2 Culturing and Extraction of Wai 7-1-1 
4.2.1 Preliminary investigations 
A Cephalosporium-like unidentified fungus, Wai 7-J -J, was isolated from driftwood 
collected at the low tide zone near the mouth of the Waiho River on the West Coast of 
the South Island of New Zealand in February 1999. This isolate produced an unusual 
green-brown pigment that was excreted into the medium (Figure 4.2) and also showed 
sporing characteristics similar to that of the Cephalosporium complex. 
An EtOAc extract from a I mL broth culture of Wai 7-I-J showed moderate 
cytotoxicity which, in association with its affiliation to a creative group of fungi made it 
an excellent candidate for chemical investigation. For the initial investigation the 
isolate was cultured in 500 mL POB broth at 26°C for four weeks. Extraction of this 
broth culture with EtOAc and su bsequent concentration under vacuum yielded a deep 
green-brown solid with significant cytotoxicity (1498 ng/mL). 
Figure 4.2: Fungal isolate Wai 7-1-1 grown on a seawater PDA plate. 
4.2.1.1 Chemical screening 
The small scale EtOAc extract was chromatographed on CBA, CIS and LH20 cartridges 
as in Section 3.2.1.1. Chromatography on C 18 concentrated the cytotoxicity into the 
second fraction with significant carry over to the third fraction. Elution of the extract 
from the CBA cartridge also concentrated the bioactivity into the second fraction with a 
low level of activity eluting in the preceding fraction. This suggested that the 
compound(s) of interest were of medium to low polarity and positively charged. 
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Whilst fractionating the crude extract on an LH20 cartridge it was noted that a great 
deal of colour was retained on the column after the three initial fractions had been 
collected and even though colour intensity is not always attributable to the amount of 
material present, a further three fractions were collected. Biological activity was 
detected in frachons two to five from the LH20 cartridge with the cytotoxicity 
concentrated in frachon four. T his suggested that the compound(s) of interest were 
either extremely small, being retained for a long time on the LH20 column, or they were 
interacting with the LH20 in some other fashion than just size exclusion. 
4.2.1.2 HPLC bioassay 
To obtain a chemical profile of the compound(s) responsible for the bioactivity of this 
extract an aliquot of the crude extract was chromatographed by reverse phase C I8 HPLC 
as before in Section 3.2.1.2. The major region of bioactivity in this extract was centred 
on a single large peak in the HPLC chromatogram, eluting at approximately 16.5 
minutes (F igure 4.3), which showed a very distinct spectrum with mUltiple UV 
absorption maxima (Figure 4.4). 
0.0 2.5 5 a 7.5 10 0 12.5 15 0 17.0 20.0 22.5 25.0 27.5 30.0 32.5 35.0 37.5 40.0 
Figure 4.3: Spectrum max plot HPL trace (black) and bioactivity data (red) of Wai 7-1-1 extract 
showing region of biological activity (the blue line represents 50% cell death). 
Chapter 4 - Unidentified Cephalosporium-like Hyphomycetes 
270 292 
i 
m 
Wavalength Inm) 
i 
'5O i 'GO 
78 
Figure 4.4: UV profile ofbioactive peak from HPLC trace (16.5 minutes) as determined by microtitre 
plate assay 
ESI-MS of the bioactive wells from the microtitre plate showed a very intense 
molecular ion at 519 Da (MH+) , although the elution profile from the LH20 cartridge 
had suggested that the mass was actually a lot smaller. A search in the Berdy Natural 
Products Database (BNPD) for a compound with similar UV maxima and a possible 
mass of 518 Da found two matches, cephalochromin (116p29, 130] and ustilaginoidin F 
(118). [131,132] These two compounds are atropisomers of each other. 
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At this point a very limited amount of mass was available. To unambiguously assign 
the bioactive compound present in extracts of Wai 7-1-1 as either 116 or 118 a larger 
quantity of purified compound was required to obtain IH and Be NMR spectra for 
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comparison to the literature data.[126, 129, 131, 133] To this end a large scale extract was 
prepared. 
4.2.2 Large scale culturing and extraction 
To obtain adequate mass for an accurate identification of the active component, the 
fungal isolate Wai 7-1-1 was cultured in a further 4 L of half strength PDB under the 
same conditions as described in Section 4.2.1. Repeated extraction of this culture with 
distilled EtOAc, followed by solvent removal under vacuum yielded a deep brown-
green solid (550.4 mg) with a similar bioactive profile to that of the small scale extract. 
4.3 Chromatography of Wai 7-1-1 
The chromatographic steps for the 1 arge scale extract of Wai 7-1-1 are shown in Scheme 
4.1. A more detailed description of the chromatographic steps carried out on this extract 
can be found in the Experimental Section. 
EtOAc extract of 
Wai 7-1-1 (RKP 1.39.3) 
MeOH in H20 Column A C18 (50 g) DCMinMeOH 
10% 20% 40% 60"10 70% 80% 100% 10% 50% 
16.2 8.6 20.6 22.0 18.4 40.8 53.6 21.8 12.2 144.2 14.6 156.1 Weight (mg) 
> 12500 
EtOAc inDCM 
8.3 2.8 3.3 
4939 1040 314 
0.1 3.5 
1.2 
354 
2023.3 641.7 I 
> 12500 > 12500 ICso (ng/mL) 
ColumnB DIOL(l2 g) MeOH in EtOAc 
0.4 
1.6 
449 
1.5 
1.1 1.5 0.7 0.9 1.3 0.8 0.5 
554 1072 606 2199 2713 2071 3886 
1.3 0.2 
RKP 1.169.4-5 (116) 
f-----i 2.8mg 
774ng/mL 
58.2 
>12500 
Scheme 4.1: Purification flow chart of an extract prepared from the fungal isolate Wai 7-1-1. 
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The large scale culture extract (550.4 mg) was initially fractionated on reverse-phase 
C j8 (column A), using a stepped gradient solvent system for elution. The elution profile 
started at 10% H20 in MeOH and increased to 100 % MeOH then changed to OCM in 
MeOH followed by a OCM wash. However, after eluting with 100 % OCM it was 
noted that a large amount of mat rial was still retained on the column. To recover this 
extra material from the column it was washed three times with 0.05 % TF A in varying 
percentages of MeOH/DCM, then washed a further three times with 0.1 % NH3 in 
MeOH/OCM. The two fractions (94.4 mg) that eluted between 80 and 90% 
MeOH/H 20 (RKP 1.95.6-7) were the only ones to show any cytotoxicity, 2023 and 641 
ng/mL respectively. Analysis of these two fractions (RKP 1.95.6-7) and the two side 
fractions (RKP 1.95.5 and 8) by reverse-phase HPLC (Figure 4.5) showed that the 
active component of Wai 7-1-1 was only present in fractions 6 and 7, with ESI MS 
results also showing a large signal at 519 Da (MIl") in these two fractions. IH NMR 
spectra of these two fractions indicated that they were not sufficiently pure for 
comparison to the literature NMR data of 116 and 118. 
Peak of Interest 
/ 
Solvent Front 
Solven! Change 
I 
RKP 1.95,6 
RKP 195.5 
Minutes 
Figure 4.5: IIPLC chromatogram of RKP l. 95,5-8 
Based on analytical HPLC and bioassay data fractions 6 and 7 were combined and 
further purified by normal phase chromatography on OIOL (column B). The combined 
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bioactive fractions (RKP 1.95.6-7) were eluted off column B with a stepped gradient 
system similar to that for column B in Section 3.3. The gradient elution profile started 
at 100 % DCM, moved through to 100 % EtOAc and then to 100 % MeOH, collecting 
15 fractions in total. However, after completion only half the total mass from RKP 
1.95.6 and 7 had been recovered. The material retained on column B was recovered by 
eluting with MeOH in EtOAc and EtOAc in DCM, both with 0.05 % TF A with a further 
six fractions collected. Significant biological activity was detected from fractions 2 to 
8, with moderate activity in fractions 1 and 9 to 12 and no activity in the late eluting 
fractions (13-21). At this point it was noted that the solubility of the biologically active 
fractions in MeOH was decreasing and as a result the purity of these fractions was 
subsequently determined by 1 H NMR spectroscopy rather than by analytical HPLC. 
The IH NMR spectra of fractions RKP 1.115.2-8 showed the same series of peaks in 
each fraction, but they also indicated the presence of a phthalate plasticizer. Based on 
the similarities in the IH NMR spectra and the similar biological activities these seven 
fractions were combined then further purified on a 1 g Sephadex LH20 column (column 
C). RKP 1 J 15.2-8 was eluted from column C with 100 % MeOH with six fractions 
collected in total. IH NMR spectroscopy of these six fractions located the bioactive 
component of Wai 7-1-1 in RKP 1.169.4 and 5 in a very high degree of purity. These 
fractions were combined and examined further with available NMR techniques. 
4.3. 1 Chromatography of Fox 35-2-5 
The principal bioactive component of a small 1 mL extract from a second 
Cephalosporium-like fungus, Fox 35-2-5 was also thought to be the same as the 
bioactive component ofWai 7-1-1, but it was not until extraction and purification of the 
large scale extract that this was confirmed. Fox 35-2-5 was isolated from a section of 
driftwood collected in the water below the low tide zone at the Fox River mouth on the 
West Coast of the South Island of New Zealand in October 1998. This isolate was 
cultured in 4 L half strength PDB in the dark at 26°C for four weeks. However, after 
this time very little growth was observed so the cultures were left for a further four 
weeks, after which time subsequent extraction yielded a deep green solid (280 mg). 
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Earlier work on the extracts of Wai 7-1-1 showed that the bioactive component was 
strongly retained on Sephadex LH20 whilst allowing most of the inactive fungal 
metabolites to pass through. With this in mind a small amount (5 x 10 mg) of the 
extract was initially fractionated on a small scale 1 g Sephadex LH20 column (Scheme 
4.2). 
W,ighl (mg) 2.8 14.9 
EtOAc extract of 
Fox 35-2-5 (RKP 2.184.5) 
3.7 9.7 9.1 2.0 
RKP 2.186.4-5 (116) 
18.8 mg 
760 ng/mL 
Scheme 4.2: Puriiication flow chart of an EtOAc extract of Fox 35-2-5. 
The EtOAc extract of Fox 35-2-5 was eluted from the Sephadex LH20 column with 100 
% MeOH, collecting a total of six 1 mL fractions. After 50 mg had been processed the 
purity of the fractions was detennined by lH NMR spectroscopy, which indicated that 
the bioactive component of Wai 7-1-1 was present in fractions four and five in excess of 
90 % purity, thus these two fractions were combined and examined further with 
available NMR techniques. 
4.4 Structural elucidation of Fox 35-2-5 
The NMR spectra were obtained in DMSO-d6 rather than CDCh due to solubility 
problems in the latter solvent. The IH NMR spectrum of the bioactive component of 
Fox 35-2-5 in DMSO-d6 (Figure 4.6) revealed a methyl signal at BH 1.37, five proton 
signals at BH 2.77, 2.92, 4.55, 5.72, 6.52 and three phenolic hydroxyl signals at BH 9.9, 
10.1 and OH 15.1. The DC APT spectrum (Figure 4.7) showed eight quaternary carbon 
resonances at Be 101.7, 104.3, 107.2,141.6,155.0,158.7,160.1,164.9 and a carbonyl 
peak at Be 198.2. It also showed three tertiary carbon signals at oe 100.1, 98.6 and Be 
73.0, a secondary carbon resonance at Be 42.8 and a primary carbon signal at oe 20.6. 
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A comparison of the experimental 1 Hand l3C NMR data for the bioactive component of 
Fox 35-2-5 with the literature data for 116 and 118 is shown in Table 4.1. The 
numbering system for the bis(naphtho-y-pyrones) can be seen in Figure 4.1. 
Experimental NMR data of Fox ~5-2-5 Literature NMR data for 11611; 1\ Literature NMR data for 11SI" '1 
Number 'H , (JHlJ Hz) IJC 'H. (JRlI Hz) '3C 'H. (Jim Hz) 1.1(' 
2H 4.55 (3, 6,125) 73.0 4.4 7 (7 3. (1 ) 73.3 4.43 (4.1 , 59, J 12) 733 
30: H 2.77 (3, 17.5) 42.8 26(,(13 ; 43.1 2.68 (41,17.6) 43.1 
3~ H 292 (125,17.5) 42.8 ~.66 (~Jl 43.1 27 5 (11.2. 1 ;6) 43 .1 
4 , I 198.2 198.4 198.2 
4a 101.7 102.2 101.9 
50H 15.1 164.9 14.9 164.4 15.16 164.6 
5a 104.3 105.4 105.5 
60H 10.1 158.7 9.6 160.1 974 160.2 
7H 6.52 100 I 6.49 100 I 6.55 100.1 
80H 9.9 160.1 590 160.7 5.55 161.1 
9 Dimer 1072 102.4 102.4 
9a 141.6 142.1 141.9 
10 H 5.72 98.6 6.16 99.6 5.95 99.4 
lOa 155.0 156.3 \56.2 
II CH, 137 (6) 20.6 1.39 (61) 20.9 1.41 (59) 20.9 
Table 4.1; Experimental NMR data in DMSO-do for the bioactive component of Fox 35-2-5 and literature 
:\,MR data for 116 and 1I8 in COCI 3 
As shown in Table 4.1 the carbon shifts for the experimental and two literature 
compounds are almost identical. However, the I H NMR data show a number of 
discrepancies (shown in red) between the experimental and literature values. This 
indicated that the bioactive compound in extracts of Wai 7-1-1 and Fox 35-2-5 was 
ustilaginoidin F (118) rather than cephalochromin (116). However, subsequent circular 
dichroism (CD) experiments suggested otherwise. 
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Figure 4.6: IH NMR spectrum oflhe active compound in Fox 35-2-5 extracts in DMSO-d6 
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Figure 4.7: DC APT spectrum of the active compound in Fox 35-2-5 extracts in DMSO-d6 
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4.4. 1 Circular Dichroism of the active compound from extracts 
of Wai 7-1-1 and Fox 35-2-5 
The absolute stereochemistry of chaetochromin A (119), a bis(naphtho-y-pyrone) 
related to 116 and 118, had previously been detennined by x-ray crystallography.[J33] 
OH OH 0 OH OH 0 
HO CH 3 HO ~CH3 
HO HO ;rCH3 
CH 3 
OH OH 0 OH OH 0 
119 118 
The CD spectra of chaetochromin A and cephalochromin have previously been shown 
to be the same. llJ2, \J3] Figure 4.8a shows the literature CD spectra for chaetochromin A, 
cephalochromin and ustilaginoidin F. The experimental CD spectra for the bioactive 
compound In extracts ofWai 7-1-1 and Fox 35-2-5 in MeOH is shown is Figure 4.8b. 
B X 10'· () X 10'· 
50 50 
40 40 
30 30 
20 20 
10 10 
0 0 
·10 -10 
'20 -20 
-30 - 30 
-40 -40 (b) 
-50 -50 
Figure 4.8: Literature CD spectra (a) for cephalochromin (red), chaetochromin A (green) and 
ustilaginoidin F (blue) in dioxane ll .;21''1 and experimental (b) CD spectra for the bioactive compound 
isolated from extrac ts ofWai 7-1-J and Fox 35-2-5 in MeOH 
Thus the correct stereochemistry around the C9 _C9' bond was able to be detennined by 
comparison of the CD spectrum of the bioactive compound in extracts ofWai 7-1-1 and 
Fox 35-2-5 with those of 116 and 118. It has been shown that a positive Cotton effect at 
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294 nm arises from the long axes about the C9 _C9° bond being twisted in a clockwise 
manner. The reverse is true for a negative Cotton effectJ133] The active compound of 
extracts of Wai 7-1-1 and Fox 35-2-5 showed positive first (8 45 x 104 (294 nm)) and 
negative second (8 -35 x 104 (266 nm)) Cotton effects (Figure 4.8b) which were almost 
identical to that for ll6 (Figure 4.8a).[132, 133] The slight differences between the two 
CD spectra were attributed to the different solvent systems in use. 
The differences between the IH NMR spectra of 116 and the active compound in 
extracts of Wai 7-1-1 and Fox 35-2-5 were attributed to the use of a different solvent 
while obtaining the IH NMR spectrum. To confinn this a IH NMR spectrum of the 
active compound from extracts of Fox 35-2-5 in CDCh was obtained and showed that 
the signals for the two protons on C3 were replaced with a resonance at ~ 2.74. Thus 
the active compound in extracts of Wai 7-1-1 and Fox 35-2-5 was identified as 
cephalochromin (ll6). [131] 
4.5 Summary 
An intense yellow-green pigment was purified from culture extracts of two 
Cephalosporium-like fungal isolates and identified using spectroscopic methods as 
cephalochromin (1l6). Table 4.2 shows experimcntal l H and BC data in DMSO-d6 for 
116. 
Number 'H, multiplicity, (JHH Hz) HSQC/APT CIGAR NOESY 
2H 4.55 ddq (3, 6, 12.5) 73.0 2.93,2.74, l.37 
3aR 2.77 dd (3,17.5) 42.8 198.2, 101.7 4.56 ,2.93 , 1.3 7 
3~H 2.92 dd (12.5,17.5) 42.8 198.2, no ,20.6 4.56,2.74, 1.37 
4 198.2 
4a 101.7 
SOH 15.1 164.9 10.06,9.88 
Sa 104,3 
60H 10.1 158.7 15.08,9.88 
7R 6.52 s 100.1 160.1 ,158.7,107.2,104.3 9.88 
80H 9.9 160.1 160.1 , 107.2 , 100.1 15.08,10.06,6.55 
9 Dimer 107.2 
9a 141.6 
10H 5.72 s 98.6 155.0,107.2,104.3,101.7 
lOa 155.0 
11 CfI) 1.37d(6) 20.6 73.0,42.8 4.56,2.93 ,2.74 
Table 4.2: In and DC NMR data for the bioactive component of an extract of Fox 35-2-5 in DMSO-d6 
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5.1 Introduction 
Broth extracts from Gil 12-1-3, an Alternaria sp cultured from driftwood collected 
below low tide at Gilespies Beach, showed moderate cytotoxicity against the P388 cell 
line (9.7 Ilg/mL) but no antimicrobial or antiviral activity. This fungal isolate was 
targeted for further chemical investigation because preliminary investigations (Section 
5.2.1) of the crude extract showed that the cytotoxicity was centred on a single peak in a 
very complex HPLC chromatogram (Figure 5.2). An intense yellow pigment (141) with 
significant cytotoxicity against the P388 cell line (0.68 .ug/mL) was isolated and 
purified from extracts of this fungus. The chromatography of this compound is 
discussed in Section 5.3 and the structural elucidation described in Section 5.4 of this 
chapter. 
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5.1.1 Economic importance of Alternaria spp 
Many Alternaria spp are responsible for major crop losses worldwide, through either 
plant diseases or contamination of animal feed. Diseases caused by Alternaria spp 
include early blight of potato and tomato by Alternaria solani, [134] black spot of onion 
by A. porri[135] and wheat by A. alternata and A. triticina.[136] The degree of 
pathogenicity by Alternaria spp varies depending on the type of toxin the pathogen 
produces. These are either host specific (HS) or non-specific toxins. 
5.1.2 HS Toxins 'from Alternaria spp 
HS toxins are highly toxic to a specific plant species or cultivar that serves as a host for 
the fungus, and are generally required for fungal pathogenesis to occur. Other plant 
species, or resistant cultivars, can tolerate a much higher dosage of the same toxin that 
would generally kill a susceptible plant. All HS toxin producing Alternaria strains are 
extremely pathogenic towards their hosts. However, strains that are unable to produce 
HS toxins are not pathogenic. [136] Several HS toxins have been isolated, for example 
maculosin (120) and destruxin B (121). A fuller list is given in Table 5.1. 
Fungal Species Toxin Hostplant 
Alternaria alternata Maculosin (120)[137] Centaurea maculosa Lam. (Spotted Knapweed) 
A. brassicae Destruxin B (121i138] Rapeseed 
A.mali AM Toxin (122)[139] Apple, Pear 
A. citri ACTG Toxin (123)[139] Citrus (Dancy Tangerine) 
A. citri ACRL Toxin (124i139] Citrus (Rough Lemon) 
A. kikuchiana AK Toxin (125i139] Japanese Pear 
A. kikuchiana AF Toxin (126)[139] Japanese Pear, Strawberry 
A. alternata f. sp. lycopersici AAL Toxin TAl (127i139] Tomato 
Table 5.1: HS toxins isolated from species of Alternaria. 
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5.1.3 Non-specific toxins 'from Alternaria spp 
Non-specific toxins are typically less damaging to host plants and a large number of 
these toxins have been isolated from Alternaria spp. A small proportion of this total are 
listed in Table 5.2. 
Fungal Species Toxin 
Alternaria solani Altersolanol A (128)[140J 
Alternaria solani Hydroxybostrycin (129i I41 ] 
Alternaria tagetica Zinniol (130)[142J 
Alternaria porri Alterporriol A (131)[1431 
Altel"llaria solani Tetrahydroaltersolanol B (132)[144] 
Alternaria porri Macrosporin (133i145] 
Altel"llaria altemata Altertoxin I (134)[146] 
Alternaria temlis Alternario! (13Si147] 
Aftel"llaria kikuchianrl Tenauzonic Acid (136)[147] 
Table 5.2: Some non-specific toxins isolated from Altemaria app. 
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#' I'OH 
OH 0 OH 0 OH OH 
128 129 
0 
HO~l MeO HO ~ 
OMe OH 
130 
OH 
MeO 
OH 
OH 0 OH 
132 
Chapter 5 - Alternaria species 
MeO 
HO 
o 
OH 0 
133 
o 
135 
93 
o 
HO 
134 
o 
Many of these compounds, such as altersolano1 A (128)[148] and zimliol (130)y42] have 
also been reported as dimers.[135, 143] All of these compounds have been shown to be 
phytotoxic, however some also show additional biological activities. Altersolanols A-C 
are both antibacterial[J40] and cytotoxicY45, 147, 149] The altertoxins (134) are weakly 
mutagenic in the Ames Salmonella typhimurium assay, [146] and both tenauzonic acid 
(136) and the dibenzo-a-pyrones, such as altemario1 (135), are also cytotoxic. These 
last two compounds have been repeatedly isolated from Alternaria strains commonly 
found contaminating feedstuffs and as such are considered a major class of Alternaria 
toxins. [1 47] Although many Alternaria spp have been isolated from the marine 
environment only one, Alternaria maritima, was ever considered as of marine origin.[32] 
Doubt was later cast on this identification by Kohlmeyer and Kohlmeyer, due in part to 
a lack of fungal material available for confirmation of identity. [55] 
5.2 Culturing and extraction of Gil 12-1-3 
5.2.1 Preliminary investigations 
Gil 12-1-3 was isolated from driftwood collected at the intertidal zone of Gillespies 
Beach on the West Coast of the South Island of New Zealand in February 1999. After 
purification, the isolate was cultured in 250 mL PDB broth for 28 days, at 26°C in the 
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dark. Extraction with EtOAc and subsequent concentration under vacuum yielded a 
dark brown oily solid showing moderate cytotoxicity (9.7 I-!g/mL). 
Figure 5.1: Fungal isolate Gil 1~-1-3, an Alternaria sp, grown on seawater PDA plates. 
5.2.1.1 Chemical screening 
The chemical properties (polarity, charge and size) of the small scale extract of Gil 12-
1-3 were examined by "chemical screening" as in Section 3.2.1.1. 
Chromatography on C I8 concentrated the cytotoxicity to the MeOH/water fraction, with 
slight carry over into the MeOH fraction, indicating that the cytotoxic compounds were 
of high to medium polarity. The highest degree of cytotoxicity eluting from the LH20 
cartridge was seen in the last fraction, indicating that the bioactive compound(s) were 
small to medium in size « 500 Da). The highest level of cytotoxicity seen from CBA 
was in the first fraction, signifying that the compound(s) of interest were uncharged. 
5.2.1.2 HPLC Microtitre plate screening 
To obtain a chemical profile of the compounds responsible for the bioactivity an aliquot 
of the crude extract was chromatographed with reverse phase C I8 HPLC as before in 
Section 3.2.1.2. The microtitre plilte was then assayed for cytotoxicity against the P388 
cell line. The cytotoxicity of this extract was concentrated to a single peak in the HPLC 
chromatogram, which eluted at 8.5 minutes (Figure 5.2) and displayed a very distinct 
UV spectrum (Figure 5.3). 
Chapter 5 - Alternaria species 95 
o 0 ~.5 5.0 "1.5 10.0 12 5 15.0 17.5 20 .0 22 5 25.0 27.5 30.0 325 35.0 37.5 40.0 
Minutes 
Figure 5.2: Spectrum max plot HPLC trace (black) and bioactivity data (red) of Gil 12-1-3 with region 
of biological activity at 8.5 minutes (The blue line represents 50% cell death). 
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Figure 5.3: UV profile ofblOactive peak from HPLC trace (8.5 minutes) as obtained from microtitre plate 
fraction 
Based on the HPLC microtitre plate assay the following assumptions regarding this 
compound were made: first, the intense yellow colour and the UV -visible spectrum 
indicated that the compound of interest contained a highly conjugated system, and the 
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peaks at 220 and 268 run in the UV -visible clrromophore were also characteristic of a 
quinone moiety (137)P40] 
o C¢137 
o 
Secondly, initial positive ESI-MS results from selected bioactive wells of the microtitre 
plate showed an intense signal at 338 Da (MH+) which suggested the presence of a 
nitrogen atom. A search in both MarinLit and Antibase with these parameters found no 
matches, therefore further work was deemed necessary. 
Based on the observations from chemical screening and the HPLC microtitre plate this 
sample was initially separated using reverse-phase clrromatography on CIS. 
5.2.2 Large scale culturing and extraction 
As the initial small scale extract displayed significant biological activity, Gil 12-1-3 was 
cultured in a further 2 L of half strength PDB broth under the same conditions as 
described previously (Section 5.2.1). Repeated extraction of this culture with distilled 
EtOAc, followed by solvent removal under vacuum, resulted in a deep brown oil (149.2 
mg) displaying a bioactivity profile similar to that seen in the original extract (Figure 
5.2). 
5.3 Chromatography of Gil 12-1-3 extracts 
5.3.1 Chromatography of the large scale extract 
The chromatographic steps for the large scale extract ofGi112-1-3 are given in Scheme 
5.1. A more detailed description of chromatographic steps is given in the Experimental 
Section. 
5% 
EtOAc extract of 
Gil 12-1-3 (RKP 1.4) 
Column A CI8 (50 g) 
DCMinMeOH 
10% 60% 70% 80% 100% 10% 50% 100% 50% 100% MeOn 
RKP 1.93.3-4 
9.9mg 
4.7/Lg!mL 
RKP 1.93.6-8 
26.6mg 
25.6/LglmL Column D DIOL (12 g) 
Column B DlOL (12 g) 
EtOACinDCM MeOn in EtOAc 
10% 20% 40% 60% 80% 100% 5% 
>125 
Weight(mgl 
100% 
DCM 
RKP 1.125.7-9 
2.3mg 
1.1 /LgfmL 
Column C DlOL (I g) 
100% 
EtOAc 
100% 
MeOH 
RKP 1.171.3 
O.9mg 
2D N.MR experiments run on this 
sample in both CD,OD and DMSO·d6 
10% 100% 
>125 
Same elution profile 
asColumnB 
Combined by NMR 
Weight (mg) 
ICso (J.!glmL) 
Same elution profile 
as Column C 
Combined active extracts of 
Gil 12-1-3 (RKP2.224) 
29.1 mg 
RKP 2.265.2 (141) 
O.9mg 
0.68/LglmL 
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The complete large scale culture extract (149.2 mg) was initially purified by reverse-
phase C I8 (column A). A stepped gradient solvent system was used for sample elution, 
ranging from 10% H20 in MeOH to 100 % MeOH, through to DCM and followed by a 
final MeOH wash. The fractions (9.9 mg) that eluted between 60 and 70% MeOH/H20 
(RKP 1.93.4-5) were the most active against P388 with IC so values of 4.7 flg/mL and 
9.7 ~g/ml respectively. Purity analysis by reverse-phase HPlC (Figure 5.4) showed 
that these fractions contained a number of compounds, including the compound of 
interest, as detennined earlier from the HPlC microtitre plate (Section 5.2.1.2). 
Based upon analytical HPlC, assay and mass spectrometry data, fractions 4 and 5 were 
combined and further purified with normal phase chromatography on DIOl (column B). 
RKP 1.93.4 and 5 were eluted off DIOl column B using a stepped gradient from DCM 
through to EtOAc, then MeOH, co ll ecting a total of 12 fractions. Cytotoxicity was seen 
in fractions that eluted between 20 % DCM and 100 % EtOAc (RKP 1.125.7-8). 
Analysis of these fractions by HPlC showed a higher degree of purity (Figure 5.5), but 
11-1 NMR spectroscopy indicated the presence of a phthalate plasticizer in the sample, so 
a further purification step on normal phase DIOl was performed (column C). Six 
fractions were collected, with the coloured compound being present in only one of 
these, RKP 1.171.3 (0.9 mg). 
Peak of Interest 
Sol .... ent Front \ 
RKP 1.93.6 
RKP 1.93.6 --------'1 
RKP 1.934 
RKP 1.93.3 
i , 
:J7.~ 40.D 
Minules 
Figure S.4: Analytical reverse-phase HPLC of fractions RKP 1.93.3 to RKP 1.936 
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Figure 5.5: Analytical reverse-phase HPLC of fractions RK.P 1.125.6 to RKP ][25.9. 
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Due to the low mass recovered from column C, and as the compound of interest was 
highly coloured, the presence of 141 was henceforth determined by analytical HPLC, 
rather than by its biological activity. Although only approximately 0.9 mg of 141 was 
recovered, RKP 1.171.3 was examined by 10 and 20 NMR, with the structural 
elucidation of 141 described in Section 5.4. 
5.3.1.1 Chromatography of the combined fraction s 
The recovered mass of 141 was very low « I mg) and thought to be insufficient for a 
full structural identification. As a result attempts were made to re-culture the isolate Gil 
12-1-3. Revival attempts from storage on agar slopes, the original isolation plate, or 
from cold storage at -80°C all failed. It was therefore decided to combine all bioactive 
fractions from the chemical screening and the side fractions from columns A and B. 
The combined fractions (26.6 mg) were chromatographed on DIOL (column D) using a 
stepped gradient system from OCM to EtOAc to MeOH, with the yellow compound 
eluting at 100 % EtOAc, fractions RKP 1.159.3 and 4 (1.1 mg and 1.7 mg respectively). 
Analysis of these fractions by HPLC indicated the presence of numerous impurities and 
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as a result fractions RKP 1.159.3 and 4 were purified further on nonnal phase DIOL 
(column E) using a similar elution profile to that of column D. Both HPLC and In 
NMR spectroscopy (CD30D) of fraction six (RKP 2.234.6) from this DIOL column 
showed a high degree of purity and as a result was combined with RKP 1.171.3 to give 
3.2 mg. A lH NMR spectrum of the combined fraction (RKP 2.257.1) in CD30D 
initially showed a high degree of purity but after transfer to DMSO-d6 multiple new 
signals were observed. When this fraction was re-analysed by analytical reverse phase 
HPLC multiple new peaks were seen in the HPLC trace. As a result RKP 2.257.1 
underwent a final purification step by analytical reverse phase HPLC, with the yellow 
compound collected as it eluted off the column, RKP 2.265.2 (1.0 mg). As the mass 
recovered for this sample was similar to that obtained during initial chromatographic 
steps further 1D and 2D NMR experiments were deemed unnecessary. 
5.4 Structural elucidation of 141 
Attempts to obtain the molecular mass and molecular fonnula of compound 141 were 
relatively unsuccessful, as ESI-MS data varied between injections, which indicated that 
the sample did not ionise well in either positive or negative ion modes in relation to 
sample contaminants. This compound was also analysed using alternative methods of 
ionisation (EI and LC-APcI) but the results obtained could not be rationalised. EI-MS 
suggested the parent ion to be 335 Da, but LC-APcI suggested a mass of 291 (1H-r) in 
negative ion mode and 261 (MHl in positive ion mode. The difference of 32 Da 
between positive and negative ion modes was attributed to the loss of a methoxyl group, 
hence the molecular ion was postulated to be 292 Da. It was not until the structure of 
141 had been proposed from the NMR data that the mass data were able to be 
rationalised. Re-examination of the ESI-MS data (Figure 5.6) from active wells of the 
microtitre plate (Section 5.2.1.2) showed intense signals at 359 and 695 Da in positive 
ion mode (MNa+ and M2HT- respectively), and a very weak signal at 337 (MRl. A 
negative ion ESI-MS of purified 141 showed a single intense signal at 335 (MR") and, 
when coupled to the data from positive mode ESI-MS, indicated that the mass of 
compound 141 was 336 Da. The difference of 1 mass unit between the mass used for 
Chapter 5 - Alternaria species 101 
the initial search in Antibase (MH' 338 Da) and the mass obtained after purification 
(MH+ 337 Da) was attributed to variations in the calibration of the instrument. 
% 
110.6 217.1 
157.0 
239.1 
253.1 
4132 
695.1 
454.2 
803.5 
Figure 5.6: Low resolution ESI-MS of active wells from a microtitre plate assay. 
The IH NMR spectrum (Figure 5.7) of 141 (CD30D) was very simple showing only 
eight signals, a methyl singlet (DR 1.42), an O-methyl (~ 3.91), a pair of aromatic 
proton signals (DH 7.15 and 6.74) and three methine signals (DH 3.84, 4.51 and 4.73). A 
small coupling constant of2.5 Hz was seen between the aromatic signals at DR 7.15 and 
6.74 which indicated a 1,3 relationship. The 2D NMR experiments, including HSQC 
(Figure 5.16) and CIGAR (Figure 5.17) carried out on this sample in CD30D were 
insufficiently defmitive to allow total structural assignment of 141. 
During purification it had been noted that this sample was very polar and therefore 
assumed to be highly oxygenated. If the oxygen atoms were present as hydroxyl groups 
then some signals might not be observed in the lH NMR spectrum when dissolved in 
CD30D due to deuterium exchange. Thus 141 was re-examined in DMSO-d6, which 
revealed five new signals in the IH NMR spectrum (Figure 5.8). As a result further 
HSQC and CIGAR experiments were performed on this sample in DMSO-d6. 
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Figure 5.8: lH NMR spectrum of141 in DMSO-d6, new signals are marked 1-5, 
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As the mass recovered of 141 was low no direct carbon observations were possible so 
al1 13C NMR resonances were obtained by HSQC (Figure 5.16), IJcH connectivities, and 
CIGAR experiments (Figures 5.17 and 5.19), nJCH connectivities. CIGAR experiments 
were also initially run in CD30D but were re-run in DMSO-d6 to determine if there 
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were any long range nJCH correlations from the hydroxyl protons. As stated previously 
the aromatic protons at OH 7.12 and 6.94 (DMSO-d6) showed coupling distinctive to a 
1,3 arrangement, and from HSQC experiments were attached to carbons at Oc 107.7 and 
6c 107.0 (DMSO-d6) respectively. Both of these protons showed CIGAR correlations 
to the carbons of each other (Oc 107.7, 107.0) and to a third quaternary carbon at Oe 
109.9. In aromatic systems 3.JCH correlations are often stronger than the corresponding 
2JCH correlations[150] therefore the carbon at 6c 109.9 was placed in position 5 in a 1,3,5 
arrangement. Because theSe; of the aromatic carbons were high field, coupled with the 
aromatic nature of the protons resonating at SH 7.12 and 6.94, it was concluded that the 
aromatic portion of the molecule was at least 1,3-dioxygenated (Figure 5.9). 
~CIGAR 
~ ... --- .... , 
JHH 
Figure 5.9: CIGAR correlations and 4JHH coupling constants for at 8H 7.12 and 6.94. 
A11 other proton signals were assigned to respective carbons by HSQC experiments, 
which were then connected via COSY (Figure 5.18) and 2D-TOCSY experiments 
(Figure 5.1 Oa-d). 
C5014 WH5000~ 4.58 H -...c_c--H 3.73 
68.6 I , 73.8 
I 
I 
, 
a b 
22.3 
H3C- - --
1.34 
c d 
Figure 5.lOa-d: Fragments deduced from COSY, TOCSY and HSQC (DMSO-d6) correlations for 141. 
The low field proton resonance at SH 4.0 I integrated for 3 protons which indicated an 
O-methyl group connected to either a double bond or a carbonyl group. This was 
confirmed by CIGAR experiments which showed a single intense 3 JCH correlation to a 
quaternary carbon at Sc 165.4 (Figure 5.11c). Of the hydroxyl protons, only SH 5.79 
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showed any CIGAR correlations, and this was to a quaternary carbon at be 142.1. Two 
further quaternary carbons were observed by CIGAR experiments, at be 72.9 and 144.6. 
The chemical shift ofthe carbon at be 72.9 suggested a CoO group and those at be 142.1 
and 144.6 suggested that they were part of an aromatic or conjugated double bond 
system. Further CIGAR correlations allowed the connectivity of the fragments in 
Figure 5.11 to be determined. 
a b 
OH 
5.79 
Figure 5.11a-c: CIGAR correlations (DMSO-d6) observed for 141. 
c 
The chemical shift of the quaternary carbon at be 165.4 (Figure 5 .11 c) was suggestive 
of an oxygenated aromatic carbon rather than a carbonyl group thus the O-methyl group 
was placed on the aromatic ring between the protons at bH 7.12 and bH 6.94. The 
phenolic proton resonance at bH 12.12 was attached to the other oxygenated position on 
the aromatic ring (Figure 5.12a). An important CIGAR correlation was seen from a 
proton resonating at bH 4.42 to a quaternary carbon at be 184.0. The chemical shift of 
this carbon suggested that it was a carbonyl group (Figure 5.12b). 
H 6.94 
7.12 
H 
OH 
12.12 
a 
HO H 
b 
Figure 5.12a-b: An important CIGAR correlation for OH 4.42. 
H 
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The fragments in Figure 5.12a-b were still 28 Da short of the postulated mass of 336 
Da. However, as stated previously. the purified sample was intensely coloured and thus 
to fulfil the required mass, conjugation and quinone nature of the molecule another 
carbonyl group was placed adjacent to position 4 in Figure 5.12b. The two carbonyl 
groups were then attached to the fragment in Figure 5 .12a, at positions I and 2, to give 
structure 138. 
o 
]38 
OH 0 
This structure was confirmed with In igh resolution mass spectrometry on the MNa+ ion 
rather than the weak MH+ ion. The calculated and experimental mass for this sample 
were identical, at 359.0743 Da. Structure 138 satisfies the mass, conjugation and the 
absorptions in the UV region characteristic of quinone moieties.[I40] 
A search for similar compounds in various databases found 138 to be a member of the 
al tersolano I s. 
5.4.1 Relative stereochemistry of 141 
Although the carbon experimental data were identical to those previously reported for 
altersolanol A,[134] discrepancies were seen between the experimental and previously 
reported proton data[140, 141] (Table 5.3). 
PrOUJn Number Altersolaflol A Experimental (DMSO-dJ ALtersolanol F 
H-CI-OH 4.38. "dO (4 Hz) 4.42.5.79 (65 Hz) 4.10 . 5.06 (7 Hz) 
Me-C2-0H 1.24 ,4.48 1.34,4.56 I 14.4.114 
H-C3-0H 3.64 , 5.00 (7 Hz) 3.73,5.00 (7 Hz) J.b l • 4 . ~O (7 Hz) 
H-C4-0H 4.54. 5.71 (7 Hz) 4.58.5.14 (7 Hz) 4.45.5.67 (7 Hz) 
5-0H 12.15 12.12 
H-C6 6.72 (2' Hz) 6.94 (25 Hz) 6.93 
7 3.90 401 H 
H-C8 693 (2.5 Hz) 7.12 (2.5 Hz) 6 . 9~ 
Table 5.3: Comparison of proton (I H) signals and 3JHH (Hz) in DMSO-d6 of two altersolanols and 
experimental data fo r 14]; differences are highlighted in red[l40] 
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Two discrepancies involved the inversion of hydroxyl proton signals at C1 and C4, with 
a third being a difference in proton coupling between H-C-OH at Cl . The differences in 
hydroxyl proton assignment could be due to a reporting error, but the third difference 
was attributed to an alternate stereochemistry. To confinn this, ID NOESY 
experiments were carried out on signals at OH 1.34,4.01, 6.94 and 7.12. Unfortunately 
due to an extremely low sample mass « 0.4 mg) no NOESY correlations were 
observed. 
There. are four carbon centres in altersolanol A at which the stereochemistry can vary 
and two where regioisomers are possible. The four stereocentres are CI _C4, with the 
possibility of regioisomers centred on C5 and C7• The functional groups at C1_C4 can 
exist in two confonnations, pseudo-axial or pseudo-equatorial, which would display 
differing JHH for each proton pair at each stereocentre. Therefore an examination of the 
coupling constants for these stereocentres was warranted. The O-methyl at OH 4.01 
could be attached at either C7 or C5 as in altersolanol A (139) or F (140) respectively. 
o OH 
HO 
139 
o 
o 
140 
OH 
A comparison of the reported lH signals in the A ring,P40] showed the experimental 
values (Table 5.3) to be almost identical with those of altersolanol A (139), which 
indicated that the O-methyl group was attached at C7 and the phenolic hydroxyl 
attached at C5, rather than the other way around as in altersolanol F (140). However, 
the 3 JHH coupling constant of 4 Hz between the proton signal at Oa 4.42 and the 
hydroxyl proton signal at Oa 5.79 on C1 for altersolanol A did not agree with the 
experimental value of 6.5 Hz. Of the fourteen altersolanols reported only altersolanol F 
has a coupling constant close to 6.5 Hz at C l , with the reported value being 7 Hz. [140] 
This indicates that 141 has the same relative stereochemistry for all the hydroxyl groups 
around the C ling as that seen in altersolanol F (Figure 5.13). 
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Figure 5.13: Experimental 3)1-11-1 coupling constants for 141 (a) and literature coupling constants for 
altersolanol FI140J (b) 
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The final position at which a variation in stereochemistry can occur is at C2. Since a 
methyl group is attached at this centre, no coupling is seen for the hydroxyl signal. 
However, all previously reported altersolano]s[102] have the same stereochemistry at C2 
as shown in Figure 5.13. Energy minimisation of the structure represented in Figure 
5. 13 using MM2 minimisation parameters in Chem3D (Cambridge software) indicated 
two possible conformations (Fi gure 5.14a-b). There are unfavourable dipole 
interactions in Figure 5.14a between the hydroxyl groups at C1 and C2, C1 and C3, and a 
third interaction between the methyl and hydroxyl groups attached at C2 and C4 . In 
Figure 5.14b the only unfavourabJe interaction is between the hydroxyl groups of C3 
and C4, thus suggesting that Figure 5.14b is the preferred conformation . 
• 
• • • 
• fr • .--- • • 2 3 • ~ 2 3 ... HOII'" 1_4 OH 4 • .t ~t~ • • • • • • 
a b 
Figure 5.J4a-b: Energy minimised diagrams for the two possible conformations of the C-ring of 141. 
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The dihedral angles between the protons attached at C3 and C4 (OH 3.73 and OH 4.58) 
were -80.4° (Figure 5.l4a) and -159.8° (Figure 5.l4b). Calculation of the coupling 
constants with the Karplus equation[l51] for these two confonnations gave 3 JHH 
couplings of 1.1 and 7.7 Hz respectively, thus the observed coupling of6.5 Hz between 
these two protons further indicates that Figure 5.14b is the favoured confonnation to 
give 141. 
H 0 
MeO 
141 
H 
H 
OH 0 
5.5 Discussion 
An extract from an Alternaria sp was found to possess mild cytotoxicity against the 
P388 cell line. The cytotoxic component was purified and assigned as a new member of 
the altersolanols, tentatively called altersolanol J. 
As this fungal culture was unable to be revived, future work on 141 would require a re-
isolation of Alternaria spp from substrates collected from the initial sampling site. If 
any extracts from these Alternaria spp were found to produce the yellow pigment, large 
scale culture and subsequent purification could enable the stereochemistry of 141 to be 
definitively assigned by either further NOESY experiments or X-ray crystallography. 
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Experimental 1H and 13C NMR data for compound 141 are shown in Tables 5A and 5.5, 
in CD30D and DMSO-d6 respectively. 
H 0 
MeO 
H 
OH 0 
Figure 5.15: Altersolanol numbering system for Tables 5.4 and 5.5 
Number lH, multiplicity, (JBo Hz) HSQC CIGAR 
1H 4.51 s 69.1 184.0, 144.1 ,142.4,74.2,73.6 
2Me 1.42 s 21.1 74.2,73.6,69.1 
3H 3.84 d (7) 74.2 69.6 
4H 4.73 d (7) 69.6 144.1 , 142.4,74.2 
6H 6.74 d (2.5) 105.8 110.0,107.5 
70Me 3.91 s 55.6 166.7 
8H 7.15 d (2.5) 107.5 110.0,105.8 
TabJe 5.4: IH and DC NMR data for 141 in CD30D. 
Number lH, Illultlplicity, (JHH Hz) COSY TOCSY HSQC CIGAR 
I-H 4.42 d (6.5) 5.79 5.79 68.5 184.0,144.6,142.1 .73.8,72.9 
1-0H 5.79 d (6.5) 4.42 4.42 142.1 
2-Me 1.34 s 22.3 73.8,72.9,68.5 
2-0H 4.56s 68.5 
3-H 3.73 t(6.5, 7) 5.00,4.58 5.14,5.00,4.58 73.8 68.6,22.3 
3-0H 5.00 d (7) 3.73 5.14,4.58,3.73 
4-H 4.58 t (6.5,7) 5.14,3.73 5.14,5.00,3.73 68.6 144.6, 142.1 .73.8 
4-0H 5.14 d (6) 4.58 5.00,4.58,3.73 
5-0H 12.12 br s 
6-H 6.94 d (2.5) 7.12 7.12 107.0 109.9 
7-0Me 4.01 s 56.3 165.4 
8-H 7.12d (2) 
• 
6.94 6.94 107.7 109.9 
TabJe 5.5: IH and BC NMR data for 141 in DMSO-d6• 
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Figure 5.16: HSQC spectrum of 141 in CD)OD 
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Figure 5.17: CIGAR spectrum of141 in CD30D 
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CHAPTER SIX 
FOX21-2-6a - 5TKEFTOMYCE5SF 
6.1 Introduction 
Broth extracts from Fox 21-2-6a, a Streptomyces sp isolated from driftwood collected 
near the mouth of the Fox River, showed excellent cytotoxicity towards the P388 cell 
line « 97.5 ng/mL). This microbial isolate was targeted for chemical investigation 
because it showed large zones of inhibition against some filamentous fungi when grown 
together on agar plates. Investigations (Section 6.2.1) into the small scale crude extract 
showed that the cytotoxicity was centered on a series of small peaks in a relatively 
simple HPLC chromatogram (Figure 6.2). Six intense red antibiotics (154 - 159), all 
with excellent cytotoxicity against the P388 cell line (378 - 65 ng/mL respectively) were 
purified from culture extracts. The chromatography of these compounds is discussed in 
Section 6.3 and the structural elucidations described in Sections 6.4 and 6.5 of this 
chapter. 
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6.1.1 Antibiotics 
Almost all the compounds produced by actinomycetes are termed antibiotics. The vast 
majority of antibiotics are of microbial origin and can inhibit the growth of other 
organisms, but not the antibiotic producer. The first known antibiotic was 
mycophenolic acid (7) originally described in 1896 and was followed closely by 
penicillic acid (68) in 1913[152] and penicillin in 1928. 
OH o 
o 
OH HO 
'-...0 
7 68 
Sporadic discoveries of various antibiotics, including penicillin, were made until the 
early 1940's when the number discovered started to increase significantly. The 
discovery of the actinomycins from various Streptomyces spp in 1940 by Waksman and 
Woodruf:ti153] was followed closely by streptomycin from Streptomyces griseus in 
1943Y54J In fact all of the antibiotics used in human and veterinary medicine in the 
1950's except for penicillin were derived from actinomycetesY52J Actinomycetes are 
still the most prolific source of antibiotics with approximately 4600 compounds isolated 
by 1998 followed by fungi (1600 compounds) and other bacteria (960 compounds)YJ 
6.1.1.1 Antibiotic compounds from actinomycetes 
A vast number of antibiotics that have been isolated from actinomycetes possess an 
extremely diverse range of biological activities including antitumour and immunogenic 
compounds. Some of the best known antitumour compounds include the mitomycins 
such as mitomycin C (142), various actinomycins and the aclacinomycins, such as 
aclacinomycin A (143), which is also known to act as an immunomodulator. 
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o 
142 
Although antibiotics can possess very complex structures they are still biosynthesized 
from simple building blocks such as acetate, sugars and amino acids. 
6.1.1.2 Peptide derived antibiotics from actinomycetes 
Perhaps one of the most important peptide derived antibiotics from Streptomyces spp is 
c1avulanic acid (144), a member of the ~-lactam family of antibioticsYsS] Although 
c1avulanic acid is a weak antibiotic it was found to be an irreversible inhibitor of many 
~-Iactamases This prompted interest in the development of semi-synthetic penicillin 
analogues that were also capable of ~-lactamase inhibitionys6] 
144 1 
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The major difference between clavulanic acid (144) and penicillin G (1) is replacement 
ofthe sulphur atom in the five membered ring with an oxygen atom. 
Another well known peptide antibiotic is vancomycin (145), from Amycolotopsis 
orientalis, which has been widely used in medicine especially against ~-lactam resistant 
bacteriaP 57] 
t! OH ~ - 0 
" ~~~I1"""IIiH 
HO 
lItH NH 
I 
HO 
OHHO 145 
6.1.1.3 Pofyketide derived antibiotics from actinomycetes 
Some of the best known polyketide antibiotics include the tetracyclines, the 
anthracyclines and the nystatins. Tetracyclines, such as chlortetracycline (146), are 
widely used both in veterinary and human medicine and show a broad spectrum of 
activity against both Gram-positive and Gram-negative bacteria. However, their use is 
limited as they also display significant toxicity towards humans. [156] 
146 
OH 0 OH 0 
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The anthracycline group of antibiotics, such as doxorubicin (147), are synthesized in a 
similar way to that of the tetracyclines, but nonnally contain one or more sugar residues. 
Doxorubicin and the related anthracycline daunorubicin (148) are both used for the 
treatment of various solid tumours. Once again however, these antibiotics are relatively 
toxic at high dosesY 561 
o OH 
o OH 0 
IT! 
OH \'" 
o 
147R= OH 
148 R=H 
The third class of compounds which include the antifungal nystatins are the macrolides 
which contain a lactone ring and at least one sugar residue. The macrolides can be split 
further into those compounds with 12 - 16 atoms forming the lactone ring, such as 
erythromycin A (149)p581 and those with 26 - 38 atoms in the macro lactone ring 
including two to seven unsaturated bonds such as nystatin Ai (150). [159] 
QH 
OH 
0 
HO OH OH OH 
eOOH 
# # # # 
o ~H2~ 
OH 
150 
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Another unusual but well known group of macrolides are the antihelminthic 
avermectins which include the ivermectins (151)Y60] These compounds contain a 16 -
membered lactone ring and possesses very potent anti-nematode activity with little or no 
side effects which make them ideal for the control of nematodes in farm animals. 
H 
OH 
151 
6.1.1.4 Miscellaneous antibiotics from actinomycetes 
The antimicrobial antibiotic chloramphenicol (152) was initially isolated from the 
actinomycete Streptomyces venezuelaeY61] It possesses a broad spectrum of 
antibacterial activity and works by inhibiting bacterial protein synthesis. Soon after the 
discovery of chloramphenicol it was able to be synthesized in the laboratory from p-
nitroacetophenone[l62] and is currently produced conunercially via a fully synthetic 
process. [156] 
OH OH 
152 
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Another very well known antimicrobial antibiotic, streptomycin (153), is also produced 
by various Streptomyces sp and was first discovered in 1944 by Schatz et al. [154] 
Streptomycin, an unusual trisaccharide, functions by selectively inhibiting cell wall 
biosynthesis in Gram-positive bacteria ultimately causing bacterial lysis and cell death. 
All of the antibiotics that have been isolated to date have been classified by Berdy163] 
based on their carbon skeletons into nine major groups. This classification system is 
open ended which enables newly discovered compounds with slightly different or 
previously unknown carbon skeletons to be easily integrated in the classification system 
without disrupting the numbering system in use. 
6.2 Culturing and extraction of Fox 21-2-6a 
6.2.1 Preliminary investigations 
Actinomycete isolate, Fox 21-2-6a, a Streptomyces sp, was isolated from a section of 
driftwood collected in the water below the low tide zone at the mouth of the Fox River 
on the West Coast ofthe South Island of New Zealand in October 1998. 
A small scale extract prepared from a culture grown in 250 mL starch casein broth 
showed significant cytotoxicity towards the P388 cell line « 97.5 ng/mL) and as such 
was selected for chemical investigation. 
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Figure 6.1: Isolate Fox 2 J -2- 6a (Streptomyces sp) grown on a starch-casein plate. 
6.2.1.1 Chemical screening 
The small scale EtOAc extract was chromatographed on CBA, C I 8 and LH20 cartridges 
(Section 3.2.1.1). 
Chromatography on CBA concent rated the cytotoxicity into the first two fractions with 
limited carryover to the third fraction. The second and third fractions from the LH20 
cartridge both showed activity with the highest level of cytotoxicity seen in the third 
fraction and chromatography on C I8 concentrated the activity into the third fraction. 
Thus the compound(s) responsible for the cytotoxicity were thought to be of medium 
size, non-polar and neutral to positively charged. After sample elution from the C I8 
cartlidge it was noted that a large amount of colour was retained. However, as the 
biological activity had eluted fro m the cartridge this was not considered a significant 
problem. 
6.2.1.2 HPLC Microtitre plate screening 
The biological profile of this extract showed that the bioactivity was centred on four 
small peaks eluting between 10 and 12 minutes in the HPLC chromatogram (Figure 6.2) 
and which aJJ showed the same very distinctive UV spectrum (Figure 6.3). The UV 
spectra of the bioactive compounds in this extract were similar to the UV spectrum of 
141 (Figure 5.3) suggesting that the bioactive components of this extract contained a 
similar chromophore. However, as the bioactive components of Fox 2J -2-6a absorbed 
at a longer wavelength in the UV spectrum (492 ron rather than 434 nm) it was 
postulated that the chromophoric group of the bioactive compounds from Fox 21-2-6a 
was more extensively conjugated. 
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Figure 6.2: Spectrum max plot HPLC trace (black) and bioactivity data (red) of a Fox 21-2-6a extract 
showing region of biological activity (the blue line represents 50% cell death). 
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Figure 6.3: UV spectrum of bioactive peaks from HPLC trace (10 - 12 minutes) as determined by the 
microtitre plate assay 
Chapter 6 - Streptomyces species 125 
ESI-MS of the bioactive wells from the microtitre plate showed a series of small peaks 
« 1 0 % peak intensity) between 500 - 560 Da and 800 - 860 Da with two large peaks at 
810.4 Da and 826.4 Da. The mass spectrum from the active microtitre plate wells and 
the UV spectrum from the HPLC trace indicated that the compounds most likely 
responsible for the biological activity of tlus extract were analogues of the 
aclacinomycins, a group of anthraquinone glycosides with an intense red/orange colour. 
A subsequent search in Antibase with the UV maxima found four matches with a 
molecular mass of 810 Da and a further twelve matches with a mass of 826 Da. So to 
identify which aclacinomycins the bioactive components were, the extract was further 
purified. 
6.2.2 Large scale culturing and extraction 
To obtain enough sample for purification the microbial isolate Fox 21-2-6a was cultured 
twice in starch casein broth under sinlilar conditions as described in Section 6.2.1. The 
first large scale culture was prepared in 4 L broth for 30 days and the second in 10 L 
broth for 18 days. Repeated extraction of these cultures with distilled EtOAc, followed 
by removal of the solvent under vacuum yielded a deep red solid for the first extract 
(420.5 mg) and a viscous red/purple oil for the second extract (7 mL). The first extract 
showed cytotoxicity towards the P388 cell line on a par with that of the small scale 
extract used for the prelinUnary investigations (Section 6.2.1). However, the second 
extract showed a decrease in observed cytotoxicity thought to be due to the large 
volume of oily material present in the extract. 
6.3 Chromatography of Fox 21-2-6a extracts 
6.3.1 Chromatography the first Fox 21-2-6a extract 
The chromatographic steps for the first large scale extract of Fox 21-2-6a are shown in 
Scheme 6.1. A more detailed description of the chromatographlc steps carried out on 
this extract can be found in the Experimental Section. 
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four most active fractions (RKP 1.57.8-11, ~ 2000 ng/mL) was actually much lower 
than that seen in the cmde extract (167 ng/mL). As these four fractions were very oily 
in nature the observed decrease of biological activity was thought to be due to the 
presence of a large amount of fatty acid/triglyceride material. A similar group of peaks 
was observed in the HPLC trace and the ESI-MS spectra for fractions RKP 1.57.8 and 9 
as was also the case for fractions RKP 1.57.1 0 and 11. Based upon these results RKP 
1.57.8 and 9 were combined as were RKP 1.57.10 and 11 and both subsequent fractions 
were further purified by normal phase chromatography on DIOL (columns Band C) 
using the same stepped gradient system that was used for column B in compound 141. 
None of the fractions of RKP 1.57.8-9 from column B showed any biological activity. 
However, a large quantity of material eluted from this column in the first three fractions 
and after solvent removal, these three fractions proved to be very oily. These three 
fractions were an intense red colour, and as previously indicated from the HPLC 
microtitre plate this colour was indicative of the compound(s) thought to be responsible 
for the cytotoxicity of this extract. However, further attempts to remove the oily 
material were unsuccessful suggesting that the oily material was attached to the 
chromophoric group. 
A similar mass elution profile was seen for the second set of combined fractions (RKP 
1.57.10-11) when subjected to normal phase chromatography with DIOL (column C). 
In this case however, cytotoxicity ranging from 423 ng/mL to almost 6000 ng/mL was 
observed in almost all of the fractions (RKP 1.124.2-11). The middle fractions (RKP 
1.124.2-9) all showed similar HPLC profiles with three peaks of varying intensities 
eluting between 12 and 14 minutes and as such these eight fractions were recombined 
and subjected to a further chromatographic step on Sephadex LH-20, as was the case 
with the first (RKP 1.124.1) and last (RKP 1.124.11) fractions that eluted from DIOL 
column C. Columns D and E of RKP 1.124.1 and RKP 1.124.2-9 respectively both 
showed a similar mass - elution profile with biological activity detected only in the 
second fractions (RKP 2.243.2 and RKP 2.244.2 respectively). Both of these fractions 
comprised an intense red oil which only showed cytotoxicity at very high 
concentrations. This indicated that the compound(s) of interest were present only in 
very low concentrations, but once again attempts to remove the oily material were 
unsuccessful. The third LH20 column (column F) also showed the highest level of 
cytotoxicity in the second fraction (RKP 2.245.2) with moderate activity seen in the two 
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side fractions. HPLC analysis of these three fractions all showed a similar series of 
peaks between 11 and 14 minutes (Figure 6.4). 
Solvent Front 
/ 
I 
Solvent Change 
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Figure 6.4: HIlLC chromatogram ofRKP 2.245.1-3 
The I H NMR spectrum of RKP 2.245.2 (Figure 6.5) showed three low field phenolic 
protons between bH J 2.0 and bH 13.0, some aromatic signals between bH 7.0 and bH 8.0, 
and some possible anomeric signa ls between bH 5.0 and bH 6.0. A low sample mass and 
the presence of multiple impurities within this fraction prevented further work on this 
extract and because of this a second extract was prepared from 10 L of starch casein 
broth. As stated previously this extract was cultured for only 18 days rather than 30 
days with the ensuing extract unable to be completely dried to a powder due to the high 
volume of oily material present in the extract. The chromatography of this second 
extract is detailed in Section 6.3.2. 
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6.3.2 Chromatography of the second Fox 21-2-6a extract 
The high volume of oily material suggested that a slightly different approach be used for 
purification ofthis extract. The chromatographic steps for this second extract are shown 
in Scheme 6.2 with a more detailed description of the chromatographic steps carried out 
on this extract found in the Experimental Section. 
10- 90 % 
MeOR 
Second EtOAc extract of 
Fox 21-2-6a (RKP 2.266) 
Column A CIS (50 g) 
100% MeOR 
-lOO%DCM 
50% Da.1 -100% McOR 
+0,05 % TFA 
RKP 2,267,1-7 8-11 12-13 
Weight (mg) 2 mL 46lJ.9 11.9 
Column C 
DIaL (2 x 40 g) 
23.1 96.4 
I 
PeL Ether 
Solubles 
MeOH 
Solubles 
RKP 2,270.1-5 7-10 11-14 15-16 
5.5 2.6 7.2 47.4 
RKP 2.303.1-3 4 ~ Pel. Ether MeOR 
Column E DIaL (l g) 
Solubles Solubles 
Column F DIOL (20 g) 
RKP 2.309.1 2-3 4-5 
RKP 2.307.1-7 8-15 16-17 18-28 
4.3 4.7 9,3 
Y 18.1 7.4 1.4 22.3 ........ 
RKP 2.334.1-2 MeOR Pet. Ether 
MeOH Pet. Ether 
Solubles Solubles ColumnG LH20 (20 g) 
I RKP 2.320.1 2 
Solublcs Solubles (154) 
RKP 2 348 2 (155) 58.4 7.7 2.4 
7.8mg 
65nglmL 
Analytical HPLC 
I I I I I I I 
RKP 3.363.1 RKP 3.363.2 RKP 3.363.3 (159) RKP 3.363.4 (158) RKP 3.363.5 (157) RKP 3.363.6 (156) RKP 3.363.7 (154) 
O.4mg O.5mg O.9111g 1.4mg l.4mg 1.1 mg 2.0mg 
575nglmL 525 nglmL 378 nglmL 378nglmL 227 nglmL 141 nglmL I05nglmL 
Scheme 6.2: Purification flow chart of the second extract of the microbial isolate Fox 21-2-6a 
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The second crude extract of Fox 21-2-6a was initially fractionated on CI8 with the same 
method as used for column A in Scheme 6.1. However, because the bioactivity profile 
was expected to be similar to the first extract the various fractions were collected 
together based on colour differences in the various fractions. RKP 2.267.1-7 were all 
yellow in colour and RKP 2.267.8-13 were all deep red. The last two of these fractions 
(RKP 2.267.12-13) required 0.05 % TFA in the mobile phase to elute off the column 
and as such were kept separate from the other four red fractions (RKP 2.267.8-11). The 
cytotoxicity ofRKP 2.267.8-11 and RKP 2.267.12-13 was unable to be determined due 
to the high volume of oily material present in the fractions. However, RKP 2.267.1-7 
showed no cytotoxicity towards the P388 cell line. 
RKP 2.267.12-13 
In an attempt to remove the excess oil from this combined fraction a slightly different 
elution profile with normal phase chromatography on DIOL was devised. The high 
mass of this fraction meant that it needed to be split into two then run in series. RKP 
2.267.12-13 was eluted from normal phase DIOL (column B) with a stepwise gradient 
starting at Pet. Ether (bp 40 - 60°C) through to DCM, then EtOAc and fmally MeOH 
collecting 16 fractions in total. No cytotoxicity was observed in the first five fractions, 
but all subsequent fractions displayed excellent cytotoxicity. Analysis of fractions RKP 
2.270.7 - 10 by reverse phase CI8 HPLC showed that all four fractions contained similar 
components but were still relatively complex however, this complexity combined with 
the low mass recovery in these four fractions prevented further investigations. Analysis 
of the next four fractions (RKP 2.270.11-14) by reverse phase HPLC indicated that 
these fractions all contained the same major principle and were relatively pure and as 
such were combined. A 1 H NMR spectrum in CDCh of the combined fractions showed 
a number of peaks arising from fatty acid contamination thus this combined fraction 
was washed with Pet. Ether which left less than 1 mg of active principle. Another IH 
NMR spectrum in CD30D indicated that the residue of this fraction was relatively pure 
but the low mass prevented further investigation of this fraction. The same IH NMR 
spectrum was also obtained from a later series offractions (RKP 2.307.8-15). 
The fmal two fractions from column B (RKP 2.270.15-16) both displayed relatively 
complex HPLC traces. As with the previous four fractions the IH NMR spectra 
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highlighted the presence of large amounts of contaminating fatty acid material, thus 
both fractions were combined and washed with Pet. Ether to remove the fats to leave 
less than 2 mg of sample. As with RKP 2.270.11-14 both the complexity of the IH 
NMR spectrum and the low sample mass prevented further investigations. These two 
fractions (RKP 2.270.15-1 6) were later combined with fractions RKP 2.307.18-28 for 
which the HPLC traces were virtually identical. 
RKP 2.267.8-11 
The same elution profile on normal phase DIOL for RKP 2.267.12-13 was also adopted 
for RKP 2.267.8-11 but with 20 fractions collected rather than 16. The first eight 
fractions from this round of chromatography (column C) showed no cytotoxicity and 
were very oily. However, all the subsequent fractions showed excellent cytotoxicity « 
97.5 nglmL). Reverse phase CI8 HPLC analysis of the cytotoxic fractions showed that 
RKP 2.274.10 - 13 were identical to each other and as such were combined. This was 
also the case in fractions RKP 2.274.14 and 15 which were also combined. The last five 
fractions (RKP 2.274.16 - 20) all contained over eight related compounds eluting 
between 11 and 15 minutes in the HPLC trace and as such these fractions were also 
combined. The first combined fractions (RKP 2.274.10 - 13) showed a number of peaks 
in the IH NMR spectrum typical of triglycerides thus a further purification step with 
normal phase chromatography on DIOL (column D) was done. The fraction was eluted 
from column D with a steep stepped gradient starting at 100 % Pet. Ether, through to 
DCM and finally to MeOH collecting bands of colour as they eluted. Only the second 
(RKP 2.303.2) and fourth (RKP 2.303.4) fractions from this column were red in colour. 
The second fraction (RKP 2.303.2) however, was also very oily which prevented further 
work on this sample. Both the IH NMR spectrum and the ESI-MS spectrum of the 
fourth fraction (RKP 2.303.4) indicated the presence of at least two different 
compounds thus this fraction was subjected to another purification step with normal 
phase chromatography on DIOL (column E). As the fats and oils had already been 
removed from RKP 2.303.4 this fraction was eluted from column E with a stepped 
gradient starting at DCM, into EtOAc and finally MeOH again collecting the coloured 
bands as they eluted. As with column D the coloured bands eluted in the second (RKP 
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2.309.2) and fourth (RKP 2.309.4) fractions. Reverse phase CI8 HPLC and IH NMR 
spectroscopy showed that fraction RKP 2.309.2 was identical to an earlier fraction 
(RKP 2.274.14-15) and as such these two samples were combined then washed with 
Pet. Ether to give 7.8 mg of 155. The structural elucidation for 155 is discussed in 
Section 6.5. 
The IH NMR spectra for the last two fractions from column E (RKP 2.309.4 -5) were 
identical to those of RKP 2.270.11-14, RKP 2.307.8-15 and RKP 3.363.7. However, 
only the last of these fractions (RKP 2.363.7) was examined fully by NMR 
spectroscopy. The structural elucidation of the compound in this fraction (154) is 
discussed in Section 6.4. 
RKP 2.274.16-20 
The last of the fractions from column C (RKP 2.274.16-20) were combined and purified 
on a long thin normal phase DIOL column (1000mm x 5 mm). A stepped gradient 
solvent system starting at 100 % Pet. Ether, through to DCM, EtOAc and on to MeOH 
was used for sample elution. The IH NMR spectra of the first seven fractions from this 
column indicated that they contained high levels oftriglycerides with very low levels of 
the compounds of interest which were characterised by low field phenolic protons 
between DR 12.0 - 13.0, aromatic signals between DR 7.0 and DR 8.0, anomeric signals 
between DR 5.0 and DH 6.0 and an O-methyl resonance between 8H 3.6-3.9. The IH 
NMR spectra for the remaining fractions showed signals comparable to those of the 
cytotoxic components. Fractions RKP 2.307.8 - 15 showed identical signals in the 
respective IH NMR spectra and a similar trend was also seen in the reverse phase CI8 
HPLC traces, thus these eight fractions were combined. Subsequent investigation of 
this combined fraction by NMR spectroscopy indicated that the major component was 
identical to 154. 
Fractions RKP 2.307.18 - 28 all showed a series of peaks in the reverse phase CI8 
HPLC traces that eluted between four and seven minutes which was identical to that of 
a pair of earlier eluting fractions (RKP 2.270.15 - 16) from column B. These thirteen 
fractions were subsequently combined, and subjected to size exclusion chromatography 
on Sephadex LH20 (column G). Although only one band of colour eluted from column 
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G (RKP 2.320.2) most of the mass eluted in the preceding fraction (RKP 2.320.1). 
Analytical reverse phase C 18 HPLC of the red fraction (RKP 2.320.2) indicated that 
there were at least five components in this fraction, all with the same UV spectrum and 
all eluting within hvo minutes of each other thus the final purification steps were canied 
out by HPLC. A 32 % ACN/H20 isocratic solvent system was used to separate the 
individual components of RKP 2.320.2 by analytical reverse phase C I 8 HPLC (Figure 
6.6). However, the relatively high mass of RKP 2.320.2 indicated that it would be 
easier to process this fraction by semi-preparative C I8 HPLC. Attempts to purify this 
fraction by semi-preparative HPLC were not successful as the samples were either 
retained on the column too long (approximately 2 hours) or only eluted with 100 % 
MeOH with no separation of the individual components. Compounds 154, 156 - 159 
were therefore purified from RKP 2.320.2 by analytical C I 8 HPLC, collecting the 
fractions as shown in Figure 6.6. 
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Figure 6.6: IIPLC chromatogram for RKP 2.320.2 
A further three fractions (RKP 2.307.16 - 17 and RKP 2.320.3) were subsequently 
processed to increase the yield of the compounds of interest. However, these two 
fractions also contained a seventh peak (RKP 2.363.6) located bet\veen RKP 2.363.5 
and RKP 2.363.7. All of these compounds displayed identical UV spectra suggesting 
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that they were derivatives of each other. Not enough mass was recovered for the first 
two fractions from the analytical HPLC collections thus only RKP 2.363.3 - RKP 
2.363.7 were examined by NMR spectroscopy and the structural elucidations for these 
five compounds (154, 156 - 159) are discussed in Section 6.4 
6.4 Structural elucidation 
6.4.1 Structural elucidation of 154 (RKP 2.363.7) 
High resolution ESI-MS indicated a mass of 585.2280 Da and a molecular formula of 
C30H35NOll (14 double bond equivalents). The high number of double bond 
equivalents coupled with an absorbance in the red region of the UV-visib1e spectrum 
suggested that 154 contained a highly conjugated aromatic system. The UV -visible 
spectrum also showed absorbances in the ultraviolet region similar to that seen for 141, 
suggesting that the chromophoric group of this compound was similar to that seen in 
quinones (137). However, the UV spectrum for 154 also showed a third intense peak in 
the ultraviolet region of the spectrum suggesting the presence of a third aromatic ring 
system attached to the quinone system, similar to that seen in 160. 
o o 
o o 
137 160 
The lH NMR spectrum in CD30D (Figure 6.7) showed 19 signals including two 
aromatic signals at 8H 7.5110 and 8H 7.08, an anomeric proton signal at 8H 5.56, a low 
field proton resonance at 8H 5.10, an O-Methy1 signal at ~ 3.75, two N-methy1 peaks at 
OH 2.87 and two methyl signals at 8H 1.33 and ~ 1.11 and many other signals between 
OH 4.4 and 8H 1.4. 
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A l3C spectrum was obtained for this sample and showed 33 signals (Figure 6.8) but the 
molecular formula indicated that there were only 30 carbons present in the molecule. 
Three ofthe signals however, were of a much lower intensity that those next to them. 
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Figure 6.8: DC NMR spectrum ofl54 in CD30D 
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The signals between Dc 191.6 and Dc 113.4 suggested that the postulated aromatic 
anthraquinone structure was highly oxygenated and this was further borne out by a lH 
NMR spectrum of 154 in CDCh which showed three phenolic signals below DH 12.0. 
COSY (Figure 6.35), TOCSY and HSQC (Figure 6.36) experiments enabled seven 
different spin systems to be determined (Figure 6.9a - d and Figure 6.1 Oa - c). The first 
of these spin systems showed correlations from the proton at DH 5.1 to a pair of CH2 
protons at ~ 2.56 and DH 2.28 with the proton at DH 5.1 showing a lJcH correlation to a 
carbon at Dc 72.9 which indicated the presence of an oxygen atom on this carbon 
(Figure 6.9a). The second spin system was an ethyl group with correlations from a 
methyl triplet at DR 1.11 to two proton multiplets at DH 1.76 and DH 1.56 (Figure 6.9b). 
The third and fourth spin systems were both part of an aromatic system. The first 
aromatic proton signal at ~ 7.08 integrated for two protons and showed two lJCH 
correlations in the HSQC spectrum to carbons with almost identical chemical shifts 
(Figure 6.9c). The second aromatic signal at DH 7.51 showed a lJcH correlation to a 
carbon at Dc 121.2 (Figure 6.9d). 
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Figure 6.9a-d: Fragments from correlations seen in COSY, TOCSY and HSQC experiments for 154. 
The proton in the fifth fragment at DR 4.07 showed a single lJCH correlation to a carbon 
at Dc 58.5 (Figure 6.1 Oa). The sixth fragment was relatively complex compared to those 
already assembled. The signal at ~ 5.56 was suggestive of an anomeric proton and 
showed correlations to proton resonances at ~ 2.28 and DR 2.08. The two signals at DR 
2.28 and DR 2.08 showed IJCH correlations to a carbon at Dc 28.1. The proton signal at 
DH 3.52 showed correlations to proton signals at DH 2.28, 2.08 and ~ 3.96. The proton 
resonance at DR 4.26 showed correlations to the proton signal at DH 3.96 and a methyl 
signal at DH 1.33. The lJCH correlations for the protons at DR 3.96 and DH 4.26 to carbon 
signals at Dc 66.1 and Dc 68.2 respectively were both indicative of an oxygen atom 
present on these two carbons. The IJCR correlation for the proton at DH 5.56 to a carbon 
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signal eSc 101.9 suggested the presence of two oxygen atoms on this carbon (Figure 
6.10b). One O-methyl and two N-methyl resonances were also seen. The two N-methyl 
groups showed the same lH and i3C chemical shifts. They were thought to be in a 
similar environment thus were placed on the same nitrogen atom (Figure 6.10c). 
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Figure 6.10a-c: Fragments from correlations seen in COSY, TOCSY and HSQC experiments for 154. 
Correlations in the CIGAR spectrum (Figure 6.37) enabled a full structural assignment 
of the non aromatic portion of 154. However, due to the high number of 
spectroscopically silent centres in the aromatic portion a full assignment was not 
possib Ie by NMR spectroscopy alone. The proton at eSH 5.1 0 showed correlations to 
three aromatic carbons at eSc 163.6, 144.1 and eSc 133.1, an oxygenated quaternary 
carbon at eSc 72.2 and the anomeric carbon at eSc 101.9. The CH2 protons at eSH 2.56 and 
OH 2.28 (Figure 6.9a) also showed correlations to an aromatic carbon at eSc 133.1, the 
oxygenated quaternary carbon at eSc 72.2 and the methine carbon at eSc 58.5 which 
enabled the connection of Figures 6.9a, 6.9d and 6.10b (Figure 6.11). 
Figure 6.11: CIGAR correlations observed for the protons at OJ[ 5.10,2.56 and 011 2.28. 
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The proton at DH 4.07 showed correlations to a carbonyl group at Dc 172.8, three 
aromatic carbons at Dc 144.1, 133.1 and 121.2, the oxygenated quaternary carbon atom 
at Dc 72.2 and the CH2 group at Dc 36.2 (Figure 6.12). 
o 
Figure 6.12: Observed CIGAR correlations for DR 4.10. 
The aromatic proton at DH 7.51 showed correlations to two aromatic carbons at Dc 133.1 
and Dc 116.0, a carbonyl at Dc 186.7 and the tertiary carbon at Dc 58.5. The correlations 
from DH 7.51 to Dc 133.1 and Dc 58.5 were both 3JCH correlations and as 3JCH 
correlations are often stronger in aromatic systems than the corresponding 2 JCH 
correlations it also places the other two correlations from this proton to the carbons at Dc 
186.7 and Dc 116.0 three bonds away. The low field chemical shift of the carbonyl 
resonance at Dc 186.7 was suggestive of an anthraquinone moiety (Figure 6.13). 
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Figure 6.13: CIGAR correlations observed for 8H 7.51. 
141 
The two aromatic protons at ~ 7.08 showed correlations to two low field oxygenated 
aromatic carbon signals at Dc 159.4 and Dc 159.0. The two remaining phenolic signals 
observed in the IH NMR spectrum of 154 in CDCb were attached to the to low field 
aromatic carbons at Dc 159.4 and Dc 159.0. Further correlations from the aromatic 
proton signals at DR 7.08 to carbons at Dc 113.4 and Dc 113.5 were also observed. The 
O-methyl resonance at DR 3.75 showed a single correlation to a carbonyl signal at Dc 
172.8 (Figure 6.14). 
4.26 I 
1.33~H 0, b 
H3C : 
3.96 H 
H 3.52 
H 2.08 
,0 
H 5.56 
Figure 6.14: CIGAR correlations observed for 8H 7.08 and 8H 3.75. S\jI1; interchangeable signals 
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The methyl resonance at bH 1.11 showed a correlation to the oxygenated quaternary 
carbon at be 72.2 which enabled connection of this fragment to the free position in the 
D- ring of the anthraquinone. This was supported with correlations from the two CH2 
protons of the ethyl group at bH 1.76 and bH 1.56 to the carbon at be 72.2 as well as 
individual correlations to carbons at be 36.2 and be 58.5 respectively (Figure 6.15). 
OH 
OH 
3.96 H 
" 
',.' 
II 
II 
II 
o OH 
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Figure 6.15: CIGAR correlations observed for OIl 1.76, 1.56 and OIl 1.11. 
The two N-methyl groups at bH 2.87 showed a single correlation to a carbon at be 63.9 
and the anomeric proton at bH 5.56 showed an important correlation to the carbon at be 
68.2 which enabled closure of the sugar ring (Figure 6.16). 
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Figure 6.16: CIGAR correlations observed for OJ{ 5.56 and OH 2.80. 
The two remaining positions in the fragment in Figure 6.16 must be filled by protons as 
the fragment has a molecular formula of C30H33NOll. This is two protons less than the 
molecular formula proposed from high resolution ESI-MS to give 154. The two 
carbons unassigned in the anthraquinone moiety were assigned from the l3C NMR 
spectrum with the very low field carbon signal at Oc 191.6 assigned as the second 
aromatic ketone group of the quinone ring which left the signal at Oc 133.8 to be 
assigned to the last available site ortho to the aromatic proton signal at OR 7.51. The 
relative stereochemistry seen in 154 below is discussed in Section 6.4.1.1. 
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There is one diastereotopic centre and three stereogenic centres in the O-ring (Figure 
6.17) of the anthraquinone moiety with a second diastereotopic centre in the ethyl group 
attached to the O-ring. 
o O~ OH o 
OH 
OH o OH o -Sugar Residue 
Figure 6.17: Ring labelling system for anthraquinones 
A further four stereogenic centres and one diastereotopic centre are also seen in the 
sugar residue. The coupling constants and 10 and 20 NOESY (Figure 6.38) spectra 
enabled the relative stereochemistry of the anthraquinone moiety and the sugar residue 
to be determined. 
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An important NOESY correlation was seen from the proton at bH 4.26 to a proton at bH 
3.52 which placed these two protons in axial positions. If one or both of these protons 
were in an equatorial position then NOESY correlations would not be observed. The 
proton at bH 3.52 also showed NOESY correlations to protons at bH 3.96 and bH 2.28. 
The final stereocentre in the rhodosamine sugar residue was at the anomeric carbon at 
be lOl .9. The 3JHH of2.5 Hz for the anomeric proton at bH 5.56 indicated that it was in 
an equatorial position. The only observable coupling for the proton signal at bH 2.28 
was a 2JHH of 15 Hz, thus the expected couplings to bH 3.52 and bH 5.56 must be small 
indicating dihedral angles approaching 90°. 
stereochemistry proposed for the sligar residue. 
--- 352W .~~ • H 4.26 
./ -'0 3.96 H ~ ~H3C)2N~b7 c~:-228H~l 1° 
I 5.56 HO 
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Figure 6.18 shows the relative 
Figure 6.18: NOESY correlations observed for the sugar residue of 154. 
The relative stereochemistry proposed for the sugar residue in Figure 6.18 indicates that 
it is a rhodosamine residue. 
The coupling constants and NO£. Y correlations for the proton signals of the D-ring 
enabled the relative stereochemistry of this ring to be assigned. The proton signal at bH 
5.10 showed a 3 JHH of 5 Hz, the proton peak at bH 2.56 showed a 3 JHH of 5 Hz and a 
2JHH of 15 Hz and the proton resonance at bH 2.28 showed a 2JH H of 15 Hz which placed 
the proton at bH 2.56 in the pseudo axial position. If the proton at bH 2.56 was in the 
pseudo equatorial position the resultmg dihedral angle would give rise to a 3 JHH of 8 -
10Hz for the proton at bH 5.10. The other two stereogenic centres were assigned with 
I D and 2D NOESY spectra. The proton signal at bH 2.56 showed a single NOESY 
correlation to the proton at bH 5.1 0 which suggested that the proton at bH 4.07 was in an 
equatorial position rather than an axial position for which a NOESY correlation would 
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have been expected. NOESY correlations were also observed from the protons at 6H 
4.07 and 6H 2.28 to the ethyl protons at 6H J .76 and 6H J .56 respectively to give a final 
relative stereochemistry of 7S*,9S*,1 OR* for the O-ring. This stereochemistry also 
allows a hydrogen bond between the OH group on C9 and the carbonyl group at C IO to 
be formed (Figure 6. J 9). 
Only the relative stereochemistry for the O-ring and the rhodosamine residue was able 
to be determined. Even if the absolute stereochemistry was known for either the O-ring 
or the rhodosamine residue this would be unable to be related to the other component 
via NMR experiments as the sugar is able to freely rotate around the anomeric bond. 
Thus NOESY correlations would be observed between 6H 5. J 0 on the O-ring and 6H 
5.56 on the sugar no matter what the absolute stereochemistry was. 
Figure 6.19: NOESY correlations observed in the anthraquinone core of 154. 
An [0:]0 of + 128° for 154 indicated that it was not a racemic mixture. 
A literature search based on 154, with no stereochemistry, indicated that 154 was a 
pyrromycin derivative.[IOl, 164, 165] However, the stereochemistry proposed for 154 had 
previously only been seen in one other anthraquinone, ruticulomycin B (161),[102, 166J 
Thus 154 was called (7S*9S* 1 OR *)-pyrromycin. 
Chapter 6 ~ Streptomyces species 147 
OH 0 
OH 
161 
OH 0 OH 
6.4.2 Structural elucidation of 156 (RKP 2.363.6) 
The second red compound from the analytical HPLC purifications was a shoulder on the 
major peak (154) and as such contained a large amount of 154. The high resolution 
ESI-MS spectrum of this fraction showed two compounds with molecular weights of 
585.2283 Da and 571.2126 Da corresponding to molecular formulae OfC30H35NOll and 
C29H33NOll respectively (both 14 double bond equivalents). The molecular weight at 
586 Da was due to the presence of 154 within this fraction thus the molecular weight of 
the compound of interest was actually 571 Da. The UV spectrum of 156 was identical 
to that of154 and therefore 156 must also contain the anthraquinone core (160). 
The IH NMR spectrum of 156 was very similar to that of 154. However, only one N-
methyl group was observed and therefore 156 must be the N-demethyl version of 154. 
The presence of only one N-methy1 group in 156 is also consistent with the slight 
increase in polarity. 
7.71 
OH 0 H 
7.38 H 
OH 
7.38 H \'H2.49 
H 2.31 
OH 0 OH H5.14 
a 
H 5.51 156 
3.92 H 
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The low mass (1.1 mg) and presence of 154 in this fraction prevented any further work 
on this sample. However, a search in Antibase found two similar N-demethyl 
compounds, pyrromycin X (162) and N-demethylaklavine (163)P02] To confirm the 
proposed structure this compound would need to be re-isolated from the culture medium 
of the isolate Fox 21-2-6a and then analysed with further NMR spectroscopic 
experiments. 
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OH 0 OH 0 OH 0 OH 0 
~ HN HN 
"" 
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162 163 
6.4.3 Structural elucidation of 157 (RKP 2.363.5) 
High resolution ESI-MS ofthis fraction indicated that 156, like 154, also had a mass of 
585.2282 Da and a molecular formula of C3oH3SNOll (14 double bond equivalents) with 
the same UV spectrum, indicative of an anthraquinone core. The lH NMR spectrunl 
(Figure 6.20) of this fraction indicated that 157 was a1so related to 154. However, there 
were significant differences in the NMR signals arising from the D-ring of the 
anthraquinone core. As the mass andUV chromophore of 157 and 154 were the same 
the difference in signal assignment must be attributed to differences in the 
stereochemistry . 
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The signals arising from the rhodosamine residue (8H 5.58, 4.17, 3.95, 3.52, 2.91, 2.85, 
2.29, 2.06 and 8H 1.33) were all almost identical to those seen in 154 thus the alteration 
in stereochemistry must be within the D-ring of the anthraquinone core. This was 
confirmed further as all the signals from the D-ring showed differences in the chemical 
shifts and the coupling constants. The signals observed for the D-ring in 154 were 8H 
5.10, 2.56, 2.28,4.07, 1.76, 1.56 and 8H 1.11, but in 157 the signals observed were 8H 
4.96,2.62,2.32,3.99, 1.49 and ~ 0.98 respectively. 
7.38 H 
7.38 H 
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6.4.3.1 Relative stereochemistry of 157 
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The proton signal at 8H 4.96 was now a triplet with a 3JHH of 6.5 Hz rather than a 
doublet at ~ 5.1 0 with a 3 JHH of 5 Hz. The two protons of the CH2 group in the D-ring 
also showed changes in their chemical shifts and coupling constants from 8H 2.56 with a 
3JHH of 5.5 and a 2JHH of 15.5 Hz and 8H 2.28 with a 2JHH of 15 Hz in 154 to ~ 2.62 
with a 3JHH of 7.5 and a 2JHH of 14 Hz and 8H 2.32 with a 3JHH of 8 and a 2JHH of 14 Hz 
for 157. The last major variations seen in the shifts of 157 were in the ethyl side chain. 
In 154 the two protons ofthe CH2 group in the ethyl side chain resonated at ~ 1.76 and 
8H 1.56. In 157 however, the proton signals of the CH2 group both resonated at ~ 1.49. 
This suggested that the stereochemistry of the ethyl side chain had altered from that 
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seen in 154. A slight increase in the polarity of 157 over ]54 was noted while purifying 
this compound. This increase in po larity was attributed to the lack of a hydrogen bond 
between the hydroxyl group at C9 and the carbonyl group at CIO. To prevent the 
fonnation of the hydrogen bond the hydroxyl group at C9 and the carbonyl group at C IO 
must both be in pseudo axial positions (Figure 6.21a - b). lfthese two groups were in 
an axial - equatorial or equatoria l - equatorial confonnation then hydrogen bonding 
between the hydroxyl group and an available oxygen could occur. This change in 
stereochemistry around the D-ring would also alter the coupling constants of the protons 
at DH 4.96, 2.62 and DH 2.32. 
b 
!...r-- A 2.62 
Figure 6.21a-b: Energy minimised conformations of the D ring of the anthraquinone core of] 57. 
Energy minimisation using MM2 minimisation parameters In Chem3D (Cambridge 
software) indicated that the structure represented in Figure 6.21 a contained dihedral 
angles between the proton at DH 4.96 and the CH2 protons of 55° and 170° and that in 
Figure 6.21 b showed dihedral angles of 33° and 145°. The KallJlus equation[15l j 
enabled an estimate of the 3 J HH for these two confonners to be established for these 
protons. If Figure 6.21a was the correct confonnation the expected coupling constants 
would be approximately 3JHH 4. 9 and 10.9 Hz. However, if Figure 6.21b was the 
correct confinnation the expected 3JHH would be 3JHH 8.1 and 7.3 Hz. When compared 
with the experimental coupling constants of 8 and 7.5 Hz it was clear that Figure 6.2 I b 
showed the correct confonnation with a 2D NOESY spectrum lending further support to 
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the stereochemistry of 157. An la]o of +228° for 157 indicated that this fraction too 
was not a racemic mixture. 
7.3R 
7.38 
2.29 
OH o 
OH o OH 0 
157 
The stereochemistry proposed for 157 (7R*,9R*,IOR*) is relative, not absolute. This 
stereochemistry had previously only been seen in (7 R,9R, I OR)-aklavinone II (164).[102. 
167) Thus 157 was also concluded to be a new isomer of pyrromycin and was called 
(7 R*9R* lOR*)-pyrromycin. 
164 
OH o OH 
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6.4.4 Structural elucidation of 158 (RKP 2.363.4) 
A high resolution ESI-MS of the fourth fraction (RKP 2.363.4) from the analytical 
HPLC purification showed a mass of 572.2138 Da (MF) and a molecular fonnula of 
C29H34NOJI (14 double bond equivalents). Once again the major compound of this 
fraction (158) contained the same UV chromophore and also showed a very similar IH 
NMR spectrum (Figure 6.22) to that of 154. As with 157 the most significant difference 
between 158 and 154 was in the ethyl side chain of the D-ring. However, in this case 
the signals corresponding to the ethyl group (bH 1.76,1.56 and OH 1.11) were replaced 
by a singlet methyl at OH 1.38. Therefore 158 must be the methyl version of 154 which 
was confinned by HSQC and CIGAR NlVIR spectroscopic experiments. 
The coupling constants for the protons at OH 5.13, 2.58 and OK 2.20 were all similar to 
those observed for the equivalent protons in 154 suggesting that the stereochemistry for 
158 is the same as that proposed in 154. However, confinnation of this was not 
possible as the mass of158 was insufficient for NOESY experiments. 
Compounds of this type with an anthraquinone core and a methyl side chain on the D-
ring are known as auramycins. Sixteen different auramycins[102] have previously been 
reported, but none of these had contained just one sugar residue. 158 has been 
tentatively named l-hydroxyauramycin T, a name derived from the parent compound 
pyrromycin which is also known as 1-hydroxyaclacinomycin T. 
Chapter 6 - Streptomyces species 154 
J f~':l 
~ (\I'" 
--:=.J }:, ~~~ 
.. ~ 
0 
~ J-~ .. 
-~ 
--:;;,. 
} ;;l 
j ]-~~ "l 
~ '" J 
]-'"! 
'" 
} }- ;: ..; 
t 
'" 'l-
... ,< 
r :r ill 
J 
}~.; 
rl 
=J r" > : 
- I "' =>-~ 
0 
ID 
to-
} ~ 
'" )-~
o 
Figure 6.22: lH NMR spectrum of 158 in CD)OD 
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6.4.5 Structural elucidation of 159 (RKP 2.363.3) 
High resolution ESI-MS of the fifth fraction from the HPLC purification showed an 
increase of 28 mass units over that seen in 154 which indicated a molecular formula of 
C31H3SNOl2 (15 double bond equivalents). This compound (159) had the same UV 
chromophore as 154 and also showed a very similar IH NMR spectrum (Figure 6.24). 
However, the IH NMR spectrum showed more differences to 154 than 156, 157 or 158 
had. The major regions of difference in the IH ]\lMR spectrum were attributable to 
signals that arose from protons in the D-ring of the anthraquinone moiety. The signals 
arising from the ethyl side chain of 154 were replaced by a methyl singlet at ~ 2.25 and 
a pair of isolated doublets at ~ 3.04 and OH 2.66. Various other minor alterations from 
the 1 H NMR spectrum of 154 were also seen for the protons of the D-ring of 159 
including the methine proton signal at OH 4.07 shifting downfield to OH 4.24. Because 
the UV spectrum and the proton signals from the sugar residue and the aromatic protons 
were all very similar to those of 154 it was concluded that 159 was biosynthetically 
related to 154. Correlations observed in COSY and HSQC spectra confirmed the 
presence of the anthraquinone core and sugar but also highlighted two more fragments 
(Figure 6.23a-c). 
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Figure 6.23a-c: Fragments of159 deduced from i R, COSY, TOCSY and RSQC NMR spectra. 
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Figure 6.24: 'H NMR spectrum of 159 in CD30D 
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The fragments in Figure 6.23 have a combined molecular formula of C30H34NOII, 29 
mass units (CHO) short of the observed mass, and also accounted for 14 of the available 
15 double bond equivalents. The methyl group at ~ 2.25 showed long range 
correlations in the TOCSY spectrum to the proton pair at fur 3.04 and fur 2.66 (Figure 
6.25). 
,(;J 
V 2,25 ~ ,51.7 • CH3 
,." .... x'" 32.5 
, \ 
, \ 
Figure 6.25: COSY correlations for the protons at Oil 3.04, 2.66 and OR 2.25. 
The carbon chemical shift of the methyl group at OH 2.25 suggested that it was next to a 
carbonyl group which was confirmed when a single correlation to a quaternary carbon 
at Oc 210.6 was observed in the CIGAR spectrum (Figure 6.26). 
3.04 2.66 
H~H ;i.~ 
_ _ 51.7 CH3 
- 210,6 ~ 
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Figure 6.26: CIGAR correlation for the methyl group at OR 2.25. 
At this point all the signals seen in the III NMR spectrum had been accounted for and 
showed a combined molecular formula of C3IH34N012 which is 1 Da short of the 
molecular formula proposed by high resolution ESI-MS. The fragment seen in Figure 
6.26 could therefore be connected to either available position in the D-ring (Figure 
6.27a and b). 
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/~CH3 0 
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Figure 6.27a-b: Possible attachment sites of the fragment in Figure 6.25 to the anthraquinone ring, 
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Ifthe structure depicted in Figure 6.27b was correct then the protons at OH 4.24, 3.04, 
2.66 and ~ 2.53 would an display much more complex splitting patterns in the IH 
NMR spectrum than those observed and would also show multiple correlations in a 
TOCSY spectmlll. As well as the increase in complexity of the D-ring signals a proton 
at C9 would also show a very distinct triplet between OH 3.5 and OH 5.0 in the IH NMR 
spectrum. As this is clearly not the case the stmcture in Figure 6.27a must be the 
correct one. Even though the stmcture in Figure 6.27a was deduced by elimination the 
second proton of the CH2 group in the D-ring remained hidden either by masking from 
another signal or because the second proton also had a shift at OH 2.53. The proton at OH 
2.53 did not show any signal splitting but rather line broadening indicating that it was at 
almost 90 0 to the proton resonating at OH 5.10 giving rise to an observed coupling of 
almost 0 Hz. If the missing proton was concealed behind another signal in the IH NMR 
spectrum then a geminal coupling of 10 - 16 Hz would be expected, but if the second 
proton also resonated at OH 2.53 then no gemina1 coupling would be observed. The 
second proton resonating at OH 2.53 could not also be at 900 to the proton at OH 5.10, but 
the coupling constant for the second proton signal OH 2.53 would also be small. This is 
because the second proton at OH 2.53 would be in a pseudo axial - pseudo equatorial 
arrangement with the proton at ~ 5.10. The latter of these two possibilities is more 
likely as the integral for this proton was 1.75. Furthermore, the only IJCH correlation 
seen for the carbon at oe 36.7 was from the proton at OH 2.53 and the shift for this 
carbon is similar to those observed for the CH2 group in the related compounds 154 and 
156 - 158. Fujiwara et al[168] previously isolated various auramycins and the 
sulfurmycins from various Streptomyces spp, hydrolysed them to the parent aglycones 
and then obtained the IH NMR spectra. Comparison of the IH NMR spectral data of 1-
hydroxysulfurmycinone (165) in CDCh with the experimental data for 159 in CD30D 
showed a large number of similarities. However, the two CH2 protons of the D-ring 
were at OH 2.42 and ~ 2.27. 
OH 0 
165 
OH o OH OH 
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This difference could be attributable to either the solvent used to dissolve the sample for 
the lH NMR spectra or it could be due to differences in the stereochemistry of 159. The 
latter reason is the most likely as differences in the stereochemistry of the D-ring had 
already been observed in the related compounds. The limited amount of mass of 159 
prevented further experimental work to detennine the stereochemistry from being 
carried out. 
OH 0 
OH fiJ 
OH \ 
159 
Anthraquinone compounds like 159 with a di-methyl ketone side chain on the D-ring 
are known as sulfunnycins and as with the auramycins sixteen different 
sulfunnycins[102] have been previously reported, but none of these sixteen contain a 
single sugar residue. 159 was called l-hydroxysulfunnycin T. 
6.5 Structural elucidation of 155 
A high resolution ESI-MS of a sixth compound (155), also with the same UV spectrum 
as seen previously, gave a mass of 825.3287 Da which indicated a molecular fonnula of 
C42HsIN016 (18 double bond equivalents). It was assumed that 155 contained the same 
anthraquinone moiety as that seen in the previous five compounds as the UV spectrum 
was the same for all these compounds and they were all isolated from the same 
organism. A lH NMR spectrum of 155 (Figure 6.28) showed a number of signals 
almost identical to those seen for the anthraquinone moiety of 154. These signals 
included aromatic proton peaks at ~ 7.70 and I5H 7.29, an O-methyl signal at I5H 3.70, 
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signals characteristic of an ethyl group at OR 1.76, 1.52 and OR 1.09 as well as the other 
signals arising from the D-ring at BH 4.09,2.59,2.28 and OR 5.24 (Figure 6.29). 
LO 
Figure 6.28: lH NMR spectrum of 155 in CDC13 
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Figure 6.29: lH and I3C NMR signals of 155 from the anthraquinone core. 
The differences between 154 and 155 were therefore assumed to be in the sugar residues 
and indeed the increase in mass from 585 Da to 825 Da suggested the presence of an 
additional two sugar residues. A search in Antibase with the anthraquinone core and the 
observed mass found three compounds that matched, pyrraculomycin (166), 1-
hydroxyaclacinomycin B (167) and spartanamycin-A (168). However, 166 contains a 
second chromophoric group in the third sugar residue which is known to show.a strong 
absorbance at approximately 280 run in the UV spectrum[169j and as 155 does not show 
this absorbance, 166 was discounted leaving only 167 and 168. 
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The only difference between 167 and 168 is in the stereochemistry of the methyl group 
of the third sugar residue, either in an axial (167) or an equatorial (168) position. 
Although a reasonably high mass of 155 was recovered, the IH NMR spectrum 
indicated that it sti11 contained relatively high amounts of contaminating fatty acid 
material which partial1y masked the signals arising from the sugars in 155. This 
contamination was not removed by further washing with Pet. Ether as the red colour 
was partially soluble in the solvent. 
As w~ll as the signals arising from the anthraquinone core the IH NMR spectrum also 
showed a series of complex muItiplets between OR 5.0 and OR 1.0 which included three 
anomeric proton peaks at OR 5.55, 5.26 and OR 5.16 and two methyl signals at ~ 1.33 
and OH 1.21. Both the molecular formula and the presence of three anomeric proton 
signals between OA 5.55 and OH 5.16 indicated the presence of three sugar residues. As 
well as the anthraquinone core COSY, TOCSY and HSQC spectra enabled four more 
spin systems to be determined. The fIrst of these spin systems showed correlations from 
an anomeric proton at OH 5.55 to proton signals at OR 2.30 and OH 1.58, which in turn 
correlated to a proton peak at ~ 3.48. A proton signal at OR 3.97 showed correlations to 
the signal at ~ 3.48 as well as a signal at OR 4.81. The proton resonating at ~ 4.81 
correlated to a methyl signal at OR 1.33. The proton signals at OH 4.81 and OH 3.97 
showed IJcH correlations to carbons at Oc 77.9 and 72.5 respectively. The chemical 
shifts of the carbon signals at Oc 77.9 and Be 72.5 indicated the presence of oxygen 
atoms (Figure 6.30a). 
The proton signals at OR 2.50 and OR 2.00 correlated to a second anomeric proton signal 
at OH 5.26 and a proton signal at OR 4.43. A proton resonance at OH 4.06 showed 
correlations to the proton signal at OR 4.43 and a second proton peak at OR 4.53. The 
proton signal at OR 4.53 showed a correlation to a methyl signal at OR 1.21. A 
combination of chemical shift and coupling constant data, along with the IJCR 
correlations of oc 65.8, 66.2 and Oc 66.2 for the protons at ~ 4.53, 4.43 and ~ 4.06 
respectively allowed defInition of the 2-deoxy-L-fucose sugar residue (Figure 6.30b). 
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Figure 6.30aM b: COSY correlations for the rhodosamine and 2-deoxy-L-fucose sugar residues of 155. 
The third anomeric proton at DH 5.16 showed a correlation to a proton resonance at DH 
4.34 which showed a correlation to a proton signal at ~ 2.55. The proton resonating at 
DH 4.34 showed a IJCH correlation to a carbon at 62.8 indicating oxygenation at this 
centre and the signal at DH 2.55 integrated for two protons to give (Figure 6.31 a). The 
[mal spin system was comprised of a methyl signal at DH 1.33 correlating to a proton 
resonating at DH 4.05 with this resonance showing a IJCH correlation to a carbon at Dc 
67.6, which indicated the presence of an oxygen atom at this centre (Figure 6.31 b). 
Figure 6.31a-b: COSY correlations for the third and fourth spin systems of 155. 
Due to the high molecular weight of 155 and the presence of the contaminating fatty 
acid material the number of correlations seen in the CIGAR spectrum was relatively low 
for the sugar residues. However, the correlations observed enabled the two fragments in 
Figure 6.31 to be connected. The l3C NMR spectrum for 155 showed a carbonyl signal 
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at eSc 208.0 indicative of a six-membered ring carbonyl and this was confirmed in the 
CIGAR spectrum. The methyl signal at eSH 1.33 and the CH2 signal at OH 2.55 both 
showed correlations to a carbonyl at eSc 208.0. This sugar was a cinerulose residue 
(Figure 6.32). 
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Figure 6.32: CIGAR correlations for the spin systems in Figure 6.29. 
The presence of fragments in Figures 5.26, 5.28 and 5.30 confmned that 155 was either 
] -hydroxyaclacinomycin B (167) or spartanamycin A (168). The 3JHH coupling 
constant of 7 Hz between the methyl signal at ~ 1.33 and the proton at ~ 4.05 in the 
cinerulose residue was the same as that observed between the methyl at OH 1.33 and the 
proton at OH 4.81 in the rhodosamine residue (Figure 6.30a) suggesting that the 
stereochemistry was the same for both sugars which indicated that 167 was the correct 
structure thus 155 was I-hydroxyaclacinomycin B. 
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Summary 
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Five new pyrromycin derivatives were isolated and purified from culture extracts of Fox 
21-2-6a with two of these derivatives (154, 157) stereoisomers of pyrromycin (169), one 
an N-demethyl derivative (156) and the fourth (158) and fifth (159) derivatives 
displaying minor variations in the side chain of the anthraquinone D-ring. A sixth 
compound (155) was also isolated, and shown to be the known compound 1-
hydroxyaclacinomycin B. 
OH 0 
OH 0 OH (5 169 
~ I N-
OH "" 
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6.6 Discussion 
The anthraquinone core of all these compounds is derived from units of acetyl CoA. In 
the case of the pyrromycin derivatives (154 - 157) the anthraquinone core is comprised 
of a starter unit of propionyl CoA plus nine acetyl CoA units connected in a head to tail 
fashion as shown in Figure 6.33. 
'_', 0 0yOH 
\-~11 "'n"~"'n" 
o 0 0 ~ ~O ' 
"("'("'("'( 
o 0 0 0 
Figure 6.33: Biosynthetic origin of the polyketide anthraquinone core ofpyrromycin (169) 
In the case of 158 however, the propionyl CoA starter unit is replaced with one acetate 
unit and in 159 it is replaced with two. The only compounds similar to 158 and 159 
previously isolated were either the aglycones or the di- or trisaccharides[102] which poses 
the question - are these compounds of natural origin, produced by the organism being 
investigated or are they artefacts of the extraction and isolation process produced by 
hydrolysis of the trisaccharide parent compounds present in the extract? 
The pyrromycin derivatives were not thought to have arisen via a partial hydrolysis of 
the di- and trisaccharide forms as random hydrolysis should have resulted in tri-, di- and 
mono-saccharides as well as the appropriate aglycones. However, only the 
monosaccharide or the trisaccharide were observed. An inspection of the original 
analytical HPLC trace of the second extract also supported the theory that these 
compounds were present in the original extract as there were many small peaks eluting 
at the appropriate time in the HPLC trace and with the appropriate UV-visible spectrum 
(Figure 6.3). However, these compounds were only present in very minor amounts 
when compared to the amount of the total extract. 
During chromatography it was also noted that both extracts of Fox 21-2-6a contained a 
large volume of fatty acid material in a number of the red fractions which was almost 
impossible to remove and indeed, all of the fractions from the fIrst extract except for 
RKP 2.245.2 and RKP 2.245.3 showed a high level of fatty acids. All attempts to 
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separate the red compounds from the fatty acids present in the fIrst extract were 
unsuccessful which suggested that the fatty acids were bound to the cytotoxic 
components possibly rendering them hannless towards the producing organism but 
creating a metabolic pool which could release the toxic compounds when the producing 
organism was damaged. This was also observed in the second extract but not to the 
same extent. The only difference between the fIrst and second extracts was in the length 
of time that they were cultured, the fIrst for 30 days and the second for only 18 days. 
This difference in growth time suggested that the longer the culture was left to grow the 
higher the levels of toxic metabolites became, possibly increasing to the tolerance 
threshold of the producing organism. The producing organism could then reduce the 
levels of toxin without degrading the toxin but rather sequestering the toxic metabolites 
by converting them to a less toxic fonn, typically by esterifIcation of any available sites 
on the toxin. 
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Figure 6.34: Numbering system for 154 -15.9 in Tables 6.1 - 6.6 
Number IH, multiplicity, (JHH Hz) COSY I TOCSY HSQCI APT CIGAR NOESY 
10H 159.4 
2H 7.08 s 131.1 159.4 , 159.0, 113.5 
3H 7.08 s 131.5 159.4,159.0,113.4 
40H 159.0 
4a 113.4 
5 191.6 
5a 116.0 
60H 163.6 
6a 133:l 
7H 5.10d(5) 256,2.28 72.9 163.6,144.1,133.1,101.9,72.2 5.55 ,2.56 , 2.28 
8nH 2.56 dd (5, 15) 5.10,2.10 36.2 5.10,2.28 
8 eqH 2.28 d (15) 5.10,4.07,2.56, 1.56 36.2 133.1,72.9,72.2,585 5.55,5.10,2.56 
90H 72.2 
10H 4.07 s 7.51,2.28 58.5 172.8,144.1 ,133.1 , 121.2,72.2,36.2 1.76 
lOa 144.1 
IIH 7.51 s 4.07 121.2 186.7,133.1,116.0,58.5 4.07 
lla 133.8 
12 186.7 
12a 113.4 
13 172.8 I 
140Me 3.75 s 53.5 
15 (l H 1.76 m 1.56 , 1.11 33.6 72.2,36.2,7.5 4.07, 1.56.1.11 
15 ~ H 1.56 m 2.28,1.76,1.11 33.6 72.2,58.5 ,7.5 
• 
1.76 
16CH, l.1lt (7) 1.76, 1.56 7.5 72.2.33.6 1.76 
l' H 556 d (2.5) 3.96 , 3.52,2.28,2.08 101.9 72.9,68.2,63.9 5.10 ,2.28,2.08 
2' ax H 2.28 d (15) 5.55 ,3.96 , 3.52,2.08 28.1 
2' eqH 2.08 dt (4, 12.5) 5.55 ,3.96 , 3.52 , 2.28 28.1 5.55,4.26,3.52 
3' H 3.52 brm 5.55 , 3.96 ,2.28,2.08 63.9 4.26,3.96,2.08 
4'H 3.96 brs 5.55,4.26,3.52,2.28,2.08 66.1 63.9,28.1 4.26,3.52 
5'H 4.26 q (6.5, 13) 3.96,1.33 68.2 66.1,17.2 3.96,3.52,2.28, 1.33 
6'CH, 1.33 d (6.5) 4.26 17.2 68.2,66.1 4.26 
7' N(Me)2 2.87 40.7 63.9,40.7 
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Number lH, multiplicity, (JllJl Hz) HSQC COSY I TOCSY NOESY 
2H 7.38 s 131.2 
3H 7.38 s 131.2 
7H 4.96 t (2.5) 73.8 2.62,2.32 5.58 
8 axH 2.62 dd (7.5 , 14) 37.3 4.96,2.32 
8 eqh 2.32 dd (8 , 14) 37.3 4.96,2.62 
IOH 3.99 s 57.9 
11H 7.60 s 121.1 
140Me 3.78 s 53.1 
15 H 1.49 m 33.1 0.98 
16 CH3 0.98 t (7) 7.7 1.49 
l' H 5.58 br s 100.9 2.06 4.96 
2' axH 2.29 dd (8,14) 27.9 2.06 
2' eqH 2.06 br s 27.9 5.58,3.95,3.52,2.29 
3'H 3.52 br d (11) 64.0 3.95,2.06 4.17,3.95 
4'H 3.95 br s 66.0 4.16,3.52,2.06,1.33 4.17,3.52,2.91 
5'H 4.17 q (7, 12.5) 68.2 3.95, 1.33 3.95,3.52, 1.33 
6'H 1.33 d (6) 17.2 4.17,3.95 4.17 
7N(Me») 2.91,2.85 41.8,40.9 2.91 ,2.85 3.95 
Table 6.2: lH and l3C NMR data for 157 in CD30D 
Number lH, multiplicity, (JHH Hz) HSQC COSY/TOCSY CIGAR 
2H 7.37 s 131.2 
3H 7.37 s 131.2 
7H 5.13 d (5) 72.4 2.58,2.20 
8 axH 2.58 dd (6 , 15) 39.4 5.13 ,2.20 
8 eqh 2.20 d (15) 39.4 5.13,2.58 
IOH 4.09 s 59.5 172.8, 144.0,70.2 
11H 7.67 s 121.0 
140Me 3.71 s 53.2 172.8 
16 CH3 1.38 s 27.8 70.2,59.5 , 39.4 
l' H 5.56 br s 101.5 2.15,2.02 
2' axH 2.15 m 28.0 5.56,3.46,2.02 
2' eqH 2.02 dt (3.5 , 12.5) 28.0 5.56,3.91,2.15 
3' H 3.46 br d (11.5) 63.8 3.91,2.15 
4'H 3.91 brs 66.0 4.24,3.46,2.02 
5'H 4.24 q (7.5, 14) 68.1 3.91,1.31 
6'H 1.31 d (6.5) 17.1 4.24 68.1,66.0 
7N(Me») 2.88,2.78 41.9,41.0 63.8,41.9,41.0 
Table 6.3: lH and l3C NMR data for 158 in CD30D 
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Number JH, multiplicity, (JHH Hz) HSQC COSY I TOCSY CIGAR 
2H 7.36 s 131.1 
3H 7.36 s 131.1 
7H 5.10 br s 72.5 2.53 
8H 2.53 br s 36.7 5.10 
10H 4.24 s 58.1 72.2 
IIH 7.71 s 
140Me 3.71 s 53.4 172.3 
15aH 3.04 d (16.5) . 51.7 2.66 
15 ~H 2.66 d (16.5) 51.7 3.04 
17CH3 2.25 s 32.5 210.6,51.7 
I'H 5.49 br s 101.7 2.15,2.03 
2' axH 2.15m 28.0 5.49,3.93,3.46,2.03 
2' eqH 2.03 m 28.0 5.49,3.93 ,3.46,2.15 
3'H 3.46 br d (11.5) 63.9 3.93,2.15,2.03 
4'H 3.93 br s 66.1 4.26,3.46,2.15,2.03 
5'H 4.26 q (7, 13) 68.2 3.93, 1.32 17.2 
6'H 1.32 d (6.5) 17.2 4.26 68.2,66.1 
7N(Me), 2.88 br s, 2.77 br s 41.7 , 40.9 2.77 , 2.88 41.7 , 40.9 
Table 6.4: lH and 13C NMR data for 159 in CD30D 
Number l~ multiplicity, (JHJI Hz) COSY I TOCSY 1R CIGAR NOESY IOH 2H 7.29 s 157.9,158.5,112.4,112.2 
3H 7.29 s ~ 157.9, 158.5, 112.4, 112.2 40H 4a 
5 190.4 
5a 114.9 
60H 162.1 
6a 130.7 
7H 5.24 br s 2.59,2.28 71.1 130.7,71.7 5.55,2.59 
8axH 2.59 br t 5.24,2.28 33.9 2.28 
8 eqH 2.28 brt 5.24,2.59 33.9 71.1 ,56.8 2.59 
90H 71.7 
10H 4.09 s 56.8 171.0,142.2,130.7,120.2,71.7 , 33.9 7.70 
lOa 142.2 
IIH 7.70 s 120.2 185.7,130.7,114.9,56.8 4.09 
Iia 133.0 
12 185.7 
12a 112.4 
13 171.0 
140Me 3.70 s 52.5 171.0 
15aH 1.76m 1.52,1.09 31.8 71.7 , 33.9,6.7 1.52, 1.09 
15 ~H 1.52m 1.76, 1.09 31.8 71.7,56.8,6.7 1.76, 1.09 
16CH; 1.09 t(7.5) 1.76, 1.52 6.7 71.7,31.8 1.76,1.52 
Number IH, multiplicity, (JIlII Hz) COSY I TOcSY HSQC/APT CIGAR NOESY 
l' H 5.55 br s 2.30 101.2 5.24 
2' axH 1.58 bI 2.30 33.8 2.30 
2' eqH 2.30 br t 5.55 ,3.48 . 1.58 33.8 1.58 
3' H 3.48 br 3.97,2.30 50.7 
4'H 3.97 br s 4.81,3.48 72.5 5.26 
5' H 4.81q (7) 3.97, 1.33 77.9 18.0 1.33 
6'H 1.33 d (7) 4.81 18.0 77.9 5.26,4.81 
7' N(Me)z 2.35 br s 41.1 
I" H 5.26 bI S 2.50 99.1 2.50,1.33 
2" axH 2.00 dd (4.5. 12.5) 4.43,2.50 26.3 99.1.66.2 4.34,2.50 
2" eqH 2.50 dd (4.5, 12.5) 5.26,2.00 26.3 5.26 ,4.34 , 2.00 
3"H 4.43 brd 4.06,2.00 66.2 4.06 
4"H 4.06 br s 4.53,4.43 66.2 4.53,4.43 
5" H 4.53 br s 4.06,1.21 65.8 4.06 
6" H 1.21 d (7) 4.53 15.8 65.8 
1'" H 5.16 d (3) 4,34 91.5 66.2,62.8 4.34 
2)" H 4.34 d (3.5) 5.16,2.55 62.8 5.16,2.55,2.50,1.95 
3'" H 2.55 d (4.5) 4.34 39.5 208.0,91.5 , 67.6 4.34 
4"'H 208.0 
5'" H 4.05 bI S 1.33 67.6 1.33 
6'" H 1.33 d (7) 4.05 15.9 208.0,67.6 4.05 
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Figure 6.35: COSY spectrum of 154 in CD30D 
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Figure 6.36: HSQC spectrum ofl54 in CD30D 
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Figure 6.37: CIGAR spectrum of 154 in CDJOD 
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Figure 6.38: NOESY spectrum of 154 in CD30D 
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CHAPTER SEVEN 
KAI11-2-1 ,.., 5TKE,TOMYCE5SF 
7.1 Introduction. 
Extracts from three Streptomyces spp cultured from various macro-algae collected from 
Kaikoura (Kai 40-1-1, 84 and Kai 11-2-1) all showed excellent cytotoxicity towards the 
P388 cell line (with IC50 values ranging from 286 nglmL - < 97.5 nglmL). Initial 
investigations (Section 7.2.1) of the crude extracts showed that the antitumour activity 
was centered on a range of peaks in a moderately complex HPLC chromatogram 
(Figure 7.3). Three actinomycins with exceptional cytotoxicity against the P388 cell 
line (177, < 1.0 ng/mL, 178,12.5 nglmL, 179,13.6 nglmL) were identified from culture 
extracts. The chromatography of these compounds is discussed in Sections 7.3 and 7.5 
and the structural elucidations described in Section 7.4 of this chapter. 
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7.1. 1 The actinomycins 
The actinomycins are a commonly occurring group of antibiotics that have been isolated 
from numerous different Streptomyces spp. One of the more cornmon actinomycins, 
actinomycin D, has been utilised as an anticancer drug against a small number of 
tumours, the most notable of which is Wilms Tumor. [170] This is a cancerous tumour of 
the kidneys common in children under 14 years of age, accounting for 6 - 7 % of all 
childhood cancers. Unfortunately, the clinical uses for actinomycins have been limited 
due to both their high toxicity and because the number of cancers that respond well to 
actinomycin treatments are relatively fewY71] 
Actinomycins are a family of chromopeptolides comprised of a phenoxazinone moiety 
called actinocin (170) and two five membered amino acid depsipeptide rings, such as 
those seen in 171. 
H 
170 
H 
o 
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After the initial discovery of the actinomycins in 1940 by Waksman and Woodruff from 
Streptomyces antibioticus[153] numerous attempts to elucidate the structure were made 
culminating in the determination of the structure of actinomycin C3 in 1956[172] and 
actinomycin D in 1957)173] Elucidation of these structures confirmed the presence of 
two five membered depsipeptide rings rather than a single ten membered dilactone ring 
as proposed by PerutzJ174] The actinomycins show some features in common with other 
antibiotics such as etamycin A (lni17S] which contains a depsipeptide ring and 
cryptomycin A (173) which contains the phenoxazinone moiety. Other than the non-
peptide phenoxazinones such as cinnabarin (174) and xanthommatin (175), cryptomycin 
A and the aurantins (171) are the only compounds, other than the actinomycins, known 
to contain the phenoxazinone moiety. [102] 
172 
Chapter 7 ~ Streptomyces species 
H~~ /N~oXo:NH2 
lXox'xo 
174 
7.1.1.1 Nomenclature 
181 
175 
The original actinomycin A complex was thought to be unifonn, but after a similar 
complex (actinomycin C) was subjected to countercurrent distribution it appeared to 
separate into three main components (Cl, C2 and C3)Y76] This assumption was proved 
incorrect with five actinomycins subsequently isolated from this complex. After 
discovering that all the actinomycins previously isolated, except for actinomycin D were 
mixtures, a naming system was developed. The new actinomycin was given a letter 
from the complex it was isolated from and then given a subscript number to further 
identify the compound. However, because of the ever increasing number of the 
actinomycins being found and because the complexes contained identical actinomycins 
this led to some degree of confusion. A second naming system was proposed based on 
the Rf values on paper chromatography. However, this method of naming was not 
widely adopted. The variability between these naming systems created further 
confusion and as such a third naming system for the actinomycins based on amino acid 
abbreviations was proposed. [153J This system split the two depsipeptide rings into fJ.-
and ~- rings and then numbered the five amino acid residues 1 through 5 starting at the 
threonine residue (Figure 7.1) and listing only those changes from a parent actinomycin. 
Thus, actinomycin D is abbreviated as Yalz-AM. 
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a 
"Figure 7.1: Amino acid numbering system for the actinomycins 
7.1.1.2 Structure activity relationships 
Numerous studies have shown that the phenoxazinone moiety of the actinomycins is 
able to intercalate with DNA between d(G-C)n (deoxyguanosine/deoxycytosine) base 
pairs[177] "thereby inhibiting cellular proliferation. The naturally occurring weak: 
antibiotic questiomycin A (176)/178, 179] which also contains a similar structure to the 
phenoxazinone moiety of the actinomycins, also functions by intercalating with DNA. 
However, the biological activity of the actinomycins is greatly increased primarily 
because of the presence of the two depsipeptide rings. 
cc~ N~NHz 176 #' o~o 
Semi-synthetic studies on the actinomycins have shown that alterations in the 
phenoxazinone moiety generally decrease the biological activity of the actinomycins by 
interfering with DNA intercalation. 
6 4 
}<'igure 7.2: Numbering system for the phenoxazinone of the actinomycins 
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Any modification of the 2- amino group of the phenoxazinone system (Figure 7.2) has 
been shown to drastically reduce or even completely remove the biological activity of 
the actinomycins, with a similar effect observed when the methyl groups at C4 and C6 
were replaced by either H or OCH3Yso, lSI] 
After the phenoxazinone moiety of the actinomycin molecule has intercalated with 
DNA it would nonnally be able to easily dissociate away from the DNA strand. 
However, the two depsipeptide rings are able to wrap around the DNA helix thereby 
fonning a relatively stable DNA - actinomycin complex thereby preventing dissociation 
of the actinomycin molecule. 
Changes in the depsipeptide nngs of the actinomycins alter the 3-dimensional 
confonnation of the peptides which can either enhance or reduce the DNA binding 
efficacy of the various actinomycins. If one or both of the depsipeptide rings are 
opened at either the lactone or the sarcosine - N-methylvaline peptide bonds the 
biological activity is abolished because the now linear peptides do not bind well to DNA 
thereby preventing fonnation of the stable actinomycin - DNA complex. Variations in 
the amino acid residues of the depsipeptides have been noted in all five positions and 
generally reduce the DNA binding efficacy with very few exceptions. One of these 
exceptions, actinomycin V (X2) which contains a 4-ketoproline residue in the 3-position 
ofthe ~-ring has been shown to increase the antimicrobial activity but decrease the anti-
tumour activity. [176] 
7.2 Culturing and extraction of Kai 11-2-1 
7.2.1 Preliminary investigations 
Kai 11-2-1, a Streptomyces sp, was isolated from a conglomeration of the red algae 
Jania micrarthrodia and Haliptilon roseum collected below the low tide zone 20 Ian 
north of Kaikoura on the east coast of the South Island of New Zealand in September 
1999. 
When grown under microscale conditions (l mL broth) an EtOAc extract displayed 
significant cytotoxicity towards the P388 cell line and as such was selected for chemical 
investigation. Extraction with EtOAc of a one month old culture grown in J 00 mL 
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starch casem broth (SCB) followed by concentration under vacuum yielded a dark 
yellow powdery solid with significant cytotoxicity (504 ng/mL). 
Figure 7.3: Isolate Kai ]]-2-1 (Streptomyces sp) grown on a seawater PDA plate. 
7.2.1.1 Chemical screening 
As before (Section 3.2.1.1) the small scale EtOAc extract was chromatographed on 
CBA, C I8 and LH20 cartridges. The initial fractionation of this extract with these 
column cartridges suggested that even minor amounts of the biologically active material 
were extremely cytotoxic as almost all fractions showed total cell death. Therefore the 
fractions were dried and re-assayed at a known concentration until the biological 
activity was observed in only one fraction. 
Chromatography on CBA concentrated the cytotoxicity into the first fraction with slight 
carryover to the next two fractions. Chromatography on C l8 concentrated the activity 
into the second fraction with some activity seen in the third fraction. Significant 
biological activity was observed in the first two LH20 fractions which, when combined 
with the CBA and C l8 results indicated that the compound(s) of interest were large (> 
1000 Oa), of medium to low polarity and uncharged. 
7.2.1.2 HPLC bioassay 
The biological profile of this ex tract showed that the major reglOn of activity was 
centred on a single large peak in the HPLC chromatogram, eluting at approximately 19 
minutes (Figure 7.4) and which possessed a very distinctive UV-visible spectrum with 
characteristic absorption maxima (F ~gure 7.5). 
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Figure 7.4: Spectrum max plot HPL trace (black) and bioactivity data (red) of Kai 11-2-1 extract 
showing region of biologica[ activity (the blue line represents 50(10 cell death). 
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Figure 7.5: UV profile ofbioactive peak from HPLC trace (19 minutes) as determined from the 
microtitre plate assay 
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ESI-MS of the bioactive wells from the microtitre plate showed a complex series of 
peaks between 620 - 640 Da and 1250 - 1280 Da. Upon closer inspection it was seen 
that the ions between 620 - 640 Da were doubly charged which indicated that the 
corresponding molecular ions were twice the size, between 1240 - 1280 Da. There were 
six major peaks observed at 1255, 1269, ]277, ]291, 1293 and 1307, which 
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corresponded to a pair of molecular ions differing by 14 Da at 1255 and 1269, and the 
sodium and potassium adducts, 1277 and 1291 MNa+, 1293 and 1307 K+ respectively. 
While the extracts of Kai 11-2-1 were being purified only two databases were available 
for dereplication, The Berdy Natural Products Database (BNPD) and Scifinder® 
Scholar. The BNPD is a text based database and allows searches to be carried out on a 
wide variety of different fields, including mass, producing organism and UV maxima. 
Scifinder® Scholar is an online database provided by the American Chemical Society. 
Although a much larger number of compounds can be search for in this database, an 
initial search based on molecular weight is not possible, limiting the usefulness of this 
database for dereplication. A search in the BNPD on the UV maxima and molecular 
weight of 1255 Da found a single match, actinomycin D. A second search on the 
molecular mass of 1269 found a further ten possible matches, nine of which were 
actinomycins and one an aurantin. A lH NMR spectrum was not able to be obtained 
from either the HPLC microtitre plate wells or from the chemical screening fractions 
(Section 7.2.1.1). This was because both the mass isolated in the microtitre plate wells 
was very low « 250 ~g) and the chemical screening fractions were not sufficiently 
pure. To determine if the molecular ion at 1269 Da was due to either a new 
actinomycin derivative or one of the ten possible matches seen in the BNPD a new 
extract was required. 
7.2.2 Large scale culturing and extraction 
To obtain adequate extract for identification of the compound responsible for the 
molecular ion at 1269 Da the microbial isolate Kai 11-2-1 was cultured in a further 2 L 
of starch casein broth under the same conditions as described in Section 7.2.1. 
Repeated extraction of this culture with distilled EtOAc, followed by solvent removal 
under vacuum yielded a deep red solid (129.6 mg) with significantly more biological 
activity than that of the small scale extract « 97.5 ng/roL). 
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7.3 Chromatography of 177 
The chromatographic steps for the large scale extract of Kai 11-2-1 are shown in 
Scheme 7.1. A more detailed description of the chromatographic steps carried out on 
this extract can be found in the Experimental Section. 
10% 20% 
8.4 9.6 
> 12500 
EtOAc extract of 
Kai 11-2-1 (RKP 1.39.1) 
ColumnA C 18 (50 g) 
MeOHinHzO DCMin MeOH 
40% 60% 70% 80% 90% 100% 10% 
4.8 5.4 4.0 4.1 18.8 27.7 19.2 
7628 612 510 <9.7 <9.7 501 
ColumnB DIOL (12 g) 
EtOAciriDCM 
0% 5% 10% 
3.5 12.6 6.2 4.4 
< 1.0 < 1.0 < 1.0 13.6 
Purity checked by I I-----j NMR spectroscopy I 
20% 40% 60% 
1.5 0.9 0.9 
67.6 21.3 63.7 
RKP 1.109.2 (177) 
13.0mg 
< 1.0 nglmL 
50% 
12.3 
4286 
80% 
1.0 
21.3 
100% 50% 100% 
1.5 1.6 1.8 Weight(mg) 
7543 2266 8762 ICso (nglmL) 
MeOH in EtOAc 
100% 5% 10% 100% 100% 
0.8 0.5 1.8 2.8 9.7 
55.7 36.6 31.5 45.8 > 125 
Scheme 7.1: Purification flow chart of an extract prepared from the microbial isolate Kai 11-2-1. 
The large scale culture extract (129.6 mg) was initially fractionated on reverse-phase 
CI8 (column A), using the same stepped gradient solvent system that was used for the 
elution of compound 141 from CI8 (Scheme 5.1). Almost all the fractions that eluted 
from the CI8 column displayed some measure of cytotoxicity however, it had previously 
been noted during the chemical screen that even minor traces of 177 resulted in 
significant levels of cytotoxicity and because of this only the two most cytotoxic 
fractions were purified further. Analysis of two most active fractions (RKP 1.46.7-8) 
and the two side fractions (RKP 1.46.6 and 9) by reverse-phase HPLC (Figure 7.6) 
showed that significant quantities of 177 were only present in fractions 7 and 8. ESI-
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MS spectra showed a similar series of ions to those seen in samples from the microtitre 
plate assay. 
Peak of Interest 
/ 
Solvent Change 
Solvent Front 
/ / 
I.l 
Minul€S 
Figure 7.6: HPLC chromatogram of RKP 1.466-9 
Based upon the analytical HPlC and ESJ-MS data RKP J .46.7 and 8 were combined 
then further purified with normal phase chromatography on DIOl (colunm B). The 
combined bioactive fractions were eluted off column B with the same stepped gradient 
system used for column B in Section 3.3. During elution the first and last fractions 
from this colunm showed distinct bands of colour within the fraction and as such these 
bands were collected individually. 
An exceptionally high level of cytotoxicity was observed in the first three fractions from 
column B with a slow tailing off of the cytotoxicity in the remaining fractions. 
Analytical HPlC of the first four fractions (Figure 7.7) showed that fraction two was 
the most pure with slightly lower purity in RKP 1.109.1 and 3. The ESI MS spectra of 
these three fractions showed that the molecular ion corresponding to 177 (MH+ 1269) 
was enriched in RKP 1.109.2 with lower levels in RKP 1.109.1 and 3. RKP 1.109.2 
was subsequently examined with 1 D and 20 NMR spectroscopy, with the structural 
elucidation ofl77 discussed in Section 7.4. 
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, , , , iii I I i 
0.0 2.5 5.0 7.5 27.5 3C.0 32.5 35.0 375 40.0 
Minutes 
Figure 7.7: HPLC chromatogram ofRKP 1.1091-4 
7.4 Structural elucidation 
7.4. 1 Structural elucidation of 177 
The I H NMR spectrum of 177 in CDCb showed a great deal of complexity (Figure 7.8) 
hindering a direct comparison with the literature data. The I H NMR spectrum showed 
numerous methyl signals between 6H 1.4 and bH 0.8, four N-methyl signals (bH 2.93 -
2.88) and two aromatic methyls (bH 2.54 and bH 2.21). The presence of these two 
aromatic methyl signals indicated that 177 was an actinomyclD rather than an aurantin, 
reducing the number of possible matches to 177 from ten to nine. The remaining nine 
possibilities for 177 arose from variations at the second and third amino acid residues in 
both the ex and ~ rings (Figure 7.1 ) . The variations resulted from the insertion of a CH 2 
group in the amino acid residues at position 2 or 3 or replacement of a CH 2 group with a 
ketone at position 3. 
The I H NMR spectrum highlighted a further four amide protons and two aromatic 
protons between bH 8.2 and bH 7.0. A pair of doublets at bH 6.55 and bH 5.95, two 
multiplets at bH 5.22 and bH 5.14 and a series of complex multiplets between bH 5.0 and 
bH 2.0 were also seen. 
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Figure 7.8: IH NMR spectrum of 177 in CDC13 
The 13C APT spectrum obtained for this sample showed over 60 signals (Figure 7.9). 
Of the low field carbons (OH 180 - 80), thirteen were assigned as carbonyl carbons 
between Oe 180 - 150, ten were aromatic quaternary carbons between oe 150 100 and 
two were aromatic CH carbons at Oe 130.3 and oe 126.2. There were thirty five high 
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field carbons from Dc 75.0 - Dc 17.0 which all arose from the various ammo acid 
residues present. There were also two very high field aromatic methyl signals at Dc 15.0 
and Dc 7.7. Again the complexity of the NMR spectrum hindered a direct comparison 
to the literature data of the possible matches obtained from a search of the BNPD. 
Figure 7.9: I3C APT spectrum of 177 in CDC1 3 
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As the complexity of the IH NMR and l3C NMR spectra precluded a direct comparison 
to the literature data, 177 was examined by further 2D NMR experiments. From COSY 
(Figure 7.25), TOCSY (Figure 7.26) and HSQC (Figure 7.27) spectra twelve spin 
systems were determined. These included two threonine, two valine, one proline, two 
N-methy1va1ine and two sarcosine residues, an aromatic system, a CH-CH2 system and a 
lone CH2 group. 
The proton at OH 4.47 showed correlations to an amide proton at OH 7.67 and a proton 
multiplet at Orr 5.22, which was in tum coupled to a methyl at Olf 1.24. The proton at on 
5.22 was attached to a carbon at DC 74.6 indicating that this carbon was oxygenated 
(Figure 7.10a) to give rise to the fIrst threonine residue. A second threonine residue 
showed the same correlations with slightly different chemical shifts, OH 7.19, 4.55, 5.14 
and OH 1.13 respectively (Figure 7.10b). 
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Figure 7.10a-b: Correlations observed for the two threonine residues of177. 
Another proton at OH 3.56 showed correlations to an amide proton at OH 7.65 and a 
multiplet at OH 2.11. The proton at OH 2.11 also showed correlations to a pair of methyl 
signals at OH 1.11 and OH 0.90 (Figure 7 .11 a) to give rise to one of the valine residues. 
A second valine residue was also identified with chemical shifts of OIl 8.19, 3.69, 2.21, 
1.14 and Orr 0.89 respectively (Figure 7.11 b). 
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Figure 7.lla-b: Correlations observed for the two valine residues of 177. 
A proton resonance at OH 4.70 showed long range coupling to an N-methyl signal at OH 
2.87. The proton signal at OR 4.70 also showed a correlation to a proton signal at OR 
3.63. The HSQC spectrum indicated that botb of these protons were attached to the 
same carbon atom indicating that this was a sarcosine residue (Figure 7.12a). A second 
sarcosine residue was also identified with chemical shifts of OH 2.88, 4.58 and OH 3.63 
respectively (Figure 7. 12b). 
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Figure 7.12a-b: Correlations observed for the two sarcosine residues of 177. 
A methyl group at OH 0.73 showed a correlation to a proton at OH 2.64, which in turn 
showed a correlation to another methyl group at OH 0.93. The multiplet signal at ~ 2.64 
showed two IJCH correlations in the HSQC spectrum to carbon atoms at Oc 71.2 and Oc 
26.8 respectively. This indicated that there were two protons at ~ 2.64 which was 
further corroborated in the IH NMR spectrum as this multiplet integrated for two 
protons. The CIGAR spectrum displayed correlations from the methyl groups at OH 
0.73 and OH 0.93 and the multiplet at OH 2.64 to both the carbons at Oc 71.2 and Oc 26.9 
indicating that these two carbons were connected to each other. An N-methyl signal at 
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iSH 2.92 also showed a CIGAR correlation to the carbon at iSc 71.2 indicating that this 
fragment was an N-methylvaline residue (Figure 7.l3a). A second N-methylvaline 
residue was also identified with almost identical chemical shifts of ~ 0.74, 0.97, 2.69 
and iSH 2.93 respectively (Figure 7.13b) . 
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Figure 7.13a-b: Correlations observed for the two N-methylvaline residues of177. 
The distinct doublet at iSH 5.95 showed correlations to a pair of protons at iSH 2.74 and 
iSH 1.83 which were attached to the same carbon at iSc 31.0. This pair of protons showed 
correlations to another pair of protons at iSH 2.27 and iSH 2.07 attached to a carbon at iSc 
22.9. The protons at iSH 2.27 and iSH 2.07 showed correlations to protons resonating at 
iSH 3.88 and iSH 3.71 attached to a carbon at iSc 47.4. The chemical shift of this last 
carbon (iSc 47.4) suggested that a nitrogen atom was attached to this carbon. A CIGAR 
correlation from the proton at iSH 5.95 to the carbon at iSc 47.4 enabled cyc1isation of this 
fragment to give rise to a proline residue (Figure 7.14). 
~COSY 
Figure 7.14: Correlations observed for a proline residue in 177. 
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An aromatic proton signal at DR 7.60 showed a single correlation to another aromatic 
proton signal at DR 7.35. The proton resonance at DR 7.35 also showed long range 
coupling to a methyl signal at DR 2.54 (Figure 7.15). 
Figure 7.15: Correlations observed for the aromatic portion of 177. 
Correlations were seen from the proton signal at DR 6.55 to proton signals at DR 3.84 and 
DR 2.30. The signals at DR 3.84 and DR 2.30 both showed IJCR correlations to the same 
carbon resonance at Dc 41.9. The final spin system contained a pair of doublet protons 
at DR 4.55 and ~ 3.96 which showed a IJCR correlation to a carbon at Dc 52.8. The 
chemical shifts of the carbons at Dc 54.2 and Dc 52.8 indicated the presence of nitrogen 
atoms attached to these two carbons (Figure 7.l6a-b). 
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Figure 7.16a-b: Correlations observed for the protons at OH 6.55, 4.55,3.96,3.84 and OH 2.30. 
Actinomycin D (179) contains a pair of identical depsipeptide rings containing five 
amino acid residues each. However, the COSY and TOCSY spectra of 177 identified 
only nine residues with the tenth residue replaced by the two fragments in Figure 7.l6a 
and b. The five protons seen in Figure 7.l6a and b (DR 6.55, 4.55, 3.96, 3.84,2.30) all 
showed strong correlations in the CIGAR spectrum to a signal at Dc 33.8. However, this 
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signal was not observed in the 13C APT spectrum and because of this it was thot.cr 
be a foldback in the CIGAR spectrum (Figure 7.28). Thus the actual shift for these 
correlations was calculated to be Oc 208.8 indicating the presence of a carbonyl group 
within a ring system. A ROESY correlation from the proton at OR 6.55 to the proton at 
OH 4.55 closed the ring system to give 4-ketoproline (Figure 7.17). 
~ CIGAR 
#~--~ .... ROESY 
Figure 7.17: CTGAR correlations to the carbonyl group at Oc 208.8. 
After the presence of 4-ketoproline had been confirmed the number of possible matches 
to 177 from the BNPD was reduced to just one, actinomycin V. A comparison between 
the literature data[182-184J for actinomycin V and the experimental data for 177 showed 
almost identical IH and BC NMR data suggesting that 177 was actinomycin V. 
However, during the interpretation of the CIGAR spectrum questions arose regarding 
the position of the 4-ketoproline residue in the depsipeptide rings of 177. If the 4-
ketoproline residue was present in the a-depsipeptide ring then 177 was novel, whereas 
if it was in the ~-depsipeptide ring then it was actinomycin V. Both of these 
compounds would be expected to show identical chemical shifts in the IH and 13C NMR 
spectra due to the symmetry of the molecule. 
The valine a-proton at OR 3.56, the amide proton resonance at OR 7.65 and the threonine 
~-proton signal at OR 5.14 all showed correlations to a carbonyl at Oc 168.7. The proton 
signal at OR 5.14, the N-methylvaline a-proton peak at OR 2.64 and the N-methyl 
resonance at ~ 2.92 all showed correlations to a carbonyl signal at Oc 167.50. The N-
methyl resonance at ~ 2.92 also showed correlations to a carbonyl at 166.3, as did the 
sarcosine proton resonance at OR 4.70. The N-methyl group of this sarcosine residue 
showed a correlation to a carbonyl group at 173.1, as was also the case for the proline 
a-proton at OR 5.95. The proline a-proton showed a correlation to a second carbonyl at 
oc 173.5. No further correlations were seen to the carbonyl at Oc 173.5. However, all 
previously identified actinomycins contain a pair of five membered depsipeptide rings 
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thus the carbonyl at Oe 173.5 is most likely connected to the free end of the valine 
residue (Figure 7.18a). 
The second depsipeptide nng also contained threonine, valine, N-methylvaline and 
sarcosine residues connected in the same way as that in Figure 7.18a. However, the 
proline residue was replaced with a 4-ketoproline. The proton at Ou 5.22 and the N-
methylvaline a-proton at Ou 2.69 both showed correlations to a carbonyl at oe 167.51. 
The N-methyl group at OH 2.93 and the sarcosine proton at OH 4.58 showed correlations 
to a carbonyl at 165.9. The N-methyl group of the sarcosine residue at OH 2.88 and the 
~-protons of the 4-ketoproline residue at OH 2.30 and 3.84 all showed correlations to a 
carbonyl group at 172.7. The proton at Of{ 4.55 in the 4-ketoproline residue and the a-
proton at OH 3.69 of the valine residue both showed correlations to a carbonyl at Oe 
174.0. The valine amide proton resonance at OH 8.19 and the threonine a-proton at OH 
4.47 showed correlations to a carbonyl at Oc 168.9 thereby closing the second 
depsipeptide ring (Figure 7 .18b). Finally the amide protons of the threonine residues at 
OH 7.19 and OH 7.67 both showed correlations to carbonyl groups at Oe 166.0 and Oc 
166.5 respectively. 
5.14 H 
H3C 
4.55 H 
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~ll66.0 
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a 
Figure 7.18a-b: CIGAR correlations for the depsipeptide rings. 
If the 4-ketoproline residue was in the a-ring the aromatic proton at Ou 7.60 would be 
expected to show a 3 JCH correlation to the carbonyl at oe 166.5. Whereas if it was in the 
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p-ring the 3 JeH cOlTelation would be to Dc 166.0. A correlation from the aromatic 
proton at DH 7.60 to the carbonyl at Dc 166.0 was observed, thus the 4-ketoproline 
residue was located in the p-ring. Therefore 177 was indeed actinomycin V. 
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Unfortunately at the time of work on this compound a high resolution mass spectrum 
was unable to be obtained. However, after 177 had been identified as actinomycin V a 
high resolution ESI-MS showed a molecular formula the same as that for actinomycin V 
of C62H84NI 2017 (27 double bond equivalents). 
7.4.1.1 Confirmation of multiplet signal assignments 
After identification of 177 as actinomycin V, spectral simulation using the experimental 
coupling constants and chemical shifts of the multiplets between DH 5.0 - 3.0 in the 1 H 
NMR spectrum was performed with ACDLabs lH NMR viewer to confrrm that the 
COlTect signal assignments had been made. 
7.4.1.2 Multiplets between DH 5 - 4 
There were two well defined signals between DH 4.75 and 8H 4.65 and a relatively 
complex multiplet between ~ 4.62 - ~ 4.50 which arose from a sarcosine proton, a 
threonine a-proton and a D-proton in the 4-ketoproline residue. The coupling constants 
for the threonine a-proton were unable to be detemlined directly from this multiplet 
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(Figure 7.19a). However, the other threonine a-proton signal was well separated and as 
such the coupling constants were estimated from this signal instead. Spectral simulation 
of this multiplet with coupling constants of 2J HH = 17 Hz for OR 4.58, 2JHH = 19 Hz for 
OR 4.55 and 3 JHH = 2 Hz and 5.5 Hz for ~ 4.55 plus a line width of 2 Hz showed a very 
similar multiplet indicating that this was the correct signal assignment for these protons 
(Figure 7.19b). 
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(a) (b) 
Figure 7.19: Experimental (a) and simulated (b) peaks for the multiplet between OR 4.50 - 4.62 
7.4.1.3 Multiplets between OR 4 - 3 
There were two complex multiplets between OR 4.0 - 3.0 both of which integrated for 
two protons. The first of these multiplets, between OR 3.92 and ~ 3.80 arose from a 0-
proton in the proline residue and a ~-proton in the 4-ketoproline residue (Figure 7.20a-
b). 
""1\ H2.07 _---N----A~H227 
H 3.88 
3.71 
a b 
Figure 7.20a-b: Position of the signals at OR 3.88 and OR 3.84 in 176 
Chapter 7 ~ Streptomyces species 200 
Spectral simulation of this multiplet with 3 JHH coupling constants of 6.5, 10.5 and 11 Hz 
for OH 3.88, and a 3 JHH of 11 Hz plus a 2 JHH of 15.5 Hz for OH 3.84 with a line width of 3 
Hz showed a multiplet almost identical to the experimental one (Figure 7.21). 
f' i . I" I . I' 'Ii . j !. j' i I . i ">' i l' ", 
U2 3.11 UO ).81 us 181 3.8i US 3,14 113 til J,81 K8 U2 Ul UO 3,n Ui 3.81 li6 US J.U 3,83 3.12 Ul I¥' 
(s) (b) 
Figure 7.21: experimental (a) and simulated (b) peaks for the multiplet between OR 3.92 - 3.80 
The second of these multiplets, between OH 3.75 and ~ 3.67, arose from the second 0-
proton on the proline residue (Figure 7.22a) and an a-proton from the valine residue in 
the ~-ring (Figure 7.22b). 
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Figure 7.22a-b: Position ofthe signals at OR 3.71 and OR 3.69 in 176 
Spectral simulation of this multiplet with coupling constants of 3 JHH = 1, 9 and 11 Hz 
for OH 3.71 and 3JHH = 6 and 9.5 Hz for OH 3.69 and a line width of 3 Hz showed a 
multiplet displaying many similarities to the experimental one (Figure 7.23). 
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Figure 7.23: experimental (a) and simulated (b) peaks for the multiplet between 8H 3.92 - 3.80 
7.4.1.4 Relative stereochemistry of 177 
Further work on the stereochemistry of 177 was deemed unnecessary because the 
experimental 1H and 13e chemical shifts and the nJHH coupling constants were almost 
identical to those already reported for actinomycin V. [183-185] As the NMR data for 177 
were identical to those for actinomycin V the only way that 177 could be novel is if all 
the stereo genic centres were inverted. It is more likely however, that only one or 
possibly two stereogenic centres could have been inverted. This would result in 
alterations in the 1H and 13e NMR data as well as the nJHH coupling constants, but as 
this was clearly not the case the stereochemistry was assumed to be the same as that in 
actinomycin V (177). 
7.4.2 Structural elucidation of 178 
A slightly later eluting fraction, RKP 1.109.4, from the diol column showed an 
emichment of a molecular ion 2 Da higher than 177 (MH+ 1271). However, due to the 
low mass (4.4 mg) and the relatively low purity of the recovered sample no further work 
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was performed. Even though this was the case the increase of 2 Da in the mass 
spectrum, combined with the slight increase in polarity suggested that either one of the 
available carbonyl groups had been replaced with a hydroxyl group or that one of the 
two depsipeptide rings had been hydrolysed at the ester bond. Hydrolysis of the ester 
bonds was discounted as it has previously been shown that opening of one or both of the 
lactone rings results in a considerable decrease in biological activity and RKP 1.109.4 
showed significant activity towards the P388 cell line (13.6 ng/mL),l176, 186] 
There are fourteen carbonyl groups in actinomycin V, twelve of which form the peptide 
backbone, one is present in the 4-ketoproline residue and one in the aromatic ring 
system. Replacement of the amide carbonyls was discounted as this would significantly 
alter the conformation of the depsipeptide rings which has been shown to greatly alter 
the biological properties of the actinomycinsY70] This left two accessible carbonyl 
groups present in actinomycin V, one in the aromatic system and one in the 4-
ketoproline residue. The carbonyl in the aromatic ring system could not have been 
replaced by a hydroxyl group as this would have altered the conjugation of the aromatic 
system and caused a hypsochromic shift of the UV maxima. The alteration must 
therefore be at the 4-ketoproline residue to give rise to an actinomycin Xo derivative 
(178), naturally occurring as two different diastereoisomers, Xo~ or X08. [185] The 4-
hydroxyproline residue in the actinomycin Xo diastereoisomers is not a reduced form of 
4-ketoproline, but is instead incorporated as 4-hydroxyproline.[176] 
NH N~O 
o H)--' 
NH2 
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7.5 Chromatography of 179 in Spanish extracts 
A further two powdered extracts were received from BioMar SA with preliminary 
investigations of these extracts suggesting that the biologically active components were 
also actinomycins. The chromatographic steps for these two extracts were identical to 
each other and displayed almost identical bioactivity profiles, varying only in recovered 
mass. The results for one of these two extracts, Kai 40-1-1, are shown in Scheme 7.2, 
with a more detailed description of the chromatographic steps carried out on both these 
extracts found in the experimental section. 
10% 
176.6 
LyophiHsed powder 
ofKai 40-1-1 (5 g) 
ColumnA ClB (50 g) 
H2O • McOH DCM 
I 
>12500 <97.5 2679 
ColumnB C lB (50 g) 
MeOHinH2O OCMin MeOH 
20% 40% 60% 70% 
27.1 89.8 18.2 5.7 
186.5 
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80% 90% 100% 10% 
3.9 8.9 6.2 3.7 
31.8 <9.7 <9.7 860.5 
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100% 100% 100% 
2.5 3.6 
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Scheme 7.2: Purification flow chart of an extract from the microbial isolate Kai 40-1-1. 
The powdered extracts (5 g) were initially re-suspended in distilled water (100 mL) then 
crudely fractionated by vacuum liquid chromatography (VLC) on reverse phase Cl8 (50 
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g) washing first with 200 mL each of H20, then MeOH and finally DCM. The highest 
level of cytotoxicity was seen in the second fraction with the most mass eluting in the 
first thus the second fraction of both extracts were purified further on reverse phase CI8 
column chromatography using the same stepped gradient solvent system used for the 
extract prepared from Kai 11-2-1. As with Kai 11-2-1 the major zone of biological 
activity was between 90 and 100 % MeOH and the ESI-MS spectra of these fractions 
indicated a mass of 1254 Da. A search on the available databases with this mass and the 
UV maxima from Figure 7.3 indicated that 179 was actinomycin D. A further 
chromatographic step on normal phase DIOL (column C) of these two extracts was 
undertaken to confirm this identification. The two fractions from each extract, RKP 
1.44.7-8 and RKP 1.60.7-8 respectively, were both eluted off separate normal phase 
DIOL columns with 30 mL each of DCM, EtOAc and MeOH. The IH NMR spectrum 
of the two DCM fractions were identical to a I H NMR spectrum of authentic 
actinomycin D and literature reports[183] confirming that 179 was actinomycin D. 
--1 \ 0 
Y;:\. N~/ o N o 
o ~H 
NH N~O 
o H ~ 
NH2 / 
179 
o 
7.6 Discussion 
The stereochemistry of 177 was not determined (Section 7.4.1.1) however, the absolute 
stereochemistry of the amino acid residues could easily be resolved using LC-MS and a 
modified Marfey's method.[187] This would involve hydrolysis of the actinomycin to the 
constituent amino acid residues then derivatisation of the free amino acids with FDLA 
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(1-fluoro-2,4-dinitrophenyl-5-L-Ieucine amide) for detection by a photodiode array 
detector. For comparison authentic amino acids are also sUbjected to the same 
procedures. 
The therapeutic potential of actinomycin V is relatively low in comparison to that of 
actinomycin D however, the free amine group on the phenoxazinone could be utilised in 
the production of various prodrugs. It has previously been shown that modification or 
removal of the 2-amino group in the actinomycin chromophore significantly reduces or 
completely destroys the biological activity of the actinomycinsY76] However, in some 
semi-synthetic analogues of actinomycin D (180 - 186)[188] the observed antitumour 
activities were only slightly reduced compared to that of actinomycin D. 
180 R=H 
181 R= CH3 
182 R= C2HS 
183 R = CH2C02H 
184 R = CH2CH2C02H 
185 R=CH2F 
186 R= C&Hs 
Three of these analogues (182, 185 and 186) also promoted a marked increase in the life 
span of the test organism and it was suggested that compounds 180 - 186 were being 
hydrolysed through the imine bond and the lactone in vivo to regenerate actinomycin D. 
-MeVal 
N 
sar/ "'0 
I I 
Pro", /Thr 
Val 
a Ring ~ Ring 
11 12 
Figure 7.24: Numbering system of 177 used for Tables 7.1-7.3 
Number lB, Multiplicity, (Jm., Hz) APTIHSQC COSY TOCSY CIGAR ROESY 
1 101.7 
1---..... - .... --..... --.. · .. ·--...... ·---·1-----+----......... ----+ ..... -· ... - ... · ..·--....... -_ .... -_ ... -_ .... - .... _ .......... 
2 147.6 
1-..... ·_ .. 
3
· .. --·"'if· .... --.. · ......... - ....... · ... _·_ .... ·_-· .......... I--·i·79.0._ ... _- _ .. __ ..- -.--...........,1------------... _ .... __ .......... 
4 113.5 
4a 145.0 
...... _ ...... _ ............. _ .... _ ...... _ ............... _ .... _ .... _ ... _ .................. _ ........ _ ............................ _ ..... _ .... _ ... ..........j 
5a 140.5 
..................... - ............ - ................ - .............. - ............... _ ................. - .................... _ ................ - .............. _ ................... - .. _ ..... _ .... _ ................ _ .... _ .... _ ....._ .... _ ....._ .... _ ..... __ ........ _ ..... __ .... -
6 127.8 
........................ __ .. - ...... _ ............... _ .............. _ .................. _ ............ _ ...... - .................... _ ................ - .............. _ .... - ...... - .. _ ........ _ ... _ .............................. _ ................ - .. _ ....._ ....... _ ..... _ .... _ ........ _ .. __ .... -
7 7.35, d, (8) 130.3 7.60,2.54 2.54,7.60 140.5,132.1,126.2,15.0 7.6 
..... "._.~.~ .... ~" .... ~.M.M.... .." ...... _""'" ..... ......... ~ .. """''''" ....... " .......... '''' ....... ............ "" ...... " ........... """ ....... "~ ....... ""_ ............ ~ .. ,,."""_ ... ""_~""~ .......... _""'~ .. ~ .... ,,_""'''''.~.~ .... _ ..... '''" .. _.''''_, ...... _ _, __ ",,_, .. ,_, .. ,,_, 
8 7.60, Ii, (7.5) 126.2 7.35 7.35 166.0,130.3 , 129.1 , 127.8 7.35,1.13 
...... _ .................................... _ ............. _ ............... _ ................ _.......... ............................................ .. .......................................... - .. _ ...................... _ ........... _ .............. _ .................. - ................... _ ....._ .... _ ........ -.-.... - ... - .. -
9 132.1 
.... _ ..... _ .......... _ ................ _-_ ..... _ ................ _ ... _""' ................ _ ............... _ ........................................................................................................................................................................................ "' ........... _ .................... - ............... - ............ -
9a 129.1 1--.... _ ........ - ............ _ ............... _ ..... _ ..... _ ................. _ .............................................. - ..................................... _ ................... - .................. -.................. ... ......................................................................................................................... _ ............... - ................ ..... 
lOa 145.9 1--.... _ ..... _.... .. ... _._ ..... _ .. _ .... _._ ..... _ ... _ ........ _ .... _ .... _ ... _ ........... _ ........ _ ... _ ............. _ ......... _ ........ _..... . ............... _ ............................................................................ ""' ................................................................. . 
11 2.21, s 7.7 179.0,145.0,113.5 2.54 !-------..... - ..... _ .• _ ..... _ .... _ ..... _ .•. _ ........ _ ...... _ ...... _ .... _ .... __ .• _ .......... _ ................ _ .............. _ .................. __ .............. _ ................ _ .................. _ ..... _ ....... - ............. "' ........ - ...... _ .... __ ..... _ ...... _ .. . 
12 2.54, s 15.0 7.35 7.60,7.35 140.5,130.3 , 127.8 7.35,2.21 1--"'--'" _ ... _-._-.. _ ... _.-.. _ ... _ ..... _ ... _ .... - .... _.... . .... _ .... _ ... _ .......... -_ .... _ .... _ ... 1--... -.-... _ ... - .... _ ..... _ .... _ .... _ ..... - ............. _-...... ""'_. 
13 166.0 I---.........jf-------------I--... ·--.... -f-· .. --.. --.. ·--.... ·-I--· .. --··-·-.. - ... _ .... _-....... - ... _ .............. _ ........ -. 
14 166.5 
Number IB, Multiplicity, (Jnn, Hz) APTIHSQC COSY TOCSY CIGAR ROES V 
2 4.55, dd, (2.5, 5.5) 54.7 7.19,5.14 7.19,5.14,1.13 168.7,74.7 7.65,7.19,5.14,1.13 I----· .. "'-,r .... ···--· .. ·"'--.. ·--··· 1---",--,,- _ ... __ ..... _-..... - - ..... __ .... ---..... __ ... _.---..... - ... -._.---.--._ ... - .... - .... --.-.... - ... _ .... -- ....... -.-.-............... -."'_ ...... --... _ ...... -
5.14, dd, (2.5, 6) 74.7 4.55,1.13 7.19,4.55, 1.13 167.50 7.65,4.55,1.13 1·"' .... -· .. ·-1r ___ ~..:...cc.........;c-'-_--+. ____ + .... ___ c....... ___ + ____ ......:..._-'-____ . ,..-... ----.... --.... --... - .. -."'--.1--......... - .. - .... - .......... --.-.. -3 
1.13,11,(6) 17.1 5.14 7.195.144.550.88 74.7,54.7 7.65,5.14,4.55,2.21 1--___ .,1--___ -'-.:..2_'--_ ........... ----1--------......... -1-.. "' ...... -"' ••....• : .• "'''' ....... : ............ ..:...-... -.. ''' .. -+."'-_. __ ._-"'-_ ....... -.-... _ ...... -....... -.-_ .......... - .......... - ........ "'.-4 
=:!.~jC::::' 7.19':~ (7.5) :::= .. _ 173.5 _ =~ 455 .. : .. ", ....... ", .. _ .. _."' __ . 5.14,4.54, 1.13 16?~~.~2~:~ _~:=.=: =::~ .. "'4.5::.~::::.13:=::: __ := 
2 3.56,q, (6,9.5) 58.5 7.65,2.11 7.65,2.11,1.11,0.90 168.7,31.7,18.9 7.65,5.95,2.11,1.11,0.90 
.. _-....... -.1-.. - .... _ .... - .. _ .. - ... _ .. - .. -.-............ - .. - .. _--.. ---."'- -."'--.---.--.. "'---..... -r---... --.... --...... --.... --.... --... -i--.. --.. --.-.. --._ .. -.-.... 
3 2.11, In, (7,7,9.5) 31.7 356,1.11,0.90 7.65,3.56,1.11,0.90 58.5,19.2,18.9 7.65,3.56,1.11 ,0.90 
.. _-_ ... _. . ........... _ .. _-....... __ .... .. __ .. __ ... "'- ........ _._ ..... _ .. _ .. __ ...... __ ... .. ... - ........ -
4 0.9,11,(7.5) 19.2 2.11 7.65,3.56,2.11,1.11 58.5,31.7,18.9 3.56,2.11 
._._-.......... - .............. _ ......... -.. _ ...... _ ............. - ...... -._ ..... __ ._ ..... -. __ ._-_ .... - """"--'"-''''''''--''' '--'---
... "' .... 2. .... __ . 1.11, d,(7) .... ~.~:.~ ... _ ... ........ _ .... .2:L~ .... _ ........ _ .... _ ..... _ ... ..1:?~ .. ~.?2.:.~!..?. .. ?.~~ ... _ .... _ ... __ ... __ .58.5, ~.1.7 , 19:2. ____ --1r--_ .... 5 ..... 1_4..;., .... 3...... 5.... 6""', 2 ...... 11 
NH 7.65, d, (5.5) 3.56 3.56,2.11 , 1.11 ,0.90 168.7,58.5,31.7 5.14,4.55,3.56,2.11 , 1.11 
........... -............. .. ......... _ ............... - .................. - ............ _ ... _ .. - ... _.. .. .. _ ... _ ... "'_ ... _ ... _ ................ _ ..... _ .... - ... --.. --... --... - ........ --.--+-..:...............-:----'--..:........--1 
Pro 1 173.1 
3.88 3.71,2.74,2.27 2.07 1.83 173.5 , 173.1 ,47.4,31.0,22.9 4.70 3.56.2.74 1.83 
............ _._ ... _ ... _ .... _._ .... _._ .... _ ... _ ....... _.+ ..... _ .... _ ....... "'. __ c.. ...... .......:'--.... _--1 2 5.95, d, (1,9) 56.4 2.74 " ...... " __ .... " .. ,," ... ~, .... ~ •• " ......... ~,~ ...... " .. __ .. "R'~. __ R .... __ ... _,_._"".~ ._ .......... ,....... .. ,_._." ........... _ •• ~_._~ ... ,_ .. _ .... __ .... __ ,_""'_ ... , 
3 a 2.74, m 31.0 5.95.2.07,1.83 5.95,3.88,3.71 ,2.27,2.07, 1.83 173.1 5.95,2.07,1.84 
............................... . ........... - ........... - ........... _"' ............ - .... -........... - ............ - ........... -.-......... - ... _ .............. --.... - ... - .. _.--..... - ... - ..... - ... - ..... -.-..... __ ... - .... __ .... __ .... :...........----1 
3 ~ 1.83, m, (1, 7, 12) 31.0 5.95 ,2.74,2.27 5.95 ,3.88,3.71 ,2.74,2.27,2.07 173.1 ,47.4 , 22.9 5.95 .. 2.93 ,2.74,2.27,2.07 
............................................................................................. _ ............................................................................ _ .................................................. _ ................. _ ............... _ .............. - ................. _ .............. _ .............. _ .............. _ ....._ .............................. _ ..... _ ..... _............ .. .. _ .. _ ..... _ ..... __ ..... __ ... -
4 a 2.27, m 22.9 3.71,1.83 5.95,3.88,3.71,2.74,2.07,1.83 3.71,2.74,2.07,1.84 
............. _ .......................................................................................................................... _ .......... _ ..................................................................... _ ................. _ ........... - .... _ ....... _ ..... _ ...._ ...................... _ ....._ ..... _ ............... _ ............... _ ..... _ ... _ .. _ ... _ ............... _ ........... _ ........... -
4 ~ 2.07, m 22.9 3.88,3.71,2.74,2.27 5.95,3.88,3.71,2.74,2.27,1.83 56.4,31.0 3.88,2.74,2.27 
........................... . ............... - .............. - ............. _ ............................................................................................................................... _ ......................................................... _ ..... _._ ...... _ ........ "' ...... _ ............... _ ................ _ ........... _ .... _ ..... _ ... - ..... _ .... _ ...._ ... .... 
5 a 3.71, m, (1, 9,11) 47.4 3.88,2.07 5.95,3.88,2.74,2.27,1.83 31.0 3.88,2.27 
.. _ .... _ .. - ...... _.-............ _ ... _ ........... _ ............. - ............... _ ............ - ................. _ ......... _ ................ _ ............. _ ............ _ .......................... - .............. _ ..................... _ ......... _ .......... _ .................. _._ .......... _ ................... _ ... __ .. _ ........... _ .... _ ...._ .... _ .... _ .... _ ....._ ... -
5 ~ 3.88, m, (6.5,10.5,11) 47.4 2.07 5.95,3.71 ,2.74,2.27,1.83 4.47,3.71,2.07,1.24 
... _._ .... - _ ...._-... _ .... _ .... _ ... _ ........ - .. -_ .... _ ... _ .... - ._ .. _. __ .......... _ ...... _ ....... _ .... _ .... _ ... _ .......... - ..... _ ............ _ ................... _ .............. - ............. _ ......................... _ ................................ __ ... _ ...._. __ ......... --_._ .. _. __ ._._ ..... _ ... 
Sar 1 166.3 
2 (l 4.70, 11, (I 7.5) 51.3 3.63,2.87 3.63 173.1,166.3 ,34.9 5.95,3.63 ,2.87 
, .. ,-, .............. - -"'"-...... -,,''' .. ,-.... -''''' .. -,~.---''''' 
2)3 3.63,d,(17) 51.3 4.70 4.7 165.9,172.7,34.7 5.95,4.70,2.87,0.73 1---,--,,,- ._ .... _ .... _ ....... _.-... _ .... - ... _ ... - ... _ ..... - .... - ..... - ... - ..... - ............. - ... - ........................... - .............. - ....................................... _ ................ f--.............. _ ........................................................................................ _ ......... _ ......... _ ..................................................................... .... 
~CH3 2.87, S 34.9 173.1 ,51.3 
... _ .... - .... - .. - .. - .... - .... _ ... __ ..... -.............. ...-......... _ ............. - .. _ ..... _ ...... _ ..... - ...... _ ........ - ._ ..... _ ... - ...... - ... _ .... _ ... _ .... _ ..... _ ....... f-..... _ ... _ .............. - ............. _ ................ _ ......... - .... - .............. - ........ - ...... - ...................... - .............. - ............... ..... 
MeVa11 167.5 
.. _ .............. 1--.. __ ... __ ..... __ ......... 1---.. __ ..... - _ .... --..... __ ....... - - ... --... --... - ..... - ...... - ...... - .... -... ...-... _._ ....... _ ............... _ ................ - ... _ ......... - ............ - ... _ .. _ ... _ ....... _ ............ -... _ ........................ -
2 2.64, m, (5.5, 6) 71.2 0.93,0.73 0.93,0.73 167.50,166.3 ,71.2,39.2,26.8,21.5,19.0 2.92,0.94,0.73 
_.. . .. _ ...... _ .. _ ...................... _ .. _ ...... _ ........... _ ..... _._ .......... _._. __ .... _ ... _ ......... _._-_ .... __ ._ .... _ ............... _ ...... _._--_ ..... _ ........ _._ ...... - ................................................. -............................... .. 
3 2.64 26.8 0.93,0.73 0.93,0.73 167.50,166.3,71.2,39.2 .. 26.8 .. 21.5,19.0 2.92,0.94 .. 0.73 r----+ .. --.. --.... --.... ~ .... -_ ... -- .. _ ........ __ ..... _ ........ --"' ... ---".-".-"' ... --.-... -""'" -... - ...... - .... - .... - .... - ........ - .... _ ..... - ..... - .... _ ...... _ .......... - ............. _ ............... _ ................ - ............ .. 
4 0.93, d, (6) 21.5 2.64 2.64,0.73 167.50,71.2 ,26.8,19.0 2.64 
~. 
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Number IB, Multiplicity, (JIllb Hz) APTIHSQC COSY TOCSY CIGAR ROESY 
4 1.24, d, (6.5) 
_. :t-.'I!. __ . r---.7.6~~~6) _ ... ~. 4.47 
Vall 174.0 
.. -.--... --.1----.---... ---.- '---"'-- -·· .... --.... ···- .. --····------+--------------11 .. --.. --.. --·--"-
.. _ ... _ ..... 2. .. _ .... ~. 1--..... ...l.:.~~ .. 9:l~:~.: ... 1..~ ... __ ... . .. _ .... ?2:~ .. ____ .... 8.1?.2·~L ___ .~.19, Z..:~~.4, 0.89 + __ ........... ~~.O, 168.9,31.8 .... _ ~;_19_,_6_.5~_,_2._21.._, 1_.l_4 .. ~:~_ ... 
3 2.21, ro, (7, 7.5, 10) 31.8 3.69,1.14,0.89 8.19,3.69,1.14,0.89 57.1,19.1 8.19,3.69,1.14,0.89 
--.... _ ..... _ .... _ .. --.1--...... --................ _ ...... - ...... _................ .._-..... --... - .. --·-·-.... --· .... ·--.. ·r---·-------------I----'--.. -C-..-"'---·-
4 0.89,d,(7) 19.1 2.21 8.19,3.69,2.21,1.l4 57.1,31.8,18.8 3.69,2.21 
.. -.-.... - .... _ .. _ .. 1--..... _.-_ .. _._ ... -._ .. ---............... --... __ ... _-... -_ .... _- ---.f---.. ------ --.. -------.----
5 1.14,d,(7) 18.8 2.21 8.19,3.69,2.21,0.89 57.1,31.8,19.1 8.19,5.22,3.69,2.21,0.90 
..... -._ .............. _ .... -._. 1--..... -.. _ .. _ ... _.-... - .... - ................... _ .. _ .... _._ .. - ..... _ ...... -_ ... _ ...................... - .. ---···-.... - .. ·-.... - .... ·-.. 1--.. · .. ---.. ---.. --.. - .. --.. --.... 1----"-----'---'-----I 
NH 8.19, d, (6) 3.69 3.69,2.21 ,1.14,0.89 168.9,57.1,31.8 5.22,4.47,3.69,2.21,1.14 
.-.-._ ....... -... _-.. _. . ..-.... -.~-... - ..... ---.. --.- .. -·-· .. - .... -···-.. · .. ·-.. ·-· .. ·f--.. · .. -·_ .. · .. -_ .... _--· __ · .. ·--.... ·I __ ':""""'''''''''':''''''''';'''''''':''_''''''''';_-1 
4-KetoPro I 172.7 
.. --.... - ......... ---............................... - ..... - ............ - .. -.-........ --'"........ . ............ _ ............... --............... _ ............. - .. - ...... _ ............ _ ................. _ ...... _ ....... f--..... - ....... - ..... - ... - .... - ..... - ......... - .... - ... ~ .... - _ .... --.. __ .... _--.. -_ .. -
.. _ ..... _ .. 2 ..... _ ..... _ ............ ~.~:~.~: .. d, (!,~ .. ~~L. ....... _... _ ..... ~4.2_ ........ _ ..... ~ .. :.~~.2:.J.2.._._ .. _ .. _._.,},.:.~.~L~~.~_ .... _ ... f--.... _.~ ... ~.~~:..~I..:9 , 208.:_8 _ .... __ ... __ 4:.55 , 3.~._9 :....' 3_.8_4 __ -1 
3a 3.84,dd,(11, 18) 41.9 6.55,2.30 6.55,2.30 208.8,172.7,54.2 6.55,2.30 
............................................... _ ................ _ ................. _ ............... _.............. ._ .......... _ ................ _ ...... _ ................... _ ..... - .. _ .............. _ .... _ ... _ .... _ ..................... _ .............. _ ................ _ ... _ .... _ .... _ ...... _ ... _ ..... _ ...... _ ... _ ...... _ .. __ .. __ ... _-_ .. _-
3 ~ _ ...... __ .~:~~.: .. ~.Q!.~.~.L_. __ ... ......... _ ..... ___ ...... _._ .... _?.:.~:...:..~.:.~~._ .. _ .. __ .. _._ . ....?.:~~.:_3 .8~._._ .. __ .... _ ...... _ .............. __ ~~~.~.:~~2.. .... _. ____ .... 3.84 
4 208.8 
._ .......... _ .......... -.. __ ._ .... _ ................ -............ _ .. _ ............... -.... -... __ ._ ...... _-_ ......... _ ..... _--- ...... -... _._ .. _--_._--... __ ._ ..... _-- _._ .. __ ... _ ... _._ .... __ ._ ... __ .... __ ... --_ ... _ ..._._ .... _ ...__ .. -
4.55, d, (19) 52.8 3.96 3.96 208.8, 174.0,54.2 3.96 
...... · .. ·_· .. · .... _· .. - .. · ........ -H .. · .. · ........ _ .. ·· .. ··· ........ ; .... _··: .. _· .. ; ...... - ................ +-............ _ ............... - .................................... -......................................... _ ................... _ ................... _ .......... -_ ... _ ............... _ .................. _ ............................. _.-................ _ .. -.. - ..... --._ .. _._ ... -.-.. _-_ .. .. 5a 
1-. __ ............ 5 .. _.:.. ~ ................ ..,I ................. ....2.:.~~: .. ~Q.?2 ........................... _ ............... _ ............... _ .............. ~:2.~ .............. _ .............. _ ............... ~:~2. ........... _ ...................... _ ..... _ ........ _ ............. ...2~.~~.~_ ................. _ ................. _ ... _ ...... _ ..... _.~1.~ . .:..3 .. ~ .. _ .... _ ... _ ... . 
Sar 1 165.9 
'-"-"'''-''-'''- ... _ ..... _ .................. _ ...... _ ..... _ .... _ .. -"'-'''-'''- ... _ ....... _ ......................................................................................... __ ............. _ ......... __ ................. -._ ............. _ ................ _ ................... - .... _ ..... _ .... _ ... _ .... _._ .... _ ... _ ...-
2 a 4.58, d, (17.5) 51.3 3.63 ,2.88 3.63 172.7, 165.9,34.7 6.55 ,3.63 , 2.88 
_ ........ _. __ .... _....... .. ... - ....... _.- ... _ ............ _ ................. _ ... - ........ _ ............ _ ................. _ ....................... _ ......... _ ............................... _ .................................... _ ............. _ ..._ ..._ ........ _ ... _ .. _ ..... __ .... _ ..._ .... _._ .. _ ............. -
2 J3 J .63, d, (17) .. _. __ .. _ ..... ~?~ .. _ .... _ .......... _ ..... _ .... _~:~.~ .. _ .... _ ......... _ .......... _ ... _J.~~J._~J.?~.:~ .. : .. ~.~.?. ............... _._._ ........ _.~:.? .. ?..~:2..~ .. :2:~.:.~.:?.~ ....... _ 
NCH, 2.88, s 34.7 172.7,51.3 
_ .. _ .. _ .... _............... .. .......... _ ................ _ ....... _ ......... _ ........ _.- .............. _ ..... _._ ... _ ................ _........ . ... _ .................. _._._ ............... _ .. __ .... _._ .. __ .... _ ... _._ ...... _ .................... -.--....... --......................... -...... .. 
MeVall 167.5 
_ ... _ ... _ ... _ ....... _ ... - ...... _ .... _ ..... _ ...._ ....._ ... _ ..... - ._ ... _ ...._ .... - .... _ ....... _ .... _ ..... _ ... - ........ _ ... _ ..... _ ... _ ..... _ ... __ ...... - ....... _ .... _ ..._ ............. _ .............. _ .................. _ .................. - ..... _ ................................................ _ .............. _ ......... . 
2 2.69, m, (6, 6) 71.4 0.97,0.74 0.96,0.74 167.51,165.9,71.4,39.4,26.9,21.7 2.93,0.97,0.74 
_. __ ... __ .... -1--.... __ .... __ .. ...- .... __ ..... _ .............. - ..... - ..... - ..... - ... _ ..... _ ...... - ....... - .... - ... - ... _ .. -.-... _ ............. _ ............ _ ......... _ ... _ .................. _ ................ - ................................. _ ........ . 
3 2.69 26.9 0.97,0.74 0.96,0.74 167.51,165.9,71.4,39.4,26.9,21.7 2.93,0.97,0.74 
............. _ .............. -"-... "-"-".- .. _ .. _ .... _ ... _ ...._ ... _ ..... - ._ ... _ .. _ ..... _._ ......... _ ........... _ ............... _ ............ _._ ... _ ...... _ ............................ _ .......................... .. 
_ .. _4 _ .. _-1" .. __ .° ..1 .... --,-'97" d...:." .. (,6 . ...:..)_ ..... _+-.. _2_1._7 ... __ ..... _2_.6_9 .... _ .... _._ .... 2:?.9....:..?.74 ..... _ ...... _ ... _ ..... _ .. 167.:~.:21.~.~.:?..J.?.:.! ....... _ ........ .... _._ ......... _ ...... ~:69_._ ..... _ ................... . 
0.74, d, (6) 19.1 2.69 2.69,0.97 167.51,71.4,26.9,21.7 3.63,2.93,2.69,0.97 I------..... n ..---........:.......:..........:....--+···--.. ·- - ... -_ .... - -_ ... _-... _-.... _ .. f--..... _ ... _ .. _._ .... _ ... _ ...... _ ... _ .. __ .. _ ....... _-_ ....... -_ ........... _ ...... - .... __ ......... .. 5 
2.93, s 39.4 167.51 .. 165.9 .. 71.4 N o 
00 
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Figure 7.25: COSY spectrum of177 in CDC13 
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CONCLUSIONS 
This body of work serves to demonstrate that marine derived micro-organisms, 
especially fungi and actinomycetes, are capable of producing a wide variety of 
secondary metabolites. Even though no compound isolated and characterised in this 
study possessed a new carbon skeleton a high proportion did display modifications to 
known carbon skeletons and are in that sense novel. 
Only a small number of the total micro-organisms isolated in this study were able to be 
investigated. The results obtained from the microassay however, indicated that a high 
proportion of these micro-organisms (~ 30 %) produce bioactive metabolites. Those 
microbes that were not investigated in this study remain a lucrative source of potentially 
novel metabolites. Indeed this high percentage of active microbial isolates almost 
certainly will lead, in the future, to the discovery of compounds with novel carbon 
skeletons as well as known compounds and new derivatives of known carbon skeletons. 
In brief, manne derived micro-organisms are capable of producing a plethora of 
potentially useful bioactive compounds. 
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CHAPTER EIGHT 
EXFE.RJME.NT AL 
8.1 General Methods. 
B.1.1 Preparation of macro-algae and driftwood samples 
Small sections of surface sterilized macro-algae and driftwood were plated out on 
minimal and complex media (Section 8.1.2) containing antibiotics such as streptomycin 
and chloramphenicol to inhibit bacterial growth. [32J 
Macro-algae 
Sections of macro-algae were rinsed with sterile distilled water, blotted dry on sterile 
filter paper, cut into small pieces (approximately 0.5 cm1 ) and placed onto a minimal 
isolation medium (medium I) and a complex medium (medium II). 
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Driftwood samples 
The outer layer of driftwood samples were aseptically scraped to remove any superficial 
organisms. Thin slices of the driftwood were then plated onto medium I and medium II. 
8.1.2 Media and incubation conditions 
Medium I 
Filtered seawater agar (SA). 15 giL agar, fresh seawater (filtered though coarse 
mirac1oth) 1000 mL, 100 ~g1L chloramphenicol, 100 ~g/L ampicillin, 50 ~g/L 
streptomycin sulphate. 
Medium II 
Seawater potato dextrose agar (sPDA). Gibco PDA 39 gIL, fresh filtered seawater 1000 
mL, 1 00 ~g/L chloramphenicol, 1 00 ~g/L ampicillin, 50 ~g/L streptomycin sulphate. 
Medium III 
Seawater potato dextrose agar (sPDA). Gibco PDA 39 giL, fresh filtered seawater 1000 
mL. 
Medium IV 
Potato dextrose agar (PDA). Gibco PDA 39 giL, distilled water 1000 mL 
Medium V 
Starch-casein agar. Glycerol 10 giL, peptone 140 0.3 giL, KN03 2 giL, NaCI 2 giL, 
K2HP04 2 giL, MgS04.7H20 50 mglL, CaC03 20 mglL, FeS04.7H20 10 mglL, 
distilled water 1000 ml, pH adjusted to 7.0 prior to sterilization. 
Incubation and isolation conditions 
After plating out, the macro-algae and driftwood samples were incubated at 15°C and 
20°C for seven days, after which the plates were examined daily for developing fungal 
hyphae under a stereomicroscope. Once hyphae had been detected on the macro-algal 
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or driftwood sections (typically after 10 days incubation) the hyphae were transferred to 
a nutrient rich medium (medium II). Any hyphae or sporulating structures were 
observed with a stereomicroscope and transferred to medium II with a sterile glass 
capillary. 
8.1.3 Maintenance of fungal stock cultures 
Terrestrial and facultative micro-organisms were stored in 10 % glycerol in distilled 
water and obligate marine micro-organisms were stored in 10 % glycerol in seawater. 
All were stored at - 80oe. 
8.1.4 Sample Extraction 
Fungal cultures were homogenised with an Ultra-turrax® (Janke & Kunkle) for five 
minutes or until the mycelial mat was sufficiently macerated, then filtered through celite 
under vacuum. The filtered broth was subsequently extracted three times with EtOAc at 
a ratio of 5:1. The solid mycelial residue was re-suspended in EtOAc at a ratio of 1:5 
(l00 mL EtOAc for every 20 g wet weight) and extracted three times. The initial 
EtOAc extraction was for one hour, the second overnight and the third for a final hour. 
All organic phases were combined, dried over anhydrous MgS04, and taken to dryness 
on a rotary evaporator. A small volume (50 mL) of the aqueous phase was also taken to 
dryness on a rotary evaporator. Both the aqueous and organic phases were then 
transferred to a pre-weighed vial, the weight determined and assayed for antitumour 
activity. 
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Scheme 8.1: Flow chart showing procedure used for metabolite extraction from fungal cultures. 
B.1.5 P3BB Assay 
Prior to further investigation, crude extracts were assayed for biological activity against 
the murine leukaemia cell line P388. This assay consists of a serial dilution of the 
sample of interest followed by incubation for 72 hours with P388 cells. Cell viability is 
determined colorimetrically by the addition of the yellow dye MTT tetrazolium. 
Unhealthy or dead cells cannot metabolise this dye leaving a yeUow colour, whereas 
healthy cells reduce this dye to MTT formazan resulting in an intense purple colour. 
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The concentration of sample requi red to reduce cell growth by 50 %, when compared to 
controls, is expressed as an ICso in ng/mL. All samples were dissolved in double 
distilled MeOH prior to submission to the assay. 
P388 M TT Assay 
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Figure 8.1: P388 assay dilution plate, purple indicates viable cells and yellow dead or inactive cells. 
8.1.6 HPLC microtitre plate screening 
As part of the dereplication proce s (Section 2.4) all small scale extracts were initially 
examined in the HPLC microtitre plate screen. An aliquot of the crude extract (250 ).lg) 
was analysed by reverse phase l l 8 HPLC using the following gradient solvent system: 
2 minutes of 10 % ACN/H20; a linear gradient to 75 % ACN/H20 for 12 minutes; 
isocratic at 75 % for another 10 minutes; a linear gradient for 2 minutes to 100 % A N 
followed by isocratic at 100 % ACN for 4 minutes then returned to 10% ACN/H20 in 2 
minutes and re-equilibrated for 8 m inutes; with a flow rate 1 mUmin. The eluant was 
collected into 96 well microtitre plates and assayed for cytotoxicity against the P388 
cell line. 
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B.1.7 Column Chromatography 
Column chromatography was performed with glass columns of stated dimensions. All 
solvents used for chromatography were of commercial grade and distilled once, except 
for MeOH which was doubly distilled. Reverse phase CI8 and some normal phase diol 
columns were run under pressure (0.5 kPa) with oxygen-free N2 gas. 
Normal phase flash and preparative chromatography was performed with Merck DIOL 
(40 JllTI APD). Samples fractionated by normal phase (DIOL) flash chromatography 
were dissolved in a minimal volume of 50:50 MeOHlDCM and adsorbed to fresh DIOL 
(0.2 g). Residual solvent was removed under vacuum on a rotary evaporator. 
A standard elution profile was created for normal phase (DIOL) column 
chromatography (12g, 1.2 x 60 cm). Columns were equilibrated to 100 % DCM prior to 
sample loading then eluted with the following gradient solvent system: 100 % DCM (30 
mL), 5 %, 10 %, 20 %,40 %,60 %,80 %,100 % EtOAc/DCM (20 mL); 5 %,10 % 
MeOH/EtOAc (15 mL) and 100 % MeOH (35 mL). 
Reverse phase chromatography used Bakerbond CI8 (40 JllTI prep LC packing). 
Samples fractionated on reverse phase CI8 were also dissolved in a minimal volume of 
appropriate solvent and adsorbed to fresh CI8 at a ratio of 1:50. All remaining solvent 
was removed under vacuum with a rotary evaporator. 
A standard elution profile was created for reverse phase CI8 column chromatography 
(50g, 3 x 60 cm). Columns were equilibrated to 10 % MeOHlH20 prior to sample 
loading then eluted with the following gradient solvent system: 10 %, 20 %, 40 %, 60 
%,70 %,80 %,90 %,100 % MeOHIH20 (100 mL); 10 % DCM/MeOH (100 mL); 50 
% DCMlMeOH, 100 % DCM, 50 % DCMlMeOH, 100 % MeOH (200 mL). 
Size exclusion chromatography was carried out with Sephadex LH20 (Pharmacia 
Biotech AB). Samples fractionated with Sephadex LH20 were dissolved in a minimal 
volume of initial eluting solvent. 
Chapter 8 - Experimental 221 
8.1.8 High Pressure Liquid Chromatography (HPLC) 
Analytical HPLC was carried out on a Shimadzu LC-IOADvp liquid chromatograph, 
with an SPD-MIOAvp photodiode array detector. Columns were kept at a constant 
temperature of 40°C with a CTO-MIOADvp oven. Reverse phase HPLC was carried 
out on a Phenomenex Prodigy CIS 5-0DS column (311m, 250 x4.6 mm). A standard 
flow rate of I mL/min was used with variable concentrations of ACN (HPLC grade) in 
H20 (Milli-Q). In some projects the milli-Q H20 was acidified with 0.05% TF A. All 
samples were filtered through a 0.45 11m syringe filter immediately prior to injection. 
8.1.9 Structural Elucidation 
Structures were elucidated based on ID and 2D NMR experiments and high resolution 
mass spectrometry. This was further backed up with additional experiments such as 
UV-visible and CD spectroscopy. Where appropriate compounds were identified by 
comparison of experimental data and those found in the literature. Literature searches 
were performed using multiple databases including, MarinLit, Berdy Natural Products 
Database, Antibase, Chapman & Hall Natural Products Dictionary, version 9.1, August 
2000, and Scifinder Scholar. If the metabolite of interest was not found in any of the 
above databases, but especially Scifinder Scholar, it was designated as new. 
8.1.9.1 Mass Spectrometry 
EI mass spectra were obtained on a Kratos MS80RFA spectrometer, operating with a 
4kV accelerating potential, 70eV and a source temperature of 250°C. 
Electrospray Ionisation (ESI) mass spectra were recorded on a Micromass LCT 
spectrometer using a probe voltage of 3200V, an operating temperature of 150°C and a 
source temperature of 80°C. A 10 ilL injection of sample was made from a 10 Ilg/mL 
sample. When obtaining positive ESI mass spectra some samples were protonated with 
10 IlLlmL formic acid prior to injection. When recording negative ESI mass spectra 
samples were deprotonated as required with 10 J..LLlmL DEA prior to injection. 
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LC-APcI Mass Spectra were obtained with a Waters 2790 HPLC coupled to a 
Micromass LCT spectrometer. Reverse phase HPLC was carried with a Phenomenex 
Prodigy CIS 5-0DS column (3 Jlffi, 250 x4.6 nun) at a flow rate of 1 mLimin with 
varying concentrations of ACN (HPLC grade) and H20 (Milli-Q). APcl spectra were 
recorded with a drying gas flow rate of 300 Llhr, a probe voltage of 3200V and a cone 
voltage of 45V. A probe operating temperature of 300D C and a source temperature of 
150D C were used. 
8.1.9.2 Nuclear Magnetic Resonance (NMR) 
IH NMR and BC NMR spectra were recorded on a Varian INOVA 500 spectrometer at 
23 DC, operating at 500 MHz and 125 MHz respectively. Other experiments described 
herein, including, 1D-TOCSY, 2D-TOCSY, COSY, 1D-NOESY, 2D-NOESY, APT, 
HSQC and CIGAR were all recorded on the lNOV A 500 spectrometer at 500 MHz. 
The spectrometer was fitted with a pulsed field gradient MLD driver with a 5 nun 
Indirect Detection Probe. 
Chemical shifts in this thesis are described in parts per mi11ion (ppm), on the 0 sca1e, 
and referenced to the appropriate solvent peaks: 
CDCb referenced to CHCb at ~ 7.26 ppm (IH) and CDCh at Oc 77.0 ppm (l3C); 
CD30D referenced to CHD20D at OH 3.30 ppm e H) and CD30D at Oc 49.3 ppm (l3C); 
DMSO-d6 referenced to CD3(CHD2)SO at OH 2.50 ppm (IH) and (CD3)2S0 at oc 39.6 
ppm (BC). 
IH NMR spectra were recorded with an acquisition time (AT) of 1.892 s and BC NMR 
were recorded with an AT of 1.3 s and a delay (Dl) of 1 s. COSY, 2D TOCSY, 2D 
NOESY and 2D ROESY experiments were all recorded with an AT of 0.228 s and a D1 
of 1.0 s. Both the mixing times and spectral windows for each experiment varied 
according to the sample being examined. 
HSQC experiments with the pulsed field gradient system were run with an AT of 0.140 
s, a D1 of 1.0 sand IJCH = 140 Hz. CIGAR experiments were recorded with the same 
D1 as in the HSQC experiments, but with an AT of 0.250 sand nJCH = 8.0 Hz. 
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8.1.9.3 UV-Vis Spectroscopy 
Purified samples were dissolved in MeOH at a concentration of 1 mg/mL. The UV -vis 
spectra of these samples were recorded with a Hewlett Packard 8452 diode array 
detector using a 10 mm quartz curvette. 
8.1.9.4 Circular Dichroism Spectroscopy 
CD spectra were measured in 0.1-0.01 mg/mL MeOH using a 10 mm quartz cell on a 
Jasco J 20-C spectropolarimeter. 
8.1.9.5 Optical Rotation 
Rotation values were obtained on a Perkin Elmer 341 polarimeter at 20°C with a 
wavelength of 589 nm. The optical rotation was then calculated using the following 
equation: 
Where L is the cell pathlength (dm) and C is the concentration (giL). 
8.1.10 Solvents 
Commercial grade solvents were all distilled once prior to use with the exception of 
MeOH and H20. MeOH was distilled twice and H20 was treated by reverse osmosis 
and subsequently filtered through a 0.45 Illll Millipore filter before use. 
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8.2 Experimental for Chapter 3 
8.2.1 Chromatography of Oka 2-1-1 
The large scale culture extract was adsorbed to C 1S (2 g) and fractionated on a reverse 
phase (CIS) colunm (50 g, 3 x 60 cm), using the standard stepped gradient system 
(Section 8.1.7) for elution. Thirteen fractions were collected and analysed by reverse 
phase HPLC and assayed for cytotoxicity against the P388 cell line. The three fractions 
(RKP 1.127.5-7) which eluted between 70-90% MeOII/H20 showed the highest 
cytotoxicity towards the P388 cel1line and showed common components in the HPLC 
traces eluting between 11 and 14 minutes. Based on these results these fractions were 
combined and further purified by nonnal phase chromatography on DIOL (12 g, 1.2 x 
60 cm). The combined bioactive fractions (RKP 1.127.5-7) were eluted using the 
standard DIOL elution profile (Section 8.1.7). Eleven fractions were collected, assayed 
for cytotoxicity and analysed with analytical reverse phase (CIS) HPLC and NMR 
spe·ctToscopy. Cytotoxicity was seen in the first two fractions from 0-10 % 
EtOAclDCM (RKP 2.209.1-2), and the fifth and sixth fractions from 40-60 % 
EtOAc/DCM (RKP 2.209.5-6). Based on cytotoxicity, HPLC and NMR spectroscopy 
the first two fractions (RKP 2.209.1-2) were combined. 
Analytical HPLC and NMR spectroscopy of the two later eluting fractions (RKP 
2.209.5-6) showed that RKP 2.209.5 was relatively pure, whereas RKP 2.209.6 was not. 
The major component of RKP 2.209.5 (109) was identified by 2D NMR spectroscopy 
and mass spectrometry as the 4-hydroxy derivative of 104. 
Analytical HPLC and NMR spectroscopy of RKP 2.209.1-2 highlighted many 
impurities in the combined fraction thus it was further purified on a small scale nonnal 
phase (DIOL) column (1 g, 0.5 x 7.5 cm). The combined fraction was eluted with 100 
% DCM (2 x 1 mL) and 100 % EtOAc (2 x 1 mL) collecting four fractions (RKP 
2.226.1-4). The lH NMR spectra of these four fractions indicated that the middle two 
fractions (RKP 2.226.2-3) were very pure and thus were combined. On the basis of lD 
and 2D NMR spectroscopy and mass spectrometry the major component of the 
combined fraction (RKP 2.227.1) was identified as a novel trichothecene (104). 
Chapter 8 - Experimental 225 
Compound (104) 
HR ESIMS MCs+ 527.1049 (C21H3007CS requires 527.1046). JH NMR (CDCh) 8 5.79 
(d, JHH = 5.5 Hz, 1H, H10), 5.28 (d, J HH = 5.5 Hz, 1H, H8), 4.47 (dt, J HH = 5, 12 Hz, 
1H, H3), 4.43 (d, JHH = 6 Hz, 1H, HII), 4.25 (d, JHH = 12.5 Hz, 1H, H15a), 3.95 (d, J HH 
= 12.5 Hz, 1H, H15~), 3.50 (d, JHH = 4.5 Hz, 1H, H2), 3.07 (d, JHH = 4 Hz, 1 H, Hl3a), 
2.86 (d, J HH = 4 Hz, IH, H13~), 2.45 (m, JHH = 6 Hz, 1H, H18), 2.34 (dd, JHH = 5.5, 15 
Hz, IH, H7~), 2.27 (dd, JHH = 3.5, 14.5 Hz, 1H, H4a), 2.14 (dd, JHH = 3.5, 14.5 Hz, IH, 
H4~),2.05 (s, 3H, 22Me), 1.95 (d, JHH = 15 Hz, 1H, H7a), 1.74, (s, 3H, 16Me), 1.17, 
(d, J HH = 7 Hz, 3H, 19Me), 1.16, (d, J HH = 7 Hz, 3H, 20Me), 0.80 (s, 3H, 14Me). J3C 
NMR (CDCh) 8 176.7 (C=O), 170.4 (C=O), 136.2 (C), 124.1 (CH), 79.6 (CH), 69.0 
(CH), 68.5 (CH), 67.7 (CH), 65.4 (C), 64.9 (CH2), 48.6 (CH2), 45.5 (C), 42.1 (CH2), 
41.7 (C), 34.1 (CH), 27.5 (CH2), 21.1 (CH3) 20.3 (CH3), 19.2 (CH3), 18.5 (CH3), 12.1 
(CH3). UV (MeOH, run) 195. 
Compound (109) 
HR ESIMS MNat 433.1849 (C21H300 8Na requires 433.1838). IH NMR (CDCh) 8 5.77 
(d, J HH = 5.5 Hz, 1H, H10), 5.28 (d, J HH = 5.5 Hz, 1H, H8), 4.49 (d, J RR = 2.5 Hz, 1H, 
H4), 4.34 (d, J RH = 13 Hz, IH, HI5a), 4.24 (d, J HH = 5.5 Hz, 2H, H3 Hll), 4.01 (d, JHH 
= 12.5 Hz, 1H, H15~), 3.63 (d, J HH = 5 Hz, 1H, H2), 3.03 (d, J HH = 4 Hz, 1H, Hl3a), 
2.77 (d, J HH = 4 Hz, 1H, H13~), 2.49 (m, J HH = 7 Hz, 1H, H18), 2.40 (dd, J HH = 5.5, 
14.5 Hz, 1H, H7~), 2.05 (s, 3H, 22Me), 1.90, (d, JHH = 15.5 Hz, 1H, H7a), 1.74, (s, 3H, 
16Me), 1.18, (d, J HR = 7 Hz, 3H, 19Me), 1.17, (d, JHH = 7 Hz, 3H, 20Me), 0.80 (s, 3H, 
14Me). UV (MeOH, run) 195. 
8.3 Experimental for Chapter 4 
8.3.1 Chromatography of Wai 7-1-1 
The crude extract was adsorbed to CI8 (2 g) and initially fractionated with reverse phase 
(CIS) column chromatography. The extract was eluted using a modified version of the 
CJS elution profile (Section 8.1.7) with nineteen fractions collected. The first thirteen 
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fractions were eluted with the same profile as that described in Section 8.1.7, but this 
did not recover a large majority of the crude extract from the column. The remainder of 
the extract was recovered by washing the column with 100 % MeOH, 50 % 
DCM/MeOIl and 100 % DCM containing 0.05 % TF A (200 mL) followed by 100 % 
DCM, 50 % DCMlMeOH, 100 % MeOH containing 0.1 % NIl3 (200 mL). All 
fractions were assayed against the P388 cell line and examined by analytical reverse 
phase (CIS) HPLC. Cytotoxicity was only observed in the fractions eluting at 80 and 90 
% MeOH/lhO (RKP 1.95.6-7) and the HPLC trace of these two fractions indicated the 
presence of the bioactive peak eluting at 17.5 minutes as detennined in preliminary 
investigations (Section 4.2.1.2). These two fractions were subsequently combined, 
adsorbed to DIOL (1 g) and further purified on a nonnal phase (DIOL) column (12 g, 
1.2 x 60 cm). The combined fractions were eluted using a modified version of the 
DIOL elution profile (Section 8.1.7) with sixteen fractions collected. The first 10 
fractions were eluted with the same profile as that described in Section 8.1.7 with the 
remaining six fractions eluted as follows: 20 %, 40 %, 60 %, 80 %, 100 % 
MeOH/EtOAc (15 mL) and 100 % MeOH with 0.05 % TFA (35 rnL). The first twelve 
fractions all possessed some cytotoxicity with the major region of activity occurring 
from fraction two to eight (RKP 1.115.2-8). Analysis of these seven fractions by IH 
NMR spectroscopy indicated that they all contained the same major compound, but still 
contained contaminants. These seven fractions were subsequently combined, loaded 
onto a small Sephadex LH20 column (1 g, 0.5 x7.5 cm) and eluted with 100 % MeOH. 
Six fractions (l mL) were collected and NMR analysis showed that fractions four and 
five (RKP 1.169.4-5) were pure compounds identical to cephalochromin (116). 
8.3.2 Chromatography of Fox 35-2-5 
The EtOAc extract was taken to dryness under vacuum and redissolved in MeOH (50 
mg/mL). An aliquot (200 ~L) was loaded onto a Sephadex LH20 column (1 g, 0.5 x 7.5 
em) equilibrated to 100 % MeOn and eluted with 100 % MeOH collecting six fractions 
(1 mL). To obtain enough sample mass this was repeated five times. Examination by 
1 II NMR spectroscopy located cephalochromin (116) in the fourth and fifth fractions 
(RKP 1.186.4-5). 
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Compound (116) 
HR ESIMS MH+ 519.1297 (C28H230 lO requires 519.1291). IH NMR (DMSO-d6) () 
15.1(s,2H, 50H), 10.1 (s, 2H, 60H), 9.9 (s, 2H, 80H), 6.52 (s, 2H, H7), 5.72 (s, 2H, 
HI0), 4.55 (ddq, JHH = 3,6,12.5 Hz, 2H, H2), 2.93 (dd, JHH = 12.5,17.5 Hz, 2H, H3~), 
2.74 (dd, JHH = 3, 17.5 Hz, 2H, H3~), 1.37 (d, JHH = 6 Hz, 6H, llMe). DC NMR 
(DMSO-d6) () 198.2 (C4), 164.9 (C5), 160.1 (C8), 158.7 (C6), 155.0 (C10a), 141.6 
(C9a), 107.2 (C9), 104.3 (C5a), 101.7 (C4a), 100.1 (C7), 98.6 (ClO), 73.0 (C2), 42.8 
(C3), 20.6 (C11). UV (MeOH, run) 234, 272, 294,328,422. CD (MeOH 0.01 mg/mL) 
294 run (8 45 x 104),266 run (8 -35 x 104). 
8.4 Experimental for Chapter 5 
8.4.1 Chromatography of Gil 12 .. 1-3 
The large scale EtOAc extract of Gil 12-1-3 was adsorbed to CI8 (2 g), loaded on a 
reverse phase (CIS) column (50 g, 3 x 60 cm) equilibrated to 10 % MeOHlH20 and 
eluted using the standard CIS elution profile (Section 8.1.7). Thirteen fractions were 
collected, assayed for cytotoxicity and examined by analytical reverse phase CIS HPLC. 
The cytotoxic fractions (RKP 1.93.4-5) eluted between 40 and 60 % MeOHlH20 and 
showed the bioactive peak eluting at 8.5 minutes in the HPLC trace. Thus they were 
combined. The combined fractions were adsorbed to DIOL (1 g) and further purified 
with normal phase (DIOL) column chromatography (12 g, 1.2 x 60 cm) using the 
standard DIOL elution profile (Section 8.1.7). Eleven fractions were collected, assayed 
for cytotoxicity and examined by reverse phase HPLC. Based on cytotoxicity and 
HPLC the fractions that eluted between 80 % EtOAc/DCM and 5 % MeOHlEtOAc 
(RKP 1.125.7-9) were combined. A IH NMR spectrum of the combined fractions 
showed the presence of phthalate plasticizers which were removed with another 
chromatographic step on a small scale normal phase (DIOL) column (1 g, 0.5 x7.5 cm) 
equilibrated to 100 % DCM (column C). The sample was eluted from this column with 
100 % DCM (3 x 1 mL), 100% EtOAc (3 x 1 mL) and 100% MeOH (3 x 1 mL) 
collecting any coloured bands as they eluted. An intense yellow band (RKP 1.171.3) 
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eluted in EtOAc and was subsequently identified with 2D NMR experiments and mass 
spectrometry as a novel altersolanol (141). 
Chromatography of the side fractions 
Before an identification had been made it was believed that more of 141 would be 
required for an identification thus all cytotoxic side fractions from the first round of 
chromatography were combined, adsorbed to DIOL (1 g) and purified on a normal 
phase (DIOL) column (12 g, 1.2 x 60 cm) equilibrated to 100 % DCM. The side 
fractions were eluted with the standard DIOL elution profile collecting eleven fractions 
which were examined by I-IPLC only. Three yellow fractions which showed the 
bioactive peak eluting at 8.5 minutes in the HPLC trace were combined with the 
bioactive chemical screening fractions of the small scale extract and purified on normal 
phase DIOL (l2 g, 1.2 x 60 cm) equilibrated to 100 % DCM (column E). The 
combined fractions were eluted with 100 % DCM (l00 mL), 100 % EtOAc (l00 mL) 
and 100 % MeOH (100mL). Bands of colour were collected as they eluted, then 
examined by HPLC and the fractions containing the bioactive peak (RKP 2.229.2-3) 
were further purified on another small scale normal phase (DIOL) column (1 g, 0.5 x7.5 
cm) with the same elution proftle used for column C. Nine fractions were collected and 
examined by NMR spectroscopy which showed that RKP 2.234.6 was the only fraction 
containing 141 and as such this fraction was combined with the earlier fraction RKP 
1.171.3 to give RKP 2.257.1. 
After combining the fractions a number of new signals were observed in the IH NMR 
spectrum, thus the combined sample (RKP 2.257.1) was subjected to a final purification 
step on analytical reverse phase (CIS) HPLC. RKP 2.257.1 was purified using the same 
gradient solvent system that was used for the microtitre plate screen (Section 8.1.6) and 
collecting the bioactive peak (8.5 minutes) as it eluted. 
Compound (141) 
HR ESIMS MNa+ 359.0743 (C16H160sNa requires 359.0743). IH NMR (CD30D) 0 
7.15 (d, JHH = 2.5 Hz, 1H, H8), 6.74 (d, J HH = 2.5 Hz, lH, H6), 4.73 (d, JHH = 7 Hz, lH, 
H4), 4.51 (s, 1H, Hl), 3.91 (s, 3H, OMe7), 3.84 (d, JHH = 7 Hz, lH, H3), 1.42 (s, lH, 
2Me). IJ-1 NMR (DMSO-d6) 0 12.12 (s, lH, 50H), 7.12 (d, JHH = 2 Hz, JH, H8), 6.94 
(d, JHH = 2 Hz, lH, H6), 5.79 (d, JHH = 6 Hz, 1H, lOB), 5.14 (d, JHH = 6 Hz, lH, 40H), 
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5.00 (d, JHH = 7 Hz, 1H, 30H), 4.58 (t, JHH = 6.5, 7 Hz, IH, H4), 4.56 (s, IH, 20H), 
4.42 (d, JHH = 6 Hz, 1H, HI), 4.01 (s, 3H, 70Me), 3.73 (t, Jilli = 6.5, 7 Hz, 1H, H3), 
1.34 (s, 3H, 2Me). UV (MeOH, nm) 220, 268, 434. 
8.5 Experimental for Chapter 6 
8.5.1 Chromatography of the first Fox 21-2-6a extract 
The first extract of Fox 2l-2-6a was adsorbed to CIS (2 g) and fractionated on a reverse 
phase (CIS) column (50 g, 3 x 60 cm) equilibrated to 10 % MeOHlH20. The extract 
was eluted from the CIS column using the standard elution profile (Section 8.1.7) with a 
total of fourteen fractions collected. The fourteenth fraction eluted with 100 % MeOH 
containing 0.05 % TF A. Fractions eight to eleven (RKP 1.57.8-11) showed peaks that 
eluted between 10 and 12 minutes and had previously been shown to be bioactive. 
These fractions were also the only ones to possess cytotoxicity. Based on the 
cytotoxicity and HPLC traces fractions eight and nine (RKP 1.57.8-9) were combined as 
were fractions ten and eleven (RKP 1.57.10-11). 
The first combined fraction (RKP 1.57.8-9) was fractionated on a normal phase (DIOL) 
column (12 g, 1.2 x60 cm) and eluted with the standard DIOL elution profile (Section 
8.1.7). Eleven fractions were collected from this column, but none showed cytotoxicity 
and thus these fractions were not examined further. 
The second combined fraction (RKP 1.57.10-11) was also purified on a normal phase 
(DIOL) column with the standard elution profile and again, eleven fractions were 
collected. Cytotoxicity was observed in all but the first fraction and analytical reverse 
phase (CIS) HPLC showed that the fractions contained the appropriate peaks responsible 
for the cytotoxicity. Based on HPLC traces and cytotoxicity data fractions two to nine 
(RKP 1.124.2-9) were combined. The combined fractions (RKP 1.124.2-9), fraction 
one (RKP 1.124.1) and fraction eleven (RKP 1.124.11) were chromatographed on three 
separate Sephadex LH20 (20 g, 1.2 x 60 cm) columns. The three LH20 columns were 
all eluted with 100 % MeOH collecting bands of colour as they eluted. Five fractions 
were collected from each LH20 column with colour observed in the second and fourth 
fractions of each column. However, only one fraction (RKP 2.245.2) possessed any 
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significant cytotoxicity, but the mass was too low for this fraction to be examined 
further. 
8.5.2 Chromatography of the second Fox 21-2-6a extract 
The second crude extract of Fox 21-2-6a was adsorbed to CI8 (5 g) and fractionated on a 
reverse phase (CIS) column (50 g, 3 x 60 cm) conditioned to 10 % MeOH/H20. The 
extract was eluted from the column using the standard elution profile developed for C18, 
but the final two fractions also contained 0.05 % TFA. Based on the chromatographic 
steps used for the first extract of Fox 21-2-6a the fractions were combined as follows: 
Fractions one to seven (RKP 2.267.1-7), fractions eight to eleven (RKP 2.267.8-11) and 
fractions twelve and thirteen (RKP 2.267.12-13). A very high level of cytotoxicity was 
seen in the second (RKP 2.267.8-11) and third (RKP 2.267.12-13) set of combined 
fractions from the CIS column, but no cytotoxicity was observed in the first set of 
fractions (RKP 2.267.1-7). 
RKP 2.267.12-13 
This combined fraction was adsorbed to DIOL (5 g), loaded onto a nonnal phase 
(DIOL) column (40 g, 1.2 x 60 cm) equilibrated to 100 % Pet. Ether and eluted with the 
following gradient solvent system: 100 % PE, 20 %, 40 %, 60 %, 80 %, 90 %, 100 % 
DCM/PE, 20 %, 40 %, 60 %, 80 %, 90 %, 100 % EtOAc/DCM, 20 %, 50 %, 100 %, 
MeOH/EtOAc (70 mL). Of the sixteen fractions collected fractions six to sixteen (RKP 
2.270.6-16) all contained cytotoxic components. 
Analysis of the first five cytotoxic fractions (RKP 2.270.6-10) with IH NMR 
spectroscopy showed a very high level of fatty acids which were unable to be removed 
from the fractions thereby preventing further purification of these fractions. 
Analytical reverse phase (CIS) HPLC analysis of fractions eleven to fourteen (RKP 
2.270.11-14) showed a single common component eluting at 11.5 minutes and as such 
these four fractions were combined. NMR spectroscopy of this combined fraction 
highlighted the presence of fatty acids which were removed by taking the fraction to 
dryness under vacuum and washing twice with 100 % Pet Ether (2 mL). The remaining 
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MeOH soluble residue was combined with a fraction (RKP 2.307.8-15) from another 
column. 
Analytical HPLC and NMR spectroscopy indicated that the last two fractions (RKP 
2.270.15-16) from this column contained common components which were also shown 
to be identical to those seen in fractions from a later DIOL column (RKP 2.307.18-28) 
and as such all these fractions were combined. 
RKP 2.267.8-11 
This combined fraction was adsorbed to DIOL (5 g), loaded onto a normal phase 
(DIOL) column (40 g, 1.2 x 60 cm) equilibrated to 100 % Pet. Ether and eluted with the 
following gradient solvent system: 100 % Pet. Ether (100 mL), 10 %, 20 %, 40 %, 60 
%,80 %,100 % DCM!Pet. Ether, 10 %, 20 %, 40 %,60 %,80 %,100 % EtOAc!DCM, 
10 %, 20 %, 40 %, 60 %, 80 % MeOHIEtOAc (70 mL). Of the twenty fractions 
collected cytotoxicity was observed in fraction nine (RKP 2.274.9) onwards. 
Reverse phase HPLC analysis of fractions ten to thirteen (RKP 2.274.10-13) showed a 
single comnlon component eluting at 13.5 minutes thus these four fractions were 
combined. Fractions fourteen and fifteen (RKP 2.274.14-15) also showed a common 
component eluting at 13.5 minutes in the HPLC trace, but were combined with a 
fraction from a later column (RKP 2.309.2-3). The last four cytotoxic fractions from 
this column (RKP 2.274.16-20) all showed a similar series of peaks eluting between 9 
and 15 minutes in the HPLC and as such were combined. 
RKP 2.274.10-13 
This combined fraction was adsorbed to DIOL (100 mg), loaded onto a small nonnal 
phase (DIOL) column (1 g, 0.5 x 7.5 cm) equilibrated to 100 % Pet. Ether and eluted 
with the following gradient solvent system: 100 % DCM (2 x 1.6 mL), 100 % MeOH (3 
x 1.6 mL). Five fractions were collected and examined by analytical reverse phase (CIS) 
HPLC and IH NMR spectroscopy. Fractions two (RKP 2.303.2) and four (RKP 
2.303.4) were both intensely coloured, but HPLC and NMR spectroscopy of fraction 
two indicated a large mass of fatty acids present. HPLC and NMR analysis of the 
fourth fraction (RKP 2.303.4) indicated the presence of two compounds and thus this 
fraction was further purified on another small nonnal phase (DIOL) column. 
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RKP 2.303.4 
This fraction was adsorbed to DIOL (100 mg), loaded onto a small nonnal phase 
(DIOL) column (1 g, 0.5 x 7.5 cm) equilibrated to 100 % DCM and eluted with the 
following gradient solvent system: 100 % DCM (7.2 mL), 100 % EtOAc (2.4 mL) 20 % 
MeOHIEtOAc (1.6 mL), 50 % MeOHIEtOAc (3.2 mL). Five fractions were collected 
and analysed by analytical reverse phase (CI 8) HPLC and IH NMR spectroscopy. 
Fractions two (RKP 2.309.2) and four (RKP 2.309.4) were both intensely coloured and 
HPLC and NMR analysis of both fractions showed a high level of purity. The second 
fraction (RKP 2.309.2) was combined with fractions (RKP 2.274.14-15) from an earlier 
column, taken to dryness under vacuum and washed with 10 mL Pet. Ether to remove 
any residual fatty acids. The MeOH soluble residue (RKP 2.348.2) was identified by 
NMR spectroscopy and mass spectrometry as I-hydroxyaclacinomycin T (155). 
The fourth fraction (RKP 2.309.4) was combined with fractions from two other 
chromatographic sequences (RKP 2.270.11-14 and RKP 2.307.8-15). 
RKP 2.274.16-20 
The last of the fractions from the DIOL column ofRKP 2.267.8-11 (RKP 2.274.16-20) 
were taken to dryness under vacuum and washed with 100 % Pet. Ether. The MeOH 
soluble residue was adsorbed to DIOL (0.5 g) and loaded onto a nonnal phase (DIOL) 
column (20 g, 0.5 x 100 cm) equilibrated to 10 % MeOHIEtOAc and eluted with the 
following gradient solvent system: 10 - 25 % MeOH/EtOAc (18 mL) in 1 % increments, 
25 - 50 % MeOH/EtOAc (18 mL) in 5 % increments, 100 % MeOH (5 x 18 mL). 
Twenty eight fractions were collected, analysed by analytical reverse phase HPLC and 
examined with IH NMR spectroscopy. The gradient elution profile used for analytical 
HPLC of these twenty eight fractions is as follows: 2 minutes of 40 % ACNIH20; a 
linear gradient to 70 % ACN/H20 for 8 minutes; isocratic at 75 % for 3 minutes; a 
linear gradient for 2 minutes to 100 % ACN followed by isocratic at 100 % ACN for 3 
minutes then returned to 40 % ACN/H20 in 1 minute and re-equilibrated for 4 minutes; 
with a flow rate 1 mUmin. 
RKP 2.307.1-7 
The first seven fractions (RKP 2.307.1-7) from this column contained a high level of 
fatty acids thus these fractions were not examined further. 
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RKP 2.307.8-15 
The next eight fractions (RKP 2.307.8-15) showed a single common component eluting 
at 6.5 minutes and showed identical IH NMR spectra to RKP 2.309.4 and RKP 
2.270.11-14 and as such these fractions were all combined. The combined fractions 
were taken to dryness under vacuum and washed with 100 % Pet. Ether to remove any 
residual fatty acids. The major component of this fraction was identified by 1D and 2D 
NMR spectroscopy and mass spectrometry as the novel pynomycin derivative, 9-epi-
pynomycin (154). 
RKP 2.307.18-28 
Analytical HPLC analysis of the last eleven fractions showed a number of common 
components eluting between 4 and 7 minutes which were also seen in fractions from an 
earlier DIOL column (RKP 2.270.15-16) and as such these fractions were combined. 
The combined fractions were dissolved in a minimum volume of MeOH, loaded onto a 
Sephadex LH20 column (20 g, 1.2 x 60 cm) equilibrated to 100 % MeOH and eluted 
with 100 % MeOH. Fractions were collected based on colour, but only one band of 
colour was observed (RKP 2.320.2) eluting from this column 
RKP 2.320.2 
Analytical reverse phase CIS HPLC of RKP 2.320.2 indicated that there were at least 
five major components in this fraction all with the same UV spectra and all eluting 
within two minutes of each other. The final purification of this fraction was canied out 
on analytical reverse phase (CIS) HPLC. The fraction was eluted with an isocratic 
solvent system of 32 % ACN/H20 and the individual components (compounds 154 and 
156 - 159) were collected as they eluted. 
Compound (154) 
HR ESIMS MH'- 586.2297 (C30H36NOll requires 586.2288). lH NMR (CD30D) 87.51 
(s, 1H, Hll), 7.08 (s, 2B, H2 H3), 5.56 (d, JHH = 2.5 Hz, IH, HI'), 5.10 (d, JHH = 5 Hz, 
1H, H7), 4.26 (g, J HH = 6.5, 13 Hz, HI, H5'), 4.07 (s, 1H, HID), 3.96 (s, 1H, H4'), 3.75 
(s, 3H, 140Me), 3.52 (m, 1H, H3'), 2.87 (s, 6H, 7'N(Me)2), 2.56 (dd, JHH = 5, 15 Hz, 
1H, H8ax), 2.28 (d, JHH = 15 Hz, 2H, H8eq H2'ax), 2.08 (dt, J HH = 4, 12.5 Hz, 1H, 
H2'eq), 1.76 (m, HI, H15a), 1.56 (m, HI, H15~), 1.33 (d, JHH = 6 Hz, 3R, 6'Me), 1.11 
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(t, J HH = 7 Hz, 3H, l6Me). l3C NMR (CD30D) 0 191.6 (C5), 186.7 (e12), 172.8 (C13), 
163.6 (C6), 159.4 (C1), 159.0 (C4), 144.1 (C10a), 133.8 (Clla), 133.1 (C6a), 131.5 
(C3), 131.1 (C2), 121.2 (C11), 116.0 (C5a), 113.4 (C12a, C4a), 101.9 (C1'), 72.9 (C7), 
72.2 (C9), 68.2 (C5'), 66.1 (C4'), 63.9 (C3'), 58.5 (CIO), 53.5 (C14 OMe), 40.7 (NMe), 
36.2 (C8), 33.6 (C15), 28.1 (C2'), 17.2 (C6'), 7.5 (C16). UV (MeOH, run) 202,234, 
258,290,492. [a]D = +128.0° (0.25 mg/mL, MeOH). 
Compound (155) 
HR ESIMS NIH+ 826.3280 (C42Hs2N016 requires 826.3286). IH NMR (CDCb) 07.70 
(s, 1H, H11), 7.29 (s, 2H, H2 H3), 5.55 (br s, 1H, HI'), 5.26 (br s, 1H, HI"), 5.24 (br s, 
1H, H7), 5.16 (d, JHH = 3 Hz, 1H, HI"'), 4.81 (q, JHH = 7 Hz, HI, H5'), 4.53 (br s, 1H, 
H5"), 4.43 (br d, 1H, H3"), 4.34 (d, JHH = 3.5 ilz, 1H, H2"'), 4.09 (s, 1H, HIO), 4.06 (br 
s, 1H, H4"), 4.05 (br s, 1H, H5"'), 3.97 (br s, 1H, H4), 3.70 (s, 3H, 140Me), 3.48 (br, 
1H, H3'), 2.59 (br t, 1 H, H8ax), 2.55 (d, J HH = 4.5 Hz, 2H, H3"'), 2.50 (dd, JHH = 4.5, 
12.5, 1H, H2"eq), 2.35 (br s, 6H, 7'N(Meh) , 2.30 (br t, IH, H2'eq), 2.28 (br t, 2H, 
H8eq), 2.00 (dd, JHH = 4.5, 12.5, 1H, H2"ax), 1.76 (m, 1H, H15a), 1.58 (br s, HI, 
H2'ax), 1.52 (m, 1H, H15~), 1.33 (d, J HH = 7 Hz, 6H, H6', H6'"), 1.21 (d, JHH = 7 Hz, 
3H, H6"), 1.09 (t, JHH = 7.5 Hz, 3H, 16Me). DC NMR (CDCh) 0 208.0 (C4"'), 190.4 
(C5), 185.7 (C12), 171.0 (C13), 162.1 (C6), 158.5 (C4), 157.9 (C1), 142.2 (C10a), 
133.0 (Cl1a), 130.7 (C6a), 130.2 (C3), 129.9 (C2), 120.2 (C11), 114.9 (C5a), 112.4 
(C12a), 112.2 (C4a), 101.2 (CI'), 99.1 (C1"), 91.5 (C1"'), 77.9 (C5'), 72.5 (C4'), 71.7 
(C9), 71.1 (C7), 67.6 (C5"'), 66.2 (C3", C4"), 65.8 (C5"), 62.8 (C2"'), 56.8 (C10), 52.5 
(C14 OMe) , 50.7 (C3'), 41.1 (C7' N(Meh) , 39.5 (C3"'), 33.9 (C8), 33.8 (C2'), 31.8 
(CI5), 26.3 (C2"), lS.0 (C6'), 15.9 (C6"'), 15.S (C6"), 6.7 (CI6). UV (MeOH, nm) 202, 
234, 25S, 290,492. 
Compound (156) 
HR ESIMS MH+ 572.2126 (C29H34NOll requires 572.2132). IH NMR (CD30D) 07.71 
(s, 1H, H1l), 7.38 (s, 2H, H2 H3), 5.51 (d, JHH = 3 Hz, lH, HI'), 5.14 (d, JHH = 4.5 Hz, 
lH, H7), 4.24 (q, JHH = 7, 13.5 Hz, 1H, H5'), 4.10 (s, 1H, HIO), 3.92 (s, 1H, H4'), 3.68 
(s, 3H, 140Me), 3.52 (m, IH, H3'), 2.60 (s, 3H, 7'NMe), 2.49 (dd, JHH = 5.5, 15 Hz, 1H, 
HSax), 2.31 (m, 2H, HSeq, H2'ax), 1.90 (m 1H, H2'eq), 1.76 (m, 1H, H15a), 1.54 (m, 
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lR, HI5~), 1.29 (d, Jm! = 6.5 Hz, 3H, 6'Me), 1.08 (t, JHH = 7 Hz, 3H, 16Me). UV 
(MeOH, run) 202, 234, 258, 290, 492. 
Compound (157) 
HR ESIMS MH+ 586.2290 (C30H36NOll requires 586.2288). lH NMR (CD30D) 07.60 
(5, IH, Hll), 7.38 (5, 2H, H2 H3), 5.58 (br 5, IH, H1 '),4.96 (t, JHH = 2.5 Hz, IH, H7), 
4.17 (q, JHH = 7, 12.5 Hz, IH, H5'), 3.99 (5, IH, HlO), 3.95 (br 5, IH, H4'), 3.78 (5, 3H, 
140Me), 3.52 (br d, JHH = 11 Hz, IH, H3'), 2.91 (5, 3H, 7'NMe), 2.85 (5, 3H, 7'NMe), 
2.62 (dd, JHH = 7.5, 14 Hz, IH, H8ax), 2.32 (dd, JHH = 8, 14 Hz, IH, H8eq), 2.29 (dd, 
J HH = 8,14 Hz, IH, H2'ax), 2.06 (br 5, IH, H2'eq), 1.49 (m, 2H, HI5), 1.33 (d, JHH = 6 
Hz, 3H, 6'Me), 0.98 (t, JHH = 7 Hz, 3H, 16Me). UV (MeOH, nm) 202, 234, 258, 290, 
492. [a]D = +224.0° (0.125 mg/mL, MeOH). 
Compound (158) 
HR ESJMS MH+ 572.2138 (C29H34NOll requires 572.2132). IH NMR (CDJOD) 07.67 
(5, 1H, Hll), 7.37 (5, 2H, H2 H3), 5.56 (br 5, IH, HI '), 5.13 (d, JHH = 5 Hz, IH, H7), 
4.24 (q, JHH = 7.5, 14 Hz, IH, H5'), 4.09 (5, IH, HlO), 3.91 (br 5, IH, H4'), 3.71 (5, 3H, 
140Me), 3.46 (br d, JHH = 11.5 Hz, IH, H3'), 2.88 (br 5, 3H, 7'NMe), 2.78 (br 5, 3H, 
7'NMe), 2.58 (dd, JHH = 6,15 Hz, IH, H8ax), 2.20 (d, JHH = 15 Hz, IH, H8eq), 2.15 (m, 
IH, H2'ax), 2.02 (dt, JHH = 3.5, 12.5 Hz, IH, H2'eq), 1.38 (5, 3H, 16Me), 1.31 (d, JHH = 
6.5 Hz, 3H, 6'Me). UV (MeOH, nm) 202, 234, 258, 290, 492. 
Compound (159) 
HR ESIMS MH+ 614.2237 (C31H36N012 requires 614.2238). lH NMR (CD30D) 07.71 
(5, lH, fIll), 7.36 (5, 2H, H2 H3), 5.49 (br 5, IH, H1'), 5.10 (hr 5, 1H, H7), 4.26 (q, JHH 
= 7, 13 Hz, IH, H5'), 4.24 (5, IH, HlO), 3.93 (hr 5, tH, H4'), 3.71 (5, 3H, 140Me), 3.46 
(br d, JHH = 11.5, IH, H3'), 3.04 (d, JHH = 16.5 Hz, IH, HI5a), 2.88 (br 5, 3H, 7'NMe), 
2.77 (br 5, 3H, 7'NMe), 2.66 (d, JmI = 16.5 Hz, IH, HI5~), 2.53 (hr 5, 2H, H8), 2.25 (5, 
3R, 17Me), 2.15 (m, IH, H2'ax), 2.03 (m, ]H, H2'eq), 1.32 (d, JHH = 6.5 Hz, 3H, 6'Me). 
UV (MeOH, nm) 202, 234, 258, 290,492. 
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8.6 Experimental for Chapter 7 
8.6.1 Chromatography of Kai 11-2-1 
The crude large scale extract was adsorbed to CIS (2 g) and purified with reverse phase 
(CIS) column chromatography and eluted with the standard Cl8 elution profile (Section 
8.1. 7) collecting thirteen fractions. Cytotoxicity was observed in almost all fractions 
from the third fraction to the last fraction, but was concentrated in fractions seven and 
eight (RKP 1.46.7-8). Based on cytotoxicity and analytical reverse phase CIS HPLC 
fractions seven and eight were combined then further purified with normal phase 
(DIOL) chromatography (12g, 1.2 x 60 cm). The combined fraction (RKP 1.46.7-8) 
was eluted using the standard column elution profile described in Section 8.1.7, but the 
first fraction was split into two as an intensely coloured band eluted within this fraction. 
The second fraction (RKP 1.109.2) was identified by IH NMR spectroscopy and MS as 
actinomycin V (X2) (177) and the fourth fraction was identified as actinomycin Xo (178) 
from mass spectrometry. 
Compound (177) 
HR ESIMS MH' 1269.6134 (C62H8SN12017 requires 1269.6156). IH NMR (CDCh) 
8.19 (d, J HH = 6 Hz, IH, P Val NH), 7.67 (d, J HH = 6 Hz, IH, P Thr NH), 7.65 (d, J HH = 
5.5 Hz, IH, a Val NIl), 7.60 (d, JHH = 7.5 Hz, HI, H8), 7.35 (d, JHH = 8 Hz, IH, H7), 
7.19 (d, JHH = 7.5 Hz, IH, a Thr NIl), 6.55 (d, JHH = 1, 10 Hz, Ill, p Pro H2), 5.95 (d, 
JHH = 1,9 Hz, IH, a Pro H2), 5.22 (dd, J HH = 2.5,6 Hz, IH, P Thr H3), 5.14 (dd, JHH = 
2.5, 6 Hz, IH, a Thr H3), 4.70 (d, JHH = 17.5 Hz, IH, a Sar H2a), 4.58 (d, JHH = 17.5 
Hz, IH, p Sar H2a), 4.55 (d, JHH = 19 Hz, IH, p Pro H5a), 4.55 (dd, Jmr = 2.5,5.5 Hz, 
IH, a Thr H2), 4.47 (dd, JHH = 2, 5.5 Hz, IH, P Thr H2), 3.96 (m, J HH = 19 Hz, IH, p 
Pro H5P), 3.88 (m, JHH = 6.5, 10.5, 11 Hz, Ill, a Pro H5P), 3.84 (dd, J HH = 11, 18 Hz, 
IH, P Pro 113 a), 3.71 (m, JHH = 1, 9, 11 Hz, IH, a Pro H5a), 3.69 (q, JHH = 6.5, 10 Hz, 
IH, P Val H2), 3.63 (d, JHH = 17 Hz, IH, a Sar H2P, P Sar H2P), 3.56 (q, JHH = 6,9.5 
Hz, IH, a Val H2), 2.93 (s, 3H, P Val NMe), 2.92 (s, 3H, a Val NMe), 2.88 (s, 3H, P 
Sar NMe), 2.87 (s, 3H, a Sar NMe), 2.74 (m, IH, a Pro H3a), 2.69 (m, JHH = 6,6 Hz, 
2H, P NMe Val H2, P NMe Val H3), 2.64 (m, JHH = 5.5, 6 Hz, 2H, a NMe Val H2, a 
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NMe Val ill), 2.54 (s, 3H, H12), 2.30 (d, JHH = 1, 18 Hz, IH, ~ Pro H3~), 2.27 (m, IH, 
a Pro H4a), 2.21 (s, 3H, H11), 2.21 (m, JHH = 7, 7.5, 10 Hz, 1H, ~ Val H3), 2.11 (m, 
JHH = 7, 7, 9.5 Hz, lH, a Val H3), 2.07 (m, 1H, a Pro H4~), 1.83 (m, JHH = 1, 7,12 Hz, 
1H, a Pro H3~), 1.24 (d, JHH = 6.5 Hz, 3H, ~ Thr H3), 1.14 (d, J HH = 7 Hz, 3H, ~ Val 
H4), 1.13 (d, JHH = 6 Hz, 3H, a Thr H3), 1.11 (d, JHH = 7 Hz, 3H, a Val H4), 0.97 (d, 
J HH = 6 Hz, 3H, ~ Val H4), 0.93 (d, JHH = 6 Hz, 3H, a Val H4), 0.90 (d, JHH = 7.5 Hz, 
3H, a Val H3), 0.89 (d, JHH = 7 Hz, 3H, ~ Val H3), 0.74 (d, JHH = 5.5 Hz, 3H, ~ Val 
H5), 0.73 (d, JHH = 5.5 Hz, 3H, a Val H5). BC NMR (CDCh) 208.8 (~ Pro C4), 179.0 
(C3), 174.0 (~ Val Cl), 173.5 (a Val C1), 173.1 (a Pro Cl), 172.7 (~ Pro Cl), 168.9 (~ 
Thr C1), 168.7 (a Thr CI), 167.5 (a NMe Val CI, ~ NMe Val Cl), 166.5 (C14), 166.3 
(a Sar C1), 166.0 (C13), 165.9 (~ Sar C1), 147.6 (C2), 145.9 (C10a), 145.0 (C4a), 
140.5 (C5a), 132.1 (C9), 130.3 (C7), 129.1 (C9a), 127.8 (C6), 126.2 (C8), 113.5 (C4), 
101.7 (Cl), 74.7 (a Thr C3), 74.6 (~Thr C3), 71.4 (~NMe Val C2), 71.2 (a NMe Val 
C2), 58.5 (a Val C2), 57.1 (~ Val C2), 56.4 (a Pro C2), 54.9 (~ Thr C2), 54.7 (a Thr 
C2), 54.2 (~ Pro C2), 52.8 (~Pro C5), 51.3 (a Sar C2, ~ Sar C2), 47.4 (a Pro C5), 41.9 
(~Pro C3), 39.4 (~NMe Val NCH3) , 39.2 (aNMe Val NCH3), 34.9 (a Sar NCH3), 34.7 
(~Sar NCH3), 31.8 W Val C3), 31.7 (a Val C3), 31.0 (a Pro C3), 26.9 W NMe Val C3), 
26.8 (a NMe Val C3), 22.9 (a Pro C4), 21.7 (~ NMe Val C4), 21.5 (a NMe Val C4), 
19.2 (a Val C4), 19.1 (~ Val C4, ~ NMe Val C5), 19.0 (a NMe Val C5), 18.9 (a Val 
C5), 18.8 (~ Val C5), 17.7 (~ Thr C4), 17.1 (a Thr C4), 15.0 (C12), 7.7 (C11). UV 
(MeOH, run) 200, 240, 427, 442. 
8.6.2 Chromatography of Kai 40-1-1 and 84 
These two extracts underwent identical purification steps. Powdered extracts (5 g) of 
these two micro-organisms were re-suspended in distilled water (l00 mL) then adsorbed 
to reverse phase C 18 (50 g) and fractionated by vacuum liquid chromatography (VLC). 
The extracts were eluted with 100 % H20 (200 mL), 100 % MeOH (100 mL) and 100 % 
DCM (100 mL) collecting three fractions. Significant cytotoxicity was only seen in the 
second fractions (RKP 1.3.3 and RKP 1.3.4) of both extracts. These fractions were 
adsorbed to C18 (2 g) and loaded onto reverse phase CI 8 columns (50 g, 3 x 60 cm) 
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equilibrated to 10 % MeOH/H20 (column B). Column B was eluted with the standard 
CI8 elution profile (Section 8.1.7) with thirteen fractions collected, assayed for 
cytotoxicity and examined by HPLC. Both extracts showed cytotoxicity from the fifth 
fraction onwards, but this cytotoxicity was concentrated in fractions seven and eight 
(RKP 1.44.7-8 and RKP l.5l.7-8 respectively). These fractions were subsequently 
combined and further purified on nonnal phase (DIOL) columns (10 g, l.2 x 60 cm) 
equilibrated to 100 % DCM. Both combined fractions were eluted with 100 % DCM 
(30 mL), 100 % EtOAc (30 mL) and 100 % MeOH (30 mL) collecting bands of colour 
as they eluted. The major principle in both of the second fractions (RKP 2.212.5 and 
RKP 2.212.2) was identified by IH NMR spectroscopy and MS as actinomycin D (179). 
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